NCT Number,Study Title,Study URL,Study_Status,Study Type
NCT03978546,Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study),https://clinicaltrials.gov/study/NCT03978546,COMPLETED,INTERVENTIONAL
NCT03978546,Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study),https://clinicaltrials.gov/study/NCT03978546,COMPLETED,INTERVENTIONAL
NCT03868462,Optos P200TE Agreement and Precision Study,https://clinicaltrials.gov/study/NCT03868462,COMPLETED,INTERVENTIONAL
NCT02338362,Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma,https://clinicaltrials.gov/study/NCT02338362,COMPLETED,INTERVENTIONAL
NCT03921372,Isometric Exercise in NTG,https://clinicaltrials.gov/study/NCT03921372,COMPLETED,INTERVENTIONAL
NCT01912638,Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma,https://clinicaltrials.gov/study/NCT01912638,COMPLETED,INTERVENTIONAL
NCT03756662,Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery,https://clinicaltrials.gov/study/NCT03756662,COMPLETED,INTERVENTIONAL
NCT00140062,Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.,https://clinicaltrials.gov/study/NCT00140062,COMPLETED,INTERVENTIONAL
NCT00913562,Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma,https://clinicaltrials.gov/study/NCT00913562,WITHDRAWN,INTERVENTIONAL
NCT02384772,Survey of Patients Taking IOP-Lowering Eye Drops,https://clinicaltrials.gov/study/NCT02384772,COMPLETED,OBSERVATIONAL
NCT01180062,Safety Study of Latanoprost Slow Release Insert,https://clinicaltrials.gov/study/NCT01180062,TERMINATED,INTERVENTIONAL
NCT00956462,Steroids Versus Non-steroidal Anti-inflammatory Drugs Following Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00956462,UNKNOWN,INTERVENTIONAL
NCT01363362,Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma,https://clinicaltrials.gov/study/NCT01363362,COMPLETED,INTERVENTIONAL
NCT02028572,Structure Function Correlation in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02028572,COMPLETED,OBSERVATIONAL
NCT03691662,A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study,https://clinicaltrials.gov/study/NCT03691662,COMPLETED,INTERVENTIONAL
NCT01348672,Prospective Study Phase: Retinal Oxygen Saturation Blood Flow Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye,https://clinicaltrials.gov/study/NCT01348672,UNKNOWN,OBSERVATIONAL
NCT00533962,IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00533962,UNKNOWN,INTERVENTIONAL
NCT04019210,Modified Trabeculectomy for Glaucoma Surgery,https://clinicaltrials.gov/study/NCT04019210,UNKNOWN,INTERVENTIONAL
NCT05532410,Optic Disc Photograph Collection Study,https://clinicaltrials.gov/study/NCT05532410,COMPLETED,INTERVENTIONAL
NCT04912310,Efficacy Evaluation and Influencing Factors of Argon Laser Peripheral Iridoplasty in Acute Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT04912310,UNKNOWN,INTERVENTIONAL
NCT03797846,Comparison of Fixation Suture Type in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT03797846,COMPLETED,INTERVENTIONAL
NCT00750646,Observational Study of How Patients Take Eye Drops,https://clinicaltrials.gov/study/NCT00750646,UNKNOWN,OBSERVATIONAL
NCT01282346,SOLX Gold Shunt for Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01282346,COMPLETED,INTERVENTIONAL
NCT03318146,Safety Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP,https://clinicaltrials.gov/study/NCT03318146,UNKNOWN,INTERVENTIONAL
NCT01637246,A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy,https://clinicaltrials.gov/study/NCT01637246,COMPLETED,OBSERVATIONAL
NCT03267862,Scleral Response to Intraocular Pressure (IOP),https://clinicaltrials.gov/study/NCT03267862,COMPLETED,OBSERVATIONAL
NCT05147610,Precision of the Icare200 for Measuring Intraocular Pressure,https://clinicaltrials.gov/study/NCT05147610,COMPLETED,INTERVENTIONAL
NCT01895972,Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT,https://clinicaltrials.gov/study/NCT01895972,COMPLETED,INTERVENTIONAL
NCT00892762,Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health,https://clinicaltrials.gov/study/NCT00892762,COMPLETED,INTERVENTIONAL
NCT00332072,Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332072,COMPLETED,INTERVENTIONAL
NCT02312362,High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP,https://clinicaltrials.gov/study/NCT02312362,UNKNOWN,INTERVENTIONAL
NCT00788762,Myocilin Variations and Familial Glaucoma in Taxiarchis,https://clinicaltrials.gov/study/NCT00788762,UNKNOWN,OBSERVATIONAL
NCT01781962,A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01781962,TERMINATED,OBSERVATIONAL
NCT03094910,Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon,https://clinicaltrials.gov/study/NCT03094910,COMPLETED,INTERVENTIONAL
NCT04202510,IOP and Medication Reduction in MIGS Procedures,https://clinicaltrials.gov/study/NCT04202510,WITHDRAWN,INTERVENTIONAL
NCT00345046,A Comparison of Three Different Formulations of Prednisolone Acetate 1%,https://clinicaltrials.gov/study/NCT00345046,COMPLETED,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05275738,The Glaucoma Nicotinamide Trial,https://clinicaltrials.gov/study/NCT05275738,RECRUITING,INTERVENTIONAL
NCT05392738,Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation,https://clinicaltrials.gov/study/NCT05392738,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT02279472,Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral Lridotomy,https://clinicaltrials.gov/study/NCT02279472,UNKNOWN,INTERVENTIONAL
NCT02865473,Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study,https://clinicaltrials.gov/study/NCT02865473,RECRUITING,INTERVENTIONAL
NCT05207761,Study to Evaluate Drug-drug Interaction Safety and Tolerability in Case of the Co-administration of D565 and D930,https://clinicaltrials.gov/study/NCT05207761,COMPLETED,INTERVENTIONAL
NCT01667861,Risk Factors for Glaucoma in Musicians,https://clinicaltrials.gov/study/NCT01667861,COMPLETED,OBSERVATIONAL
NCT01206361,Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products Duotrav And Ganfort In The United Kingdom,https://clinicaltrials.gov/study/NCT01206361,COMPLETED,OBSERVATIONAL
NCT04552964,Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma,https://clinicaltrials.gov/study/NCT04552964,COMPLETED,INTERVENTIONAL
NCT01068964,Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01068964,COMPLETED,INTERVENTIONAL
NCT02825264,STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program,https://clinicaltrials.gov/study/NCT02825264,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT01741961,Long Term Outcome After Ahmed Glaucoma Valve,https://clinicaltrials.gov/study/NCT01741961,COMPLETED,OBSERVATIONAL
NCT00802061,Sleep at 30 Degrees in Glaucoma,https://clinicaltrials.gov/study/NCT00802061,COMPLETED,INTERVENTIONAL
NCT01306461,Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations,https://clinicaltrials.gov/study/NCT01306461,COMPLETED,INTERVENTIONAL
NCT00825864,Diclofenac vs Dexamethasone in Combined Surgery,https://clinicaltrials.gov/study/NCT00825864,COMPLETED,INTERVENTIONAL
NCT04647461,Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4 Parallel Group Design Investigator-blind Active-control Randomized Multi-center Trial,https://clinicaltrials.gov/study/NCT04647461,UNKNOWN,INTERVENTIONAL
NCT00001161,Abnormalities of the Eye's Anterior Chamber Iris Cornea and Lens,https://clinicaltrials.gov/study/NCT00001161,COMPLETED,OBSERVATIONAL
NCT01157364,Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT01157364,COMPLETED,INTERVENTIONAL
NCT05495061,A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT05495061,COMPLETED,INTERVENTIONAL
NCT01310764,Trabeculectomy With Subconjunctival Bevacizumab Injection,https://clinicaltrials.gov/study/NCT01310764,COMPLETED,INTERVENTIONAL
NCT00853073,Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?,https://clinicaltrials.gov/study/NCT00853073,COMPLETED,INTERVENTIONAL
NCT04616573,A Post-market Study Of Use Of The OMNI® Surgical System In Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04616573,TERMINATED,INTERVENTIONAL
NCT02246764,Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02246764,COMPLETED,INTERVENTIONAL
NCT00443664,External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00443664,UNKNOWN,INTERVENTIONAL
NCT02024464,Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery,https://clinicaltrials.gov/study/NCT02024464,COMPLETED,INTERVENTIONAL
NCT04722861,Development of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric Properties,https://clinicaltrials.gov/study/NCT04722861,UNKNOWN,OBSERVATIONAL
NCT01426464,Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy,https://clinicaltrials.gov/study/NCT01426464,UNKNOWN,INTERVENTIONAL
NCT05696561,Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05696561,NOT_YET_RECRUITING,INTERVENTIONAL
NCT03270761,Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs),https://clinicaltrials.gov/study/NCT03270761,COMPLETED,OBSERVATIONAL
NCT02138461,Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops,https://clinicaltrials.gov/study/NCT02138461,COMPLETED,OBSERVATIONAL
NCT00971061,Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma,https://clinicaltrials.gov/study/NCT00971061,COMPLETED,INTERVENTIONAL
NCT01092273,Bimatoprost Versus Travoprost at Cairo University,https://clinicaltrials.gov/study/NCT01092273,COMPLETED,OBSERVATIONAL
NCT01212861,Surgical Treatment of Refractory Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01212861,COMPLETED,INTERVENTIONAL
NCT01263561,Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy,https://clinicaltrials.gov/study/NCT01263561,COMPLETED,INTERVENTIONAL
NCT05289453,Phacoemulsification in Acute Congestive Glaucoma,https://clinicaltrials.gov/study/NCT05289453,RECRUITING,INTERVENTIONAL
NCT04735653,The Support Educate Empower (SEE) Program,https://clinicaltrials.gov/study/NCT04735653,RECRUITING,INTERVENTIONAL
NCT00628173,Results of Different Location of Ahmed Glaucoma Valve Implantation in Refractory Glaucoma Superior Versus Inferior,https://clinicaltrials.gov/study/NCT00628173,COMPLETED,INTERVENTIONAL
NCT01863953,A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01863953,COMPLETED,INTERVENTIONAL
NCT01994564,Prevalence of Dyschromatopsia in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01994564,WITHDRAWN,OBSERVATIONAL
NCT01028664,Use of an Ocular Telemetry Sensor in Diamox Treated Patients,https://clinicaltrials.gov/study/NCT01028664,COMPLETED,INTERVENTIONAL
NCT06152861,Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT06152861,RECRUITING,INTERVENTIONAL
NCT00811564,An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects,https://clinicaltrials.gov/study/NCT00811564,COMPLETED,INTERVENTIONAL
NCT04098861,Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04098861,UNKNOWN,INTERVENTIONAL
NCT01714960,Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients,https://clinicaltrials.gov/study/NCT01714960,COMPLETED,INTERVENTIONAL
NCT02796560,Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02796560,COMPLETED,INTERVENTIONAL
NCT01192061,Autonomic Nervous System Activity and Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01192061,COMPLETED,OBSERVATIONAL
NCT01192061,Autonomic Nervous System Activity and Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01192061,COMPLETED,OBSERVATIONAL
NCT01192061,Autonomic Nervous System Activity and Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01192061,COMPLETED,OBSERVATIONAL
NCT05080153,Effect of Vitamin Supplementation in Glaucoma Patients,https://clinicaltrials.gov/study/NCT05080153,COMPLETED,OBSERVATIONAL
NCT03284853,Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03284853,COMPLETED,INTERVENTIONAL
NCT00519753,Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav,https://clinicaltrials.gov/study/NCT00519753,COMPLETED,INTERVENTIONAL
NCT01467453,Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement,https://clinicaltrials.gov/study/NCT01467453,UNKNOWN,OBSERVATIONAL
NCT01814761,A Study of Bimatoprost 0.01% in the Clinical Setting,https://clinicaltrials.gov/study/NCT01814761,COMPLETED,OBSERVATIONAL
NCT05401760,Combined Phacoaspiration and Angle Surgery Versus Phacoaspiration in Pediatric Cataract,https://clinicaltrials.gov/study/NCT05401760,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT03374553,MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications,https://clinicaltrials.gov/study/NCT03374553,COMPLETED,INTERVENTIONAL
NCT03966560,Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03966560,COMPLETED,INTERVENTIONAL
NCT04723160,Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph,https://clinicaltrials.gov/study/NCT04723160,COMPLETED,OBSERVATIONAL
NCT04723160,Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph,https://clinicaltrials.gov/study/NCT04723160,COMPLETED,OBSERVATIONAL
NCT02140060,6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02140060,COMPLETED,INTERVENTIONAL
NCT00763061,Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00763061,COMPLETED,INTERVENTIONAL
NCT00159653,A 12-Week Randomized Double-Masked Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma,https://clinicaltrials.gov/study/NCT00159653,COMPLETED,INTERVENTIONAL
NCT06077253,Danish Angle Closure Prevention Trial,https://clinicaltrials.gov/study/NCT06077253,RECRUITING,INTERVENTIONAL
NCT04454138,Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement,https://clinicaltrials.gov/study/NCT04454138,COMPLETED,OBSERVATIONAL
NCT01059162,Evaluation of OT-135P (IOPtiMateTM) : Beam Manipulating System for CO2 Laser Assisted Non-Penetrating Glaucoma Surgery,https://clinicaltrials.gov/study/NCT01059162,UNKNOWN,INTERVENTIONAL
NCT06017362,Clinical Trial To Determine The Efficacy And Safety Of Insulin Eye Drops In Dry Eye In Patients With Topical Hypotensors,https://clinicaltrials.gov/study/NCT06017362,RECRUITING,INTERVENTIONAL
NCT04202562,Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade,https://clinicaltrials.gov/study/NCT04202562,COMPLETED,INTERVENTIONAL
NCT04437446,OCT Angiography in the Glaucoma Diagnosis,https://clinicaltrials.gov/study/NCT04437446,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03752710,Biometry of Occult Lens Subluxation Misdiagnosed as Primary Acute Angle Closed Glaucoma,https://clinicaltrials.gov/study/NCT03752710,COMPLETED,OBSERVATIONAL
NCT00578110,Instrument for Glaucoma Early Detection and Monitoring,https://clinicaltrials.gov/study/NCT00578110,UNKNOWN,INTERVENTIONAL
NCT00578110,Instrument for Glaucoma Early Detection and Monitoring,https://clinicaltrials.gov/study/NCT00578110,UNKNOWN,INTERVENTIONAL
NCT00578110,Instrument for Glaucoma Early Detection and Monitoring,https://clinicaltrials.gov/study/NCT00578110,UNKNOWN,INTERVENTIONAL
NCT02051946,Novel Drug Delivery Technique Via Retroject Device,https://clinicaltrials.gov/study/NCT02051946,COMPLETED,INTERVENTIONAL
NCT02371746,Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02371746,COMPLETED,INTERVENTIONAL
NCT00545064,Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED),https://clinicaltrials.gov/study/NCT00545064,COMPLETED,INTERVENTIONAL
NCT00283764,Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device,https://clinicaltrials.gov/study/NCT00283764,WITHDRAWN,INTERVENTIONAL
NCT04274764,Screening and Intervention for Glaucoma and Eye Health Through Telemedicine,https://clinicaltrials.gov/study/NCT04274764,RECRUITING,INTERVENTIONAL
NCT04476810,Long Term Outcome of Combined Phacoemulsification and Excisional Goniotomy With the Kahook Dual Blade,https://clinicaltrials.gov/study/NCT04476810,COMPLETED,INTERVENTIONAL
NCT01194310,Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m,https://clinicaltrials.gov/study/NCT01194310,COMPLETED,OBSERVATIONAL
NCT00293761,A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00293761,COMPLETED,INTERVENTIONAL
NCT04317573,Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System,https://clinicaltrials.gov/study/NCT04317573,COMPLETED,INTERVENTIONAL
NCT02565173,Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02565173,COMPLETED,INTERVENTIONAL
NCT01404364,Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye,https://clinicaltrials.gov/study/NCT01404364,COMPLETED,INTERVENTIONAL
NCT04334564,Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome,https://clinicaltrials.gov/study/NCT04334564,UNKNOWN,INTERVENTIONAL
NCT03323164,Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study,https://clinicaltrials.gov/study/NCT03323164,COMPLETED,INTERVENTIONAL
NCT00947661,Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00947661,COMPLETED,INTERVENTIONAL
NCT01304264,Intraocular Pressure Blood Pressure Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01304264,COMPLETED,OBSERVATIONAL
NCT01304264,Intraocular Pressure Blood Pressure Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01304264,COMPLETED,OBSERVATIONAL
NCT04155164,Effect of Metformin on Visual Function in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT04155164,RECRUITING,INTERVENTIONAL
NCT01652664,Study of Travoprost Ophthalmic Solution 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients,https://clinicaltrials.gov/study/NCT01652664,COMPLETED,INTERVENTIONAL
NCT02114073,Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure,https://clinicaltrials.gov/study/NCT02114073,COMPLETED,INTERVENTIONAL
NCT01791673,Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01791673,COMPLETED,INTERVENTIONAL
NCT00815373,The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG),https://clinicaltrials.gov/study/NCT00815373,WITHDRAWN,INTERVENTIONAL
NCT00470964,Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients,https://clinicaltrials.gov/study/NCT00470964,COMPLETED,INTERVENTIONAL
NCT04736264,Malay Glaucoma Eye Study II Navigation Mobility and Reading Ability in Primary Glaucoma,https://clinicaltrials.gov/study/NCT04736264,RECRUITING,INTERVENTIONAL
NCT04736264,Malay Glaucoma Eye Study II Navigation Mobility and Reading Ability in Primary Glaucoma,https://clinicaltrials.gov/study/NCT04736264,RECRUITING,INTERVENTIONAL
NCT04465864,Investigate Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert,https://clinicaltrials.gov/study/NCT04465864,COMPLETED,INTERVENTIONAL
NCT01699464,A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months,https://clinicaltrials.gov/study/NCT01699464,COMPLETED,INTERVENTIONAL
NCT02636946,A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02636946,COMPLETED,INTERVENTIONAL
NCT01542710,Bimatoprost/Timolol Versus Travoprost/Timolol,https://clinicaltrials.gov/study/NCT01542710,COMPLETED,INTERVENTIONAL
NCT03318510,LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma,https://clinicaltrials.gov/study/NCT03318510,UNKNOWN,INTERVENTIONAL
NCT01589510,A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01589510,COMPLETED,OBSERVATIONAL
NCT04912362,The Effectiveness of YAG Iridotomy in Preventing Peripheral Anterior Synechia After CLASS in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04912362,UNKNOWN,INTERVENTIONAL
NCT01229462,Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01229462,COMPLETED,INTERVENTIONAL
NCT02981446,A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT,https://clinicaltrials.gov/study/NCT02981446,COMPLETED,INTERVENTIONAL
NCT05181046,Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients,https://clinicaltrials.gov/study/NCT05181046,COMPLETED,INTERVENTIONAL
NCT03891446,Long-term Safety and Efficacy Extension Trial of Bimatoprost SR,https://clinicaltrials.gov/study/NCT03891446,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT02544646,Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG,https://clinicaltrials.gov/study/NCT02544646,COMPLETED,INTERVENTIONAL
NCT03808688,Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting,https://clinicaltrials.gov/study/NCT03808688,COMPLETED,INTERVENTIONAL
NCT01068938,Comparison of Visual Fields: Humphrey Field Analyzer (HFA) SITA Strategy SCOPE (GATE Strategy) and Humphrey MATRIX Perimeter,https://clinicaltrials.gov/study/NCT01068938,UNKNOWN,OBSERVATIONAL
NCT03310788,Monitoring of the IOP After SLT Using iCare Home,https://clinicaltrials.gov/study/NCT03310788,UNKNOWN,OBSERVATIONAL
NCT00727038,Lucentis for New Onset Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT00727038,WITHDRAWN,INTERVENTIONAL
NCT00844389,Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy,https://clinicaltrials.gov/study/NCT00844389,UNKNOWN,INTERVENTIONAL
NCT01401088,Evaluation of Safety and Efficacy of Glaucoma Shunt (Aurolab Artificial Drainage Implant) in Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01401088,UNKNOWN,INTERVENTIONAL
NCT01467388,Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients,https://clinicaltrials.gov/study/NCT01467388,UNKNOWN,OBSERVATIONAL
NCT01252888,Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents,https://clinicaltrials.gov/study/NCT01252888,COMPLETED,INTERVENTIONAL
NCT04891588,Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD,https://clinicaltrials.gov/study/NCT04891588,UNKNOWN,INTERVENTIONAL
NCT01841450,Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT01841450,UNKNOWN,INTERVENTIONAL
NCT00811850,Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow,https://clinicaltrials.gov/study/NCT00811850,COMPLETED,INTERVENTIONAL
NCT03067415,Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily,https://clinicaltrials.gov/study/NCT03067415,UNKNOWN,INTERVENTIONAL
NCT04188015,Study of ANX007 in Participants With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04188015,COMPLETED,INTERVENTIONAL
NCT02085850,Incidence and Progression of Glaucoma in the Tema Eye Survey Cohort,https://clinicaltrials.gov/study/NCT02085850,UNKNOWN,OBSERVATIONAL
NCT05484050,VEGF in Iris Tissue in Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT05484050,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02537015,An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert,https://clinicaltrials.gov/study/NCT02537015,COMPLETED,INTERVENTIONAL
NCT05797350,Paul Glaucoma Implant Versus Ahmed Glaucoma Valve in Childhood Glaucoma,https://clinicaltrials.gov/study/NCT05797350,RECRUITING,INTERVENTIONAL
NCT01253902,Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01253902,COMPLETED,INTERVENTIONAL
NCT05201378,Deep Sclerectomy vs Xen in Solo Procedure,https://clinicaltrials.gov/study/NCT05201378,COMPLETED,OBSERVATIONAL
NCT01084902,Efficacy Comparison of Xalatan and Azopt on POAG and OH,https://clinicaltrials.gov/study/NCT01084902,UNKNOWN,INTERVENTIONAL
NCT04011878,Histopathological Examination of Iris Tissue in Buphthalmos,https://clinicaltrials.gov/study/NCT04011878,COMPLETED,INTERVENTIONAL
NCT02209077,Spectralis OCT Repeatability and Reproducibility Study,https://clinicaltrials.gov/study/NCT02209077,COMPLETED,INTERVENTIONAL
NCT02622178,How Accurately Does the Diopsys Visual Evoked Potential (VEP) Vision Testing System Detect Glaucoma?,https://clinicaltrials.gov/study/NCT02622178,COMPLETED,INTERVENTIONAL
NCT00572455,Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.,https://clinicaltrials.gov/study/NCT00572455,COMPLETED,INTERVENTIONAL
NCT02571712,Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02571712,COMPLETED,INTERVENTIONAL
NCT01997255,Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS),https://clinicaltrials.gov/study/NCT01997255,WITHDRAWN,INTERVENTIONAL
NCT01453855,Travoprost 3-Month Safety and Efficacy Study,https://clinicaltrials.gov/study/NCT01453855,COMPLETED,INTERVENTIONAL
NCT01027312,Assessment of Ability Related to Vision,https://clinicaltrials.gov/study/NCT01027312,COMPLETED,OBSERVATIONAL
NCT04683055,Phaco-Trabeculotomy Vs Phaco-Trabeculectomy,https://clinicaltrials.gov/study/NCT04683055,COMPLETED,INTERVENTIONAL
NCT01881425,InnFocus MicroShunt Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT01881425,COMPLETED,INTERVENTIONAL
NCT01495312,24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT),https://clinicaltrials.gov/study/NCT01495312,WITHDRAWN,INTERVENTIONAL
NCT00595855,A Comparison Between Deep Sclerectomy and Trabeculectomy,https://clinicaltrials.gov/study/NCT00595855,COMPLETED,INTERVENTIONAL
NCT02001155,Comparing the Effect of the Water Drinking Test on Intraocular Pressure,https://clinicaltrials.gov/study/NCT02001155,COMPLETED,OBSERVATIONAL
NCT04484155,Minimally Invasive Micro Sclerostomy: Safety and Preliminary Performance Study,https://clinicaltrials.gov/study/NCT04484155,COMPLETED,INTERVENTIONAL
NCT00051155,A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT),https://clinicaltrials.gov/study/NCT00051155,COMPLETED,INTERVENTIONAL
NCT05230355,Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma,https://clinicaltrials.gov/study/NCT05230355,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01487655,Waveform Analysis of the Doppler Curve of Ophthalmic Arteries in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01487655,COMPLETED,OBSERVATIONAL
NCT00442312,Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy,https://clinicaltrials.gov/study/NCT00442312,UNKNOWN,INTERVENTIONAL
NCT01592955,Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU),https://clinicaltrials.gov/study/NCT01592955,COMPLETED,INTERVENTIONAL
NCT02691455,The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS),https://clinicaltrials.gov/study/NCT02691455,TERMINATED,INTERVENTIONAL
NCT00273455,Lumigan Versus Cosopt,https://clinicaltrials.gov/study/NCT00273455,COMPLETED,INTERVENTIONAL
NCT03760055,Assessment of Visual Function With a Portable Brain-computer Interface,https://clinicaltrials.gov/study/NCT03760055,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT03760055,Assessment of Visual Function With a Portable Brain-computer Interface,https://clinicaltrials.gov/study/NCT03760055,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT05127525,EffiCacy Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN),https://clinicaltrials.gov/study/NCT05127525,TERMINATED,INTERVENTIONAL
NCT01425112,Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy,https://clinicaltrials.gov/study/NCT01425112,COMPLETED,INTERVENTIONAL
NCT04949555,Long Term Evaluation of Primary Congenital Glaucoma Management in Sohag University Hospital,https://clinicaltrials.gov/study/NCT04949555,RECRUITING,OBSERVATIONAL
NCT03736655,Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03736655,TERMINATED,INTERVENTIONAL
NCT03154892,The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT03154892,COMPLETED,INTERVENTIONAL
NCT01156012,Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients,https://clinicaltrials.gov/study/NCT01156012,COMPLETED,INTERVENTIONAL
NCT00571012,Aqueous Outflow Facility Changes With Posture,https://clinicaltrials.gov/study/NCT00571012,COMPLETED,OBSERVATIONAL
NCT02157025,A More Engaging Visual Field Test to Increase Use and Reliability in Pediatrics,https://clinicaltrials.gov/study/NCT02157025,RECRUITING,INTERVENTIONAL
NCT01383525,Direct Application of Selective Laser Trabeculoplasty in Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01383525,COMPLETED,INTERVENTIONAL
NCT01179555,Confronting Unequal Eye Care in Pennsylvania,https://clinicaltrials.gov/study/NCT01179555,COMPLETED,INTERVENTIONAL
NCT01179555,Confronting Unequal Eye Care in Pennsylvania,https://clinicaltrials.gov/study/NCT01179555,COMPLETED,INTERVENTIONAL
NCT01828255,Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients,https://clinicaltrials.gov/study/NCT01828255,TERMINATED,INTERVENTIONAL
NCT00333125,A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00333125,COMPLETED,INTERVENTIONAL
NCT03761992,Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in NTG,https://clinicaltrials.gov/study/NCT03761992,UNKNOWN,INTERVENTIONAL
NCT01937312,Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue,https://clinicaltrials.gov/study/NCT01937312,COMPLETED,INTERVENTIONAL
NCT00822055,Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00822055,COMPLETED,INTERVENTIONAL
NCT02376725,Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG,https://clinicaltrials.gov/study/NCT02376725,COMPLETED,INTERVENTIONAL
NCT02376725,Comparing Phaco/IOL Versus Phaco/IOL + Goniosynechialysis in Subjects With PACG,https://clinicaltrials.gov/study/NCT02376725,COMPLETED,INTERVENTIONAL
NCT01544192,Impact of Oral Versatile Antioxidants on Glaucoma Progression,https://clinicaltrials.gov/study/NCT01544192,COMPLETED,INTERVENTIONAL
NCT01753492,Trabeculectomy With Ologen,https://clinicaltrials.gov/study/NCT01753492,TERMINATED,INTERVENTIONAL
NCT02434692,Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG),https://clinicaltrials.gov/study/NCT02434692,COMPLETED,INTERVENTIONAL
NCT00941525,Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure,https://clinicaltrials.gov/study/NCT00941525,COMPLETED,INTERVENTIONAL
NCT04335825,Surgical and Refractive Outcomes of Combined Glaucoma Surgery,https://clinicaltrials.gov/study/NCT04335825,COMPLETED,INTERVENTIONAL
NCT00313092,Obstructive Sleep Apnea Syndrome in Glaucoma,https://clinicaltrials.gov/study/NCT00313092,TERMINATED,OBSERVATIONAL
NCT00000122,Fluorouracil Filtering Surgery Study (FFSS),https://clinicaltrials.gov/study/NCT00000122,COMPLETED,INTERVENTIONAL
NCT03646500,Comparing Conscious Sedation to Retrobulbar Block Anesthetics During Trans-scleral Diode Laser,https://clinicaltrials.gov/study/NCT03646500,COMPLETED,INTERVENTIONAL
NCT05968547,Evaluation of Patients' Requirements for Improved Advice and Guidance on Vision Standards for Driving in Glaucoma,https://clinicaltrials.gov/study/NCT05968547,NOT_YET_RECRUITING,OBSERVATIONAL
NCT01485822,A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution,https://clinicaltrials.gov/study/NCT01485822,TERMINATED,OBSERVATIONAL
NCT03690622,Effect of Topical Dexmedetomidine on Intraocular Pressure,https://clinicaltrials.gov/study/NCT03690622,COMPLETED,INTERVENTIONAL
NCT00695747,Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy,https://clinicaltrials.gov/study/NCT00695747,COMPLETED,INTERVENTIONAL
NCT01938287,SENSIMED Triggerfish in Closed Eyes,https://clinicaltrials.gov/study/NCT01938287,COMPLETED,INTERVENTIONAL
NCT04321122,UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04321122,UNKNOWN,INTERVENTIONAL
NCT00991822,A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00991822,COMPLETED,INTERVENTIONAL
NCT00430287,Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?,https://clinicaltrials.gov/study/NCT00430287,COMPLETED,OBSERVATIONAL
NCT00906087,Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions,https://clinicaltrials.gov/study/NCT00906087,COMPLETED,INTERVENTIONAL
NCT04639947,Reliability and Reproducibility of the Eye Check Tonometer,https://clinicaltrials.gov/study/NCT04639947,TERMINATED,INTERVENTIONAL
NCT01004900,Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT01004900,UNKNOWN,INTERVENTIONAL
NCT05335122,A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT05335122,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00293787,A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00293787,COMPLETED,INTERVENTIONAL
NCT03204487,A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness,https://clinicaltrials.gov/study/NCT03204487,COMPLETED,INTERVENTIONAL
NCT05892185,Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05892185,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04949347,Glycerin-Preserved Human-Donor Corneoscleral Patch Grafts for Glaucoma Drainage Devices,https://clinicaltrials.gov/study/NCT04949347,COMPLETED,OBSERVATIONAL
NCT03996200,MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool,https://clinicaltrials.gov/study/NCT03996200,COMPLETED,INTERVENTIONAL
NCT00454922,Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00454922,COMPLETED,INTERVENTIONAL
NCT02003547,A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects,https://clinicaltrials.gov/study/NCT02003547,COMPLETED,INTERVENTIONAL
NCT05366647,GATT Versus Canaloplasty (GVC),https://clinicaltrials.gov/study/NCT05366647,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01391247,Validation of Retinal Oximetry in Glaucoma Patients: a Structural and Functional Correlation,https://clinicaltrials.gov/study/NCT01391247,COMPLETED,OBSERVATIONAL
NCT00744666,IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids,https://clinicaltrials.gov/study/NCT00744666,UNKNOWN,INTERVENTIONAL
NCT01704248,The Effect of Eye Drop Guide on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01704248,UNKNOWN,INTERVENTIONAL
NCT01372319,Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration Activities of Daily Living (ADL) and Quality of Life (QoL),https://clinicaltrials.gov/study/NCT01372319,COMPLETED,OBSERVATIONAL
NCT02438319,Automatic vs. Manual Optic Disc Planimetry,https://clinicaltrials.gov/study/NCT02438319,WITHDRAWN,OBSERVATIONAL
NCT03166566,Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.,https://clinicaltrials.gov/study/NCT03166566,COMPLETED,INTERVENTIONAL
NCT00383019,A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).,https://clinicaltrials.gov/study/NCT00383019,COMPLETED,INTERVENTIONAL
NCT01742819,Advanced Glaucoma Progression Study,https://clinicaltrials.gov/study/NCT01742819,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT05529966,Comparing NGENUITY vs Conventional Microscope in a New Hydrus User,https://clinicaltrials.gov/study/NCT05529966,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT01345448,Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy,https://clinicaltrials.gov/study/NCT01345448,UNKNOWN,INTERVENTIONAL
NCT02030886,IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients,https://clinicaltrials.gov/study/NCT02030886,TERMINATED,INTERVENTIONAL
NCT01265719,Long-Term Non-Interventional Latanoprost Study,https://clinicaltrials.gov/study/NCT01265719,COMPLETED,OBSERVATIONAL
NCT02097719,Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02097719,COMPLETED,INTERVENTIONAL
NCT01645319,Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01645319,COMPLETED,OBSERVATIONAL
NCT01645319,Comparative Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01645319,COMPLETED,OBSERVATIONAL
NCT04872348,An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0),https://clinicaltrials.gov/study/NCT04872348,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT04903366,Absorption and Safety of Topical Timolol to Treat Chronic Wounds,https://clinicaltrials.gov/study/NCT04903366,COMPLETED,OBSERVATIONAL
NCT04981886,Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT04981886,UNKNOWN,INTERVENTIONAL
NCT04499248,AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04499248,RECRUITING,INTERVENTIONAL
NCT01122966,The Effect of Bevacizumab on the Trabeculectomy,https://clinicaltrials.gov/study/NCT01122966,UNKNOWN,INTERVENTIONAL
NCT02772666,Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect,https://clinicaltrials.gov/study/NCT02772666,COMPLETED,INTERVENTIONAL
NCT00288951,Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00288951,COMPLETED,INTERVENTIONAL
NCT03960866,Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma,https://clinicaltrials.gov/study/NCT03960866,COMPLETED,INTERVENTIONAL
NCT00672048,Partnership for Glaucoma,https://clinicaltrials.gov/study/NCT00672048,COMPLETED,INTERVENTIONAL
NCT00465348,The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients,https://clinicaltrials.gov/study/NCT00465348,WITHDRAWN,OBSERVATIONAL
NCT03541551,Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy,https://clinicaltrials.gov/study/NCT03541551,COMPLETED,INTERVENTIONAL
NCT03421548,Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1,https://clinicaltrials.gov/study/NCT03421548,WITHDRAWN,INTERVENTIONAL
NCT02410148,aICP in Glaucoma and Papilledema,https://clinicaltrials.gov/study/NCT02410148,UNKNOWN,INTERVENTIONAL
NCT01484951,AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure,https://clinicaltrials.gov/study/NCT01484951,COMPLETED,INTERVENTIONAL
NCT01481051,A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01481051,COMPLETED,INTERVENTIONAL
NCT00347451,Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.,https://clinicaltrials.gov/study/NCT00347451,COMPLETED,OBSERVATIONAL
NCT02770248,24-hr Intraocular Pressure Control With SIMBRINZA ®,https://clinicaltrials.gov/study/NCT02770248,COMPLETED,INTERVENTIONAL
NCT00546286,A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153),https://clinicaltrials.gov/study/NCT00546286,COMPLETED,INTERVENTIONAL
NCT04844619,KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial,https://clinicaltrials.gov/study/NCT04844619,RECRUITING,INTERVENTIONAL
NCT05821855,A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China,https://clinicaltrials.gov/study/NCT05821855,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00872651,Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00872651,COMPLETED,INTERVENTIONAL
NCT03782051,Combined Viscocanalostomy Phacoemulsification OIogen Implant in Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03782051,COMPLETED,INTERVENTIONAL
NCT05280366,STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05280366,RECRUITING,INTERVENTIONAL
NCT00000148,Advanced Glaucoma Intervention Study (AGIS),https://clinicaltrials.gov/study/NCT00000148,UNKNOWN,INTERVENTIONAL
NCT05344651,Comparing the Baerveldt and Paul Glaucoma Drainage Devices and Their Effects on the Corneal Endothelium,https://clinicaltrials.gov/study/NCT05344651,RECRUITING,INTERVENTIONAL
NCT02250651,Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02250651,COMPLETED,INTERVENTIONAL
NCT01630551,Omega 3 Supplementation and Ocular Surface Disease in Glaucoma,https://clinicaltrials.gov/study/NCT01630551,WITHDRAWN,INTERVENTIONAL
NCT03293251,Trabeculectomy With MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors,https://clinicaltrials.gov/study/NCT03293251,UNKNOWN,OBSERVATIONAL
NCT02767219,The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery,https://clinicaltrials.gov/study/NCT02767219,COMPLETED,INTERVENTIONAL
NCT00649766,Tailored Messages to Increase Eye Examination Behavior,https://clinicaltrials.gov/study/NCT00649766,UNKNOWN,INTERVENTIONAL
NCT00809848,Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00809848,COMPLETED,INTERVENTIONAL
NCT05014386,AGV Implantation With Ologen in Pediatric Glaucomas,https://clinicaltrials.gov/study/NCT05014386,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01055366,ELAZOP Switching Study in Korea,https://clinicaltrials.gov/study/NCT01055366,COMPLETED,INTERVENTIONAL
NCT01284166,Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01284166,WITHDRAWN,INTERVENTIONAL
NCT00486486,24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination,https://clinicaltrials.gov/study/NCT00486486,COMPLETED,INTERVENTIONAL
NCT04519619,Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG),https://clinicaltrials.gov/study/NCT04519619,RECRUITING,OBSERVATIONAL
NCT01788319,Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm),https://clinicaltrials.gov/study/NCT01788319,COMPLETED,INTERVENTIONAL
NCT00005919,Cause of Pigment Dispersion Syndrome,https://clinicaltrials.gov/study/NCT00005919,COMPLETED,OBSERVATIONAL
NCT01670266,Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01670266,COMPLETED,INTERVENTIONAL
NCT02681419,Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period,https://clinicaltrials.gov/study/NCT02681419,TERMINATED,INTERVENTIONAL
NCT05333419,Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.,https://clinicaltrials.gov/study/NCT05333419,RECRUITING,INTERVENTIONAL
NCT04445519,Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04445519,COMPLETED,INTERVENTIONAL
NCT04970251,Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT04970251,COMPLETED,INTERVENTIONAL
NCT00326066,A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.,https://clinicaltrials.gov/study/NCT00326066,COMPLETED,INTERVENTIONAL
NCT00804648,Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00804648,COMPLETED,INTERVENTIONAL
NCT05175651,Prospective Electronic Polygenic Risk Study - Second Phase,https://clinicaltrials.gov/study/NCT05175651,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05175651,Prospective Electronic Polygenic Risk Study - Second Phase,https://clinicaltrials.gov/study/NCT05175651,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05175651,Prospective Electronic Polygenic Risk Study - Second Phase,https://clinicaltrials.gov/study/NCT05175651,NOT_YET_RECRUITING,INTERVENTIONAL
NCT03675412,Caffeine Consumption in Glaucoma Patients and Healthy Subjects,https://clinicaltrials.gov/study/NCT03675412,RECRUITING,INTERVENTIONAL
NCT06057051,Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT06057051,RECRUITING,INTERVENTIONAL
NCT01646151,A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01646151,COMPLETED,OBSERVATIONAL
NCT03325751,Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects,https://clinicaltrials.gov/study/NCT03325751,COMPLETED,OBSERVATIONAL
NCT05127551,Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor,https://clinicaltrials.gov/study/NCT05127551,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01999348,A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting,https://clinicaltrials.gov/study/NCT01999348,COMPLETED,OBSERVATIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT05163951,Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG,https://clinicaltrials.gov/study/NCT05163951,RECRUITING,INTERVENTIONAL
NCT04200651,Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery,https://clinicaltrials.gov/study/NCT04200651,COMPLETED,INTERVENTIONAL
NCT01440751,Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery,https://clinicaltrials.gov/study/NCT01440751,COMPLETED,INTERVENTIONAL
NCT01440751,Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery,https://clinicaltrials.gov/study/NCT01440751,COMPLETED,INTERVENTIONAL
NCT01155219,Safety Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.,https://clinicaltrials.gov/study/NCT01155219,COMPLETED,INTERVENTIONAL
NCT03250819,Gene Polymorphisms of Corticosteroid-induced Ocular Hypertension,https://clinicaltrials.gov/study/NCT03250819,COMPLETED,OBSERVATIONAL
NCT00429819,Neurovascular Coupling in Eyes of Glaucoma Patients,https://clinicaltrials.gov/study/NCT00429819,COMPLETED,OBSERVATIONAL
NCT04741919,Superior vs Temporal Laser Peripheral Iridotomy in Primary Angle Closure Suspects (PACS),https://clinicaltrials.gov/study/NCT04741919,RECRUITING,INTERVENTIONAL
NCT02260219,Comparative Study Safety and Efficacy Ahmed Glaucoma Drainage Device Model M4 Model S2 in Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT02260219,UNKNOWN,INTERVENTIONAL
NCT00069719,Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00069719,COMPLETED,INTERVENTIONAL
NCT04517786,MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool,https://clinicaltrials.gov/study/NCT04517786,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03519386,Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution 0.5%,https://clinicaltrials.gov/study/NCT03519386,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03034486,The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930,https://clinicaltrials.gov/study/NCT03034486,COMPLETED,INTERVENTIONAL
NCT00761319,Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health,https://clinicaltrials.gov/study/NCT00761319,COMPLETED,INTERVENTIONAL
NCT01215786,Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01215786,COMPLETED,INTERVENTIONAL
NCT03634319,Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union,https://clinicaltrials.gov/study/NCT03634319,TERMINATED,INTERVENTIONAL
NCT05916066,Nicotinamide and Glaucoma,https://clinicaltrials.gov/study/NCT05916066,COMPLETED,INTERVENTIONAL
NCT01271686,24-hour IOP-lowering Effect of 0.01% Bimatoprost,https://clinicaltrials.gov/study/NCT01271686,COMPLETED,INTERVENTIONAL
NCT03369886,The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI,https://clinicaltrials.gov/study/NCT03369886,UNKNOWN,INTERVENTIONAL
NCT05351307,Retinal Vascular Changes in Primary Open Angle Glaucoma Patients,https://clinicaltrials.gov/study/NCT05351307,NOT_YET_RECRUITING,OBSERVATIONAL
NCT01279083,Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01279083,COMPLETED,INTERVENTIONAL
NCT03682783,Artificial Intelligence-assisted Glaucoma Screening (AIAGS),https://clinicaltrials.gov/study/NCT03682783,UNKNOWN,OBSERVATIONAL
NCT03682783,Artificial Intelligence-assisted Glaucoma Screening (AIAGS),https://clinicaltrials.gov/study/NCT03682783,UNKNOWN,OBSERVATIONAL
NCT05397600,Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients,https://clinicaltrials.gov/study/NCT05397600,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02376114,Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02376114,COMPLETED,INTERVENTIONAL
NCT02278614,Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients,https://clinicaltrials.gov/study/NCT02278614,COMPLETED,INTERVENTIONAL
NCT04552314,Bleb Vascularity and the Outcomes After Trabeculectomy,https://clinicaltrials.gov/study/NCT04552314,COMPLETED,OBSERVATIONAL
NCT01448837,24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice,https://clinicaltrials.gov/study/NCT01448837,COMPLETED,INTERVENTIONAL
NCT01252914,A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent,https://clinicaltrials.gov/study/NCT01252914,COMPLETED,INTERVENTIONAL
NCT05437614,Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma,https://clinicaltrials.gov/study/NCT05437614,RECRUITING,INTERVENTIONAL
NCT04333433,PRESERFLO® MicroShunt Extension Study,https://clinicaltrials.gov/study/NCT04333433,COMPLETED,OBSERVATIONAL
NCT03193333,PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM),https://clinicaltrials.gov/study/NCT03193333,RECRUITING,INTERVENTIONAL
NCT01735214,An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments,https://clinicaltrials.gov/study/NCT01735214,COMPLETED,OBSERVATIONAL
NCT02911883,Evaluation of the Repeatability and Reproducibility of AngioVue,https://clinicaltrials.gov/study/NCT02911883,COMPLETED,OBSERVATIONAL
NCT02802137,24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy,https://clinicaltrials.gov/study/NCT02802137,COMPLETED,INTERVENTIONAL
NCT01696383,Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia,https://clinicaltrials.gov/study/NCT01696383,WITHDRAWN,INTERVENTIONAL
NCT01721707,Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH,https://clinicaltrials.gov/study/NCT01721707,WITHDRAWN,INTERVENTIONAL
NCT00847483,Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks Masked Evaluator Phase IV Multi-center Study in the US,https://clinicaltrials.gov/study/NCT00847483,COMPLETED,INTERVENTIONAL
NCT02406833,Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy,https://clinicaltrials.gov/study/NCT02406833,COMPLETED,INTERVENTIONAL
NCT01758237,Dysphotopsia Following Laser Peripheral Iridotomy,https://clinicaltrials.gov/study/NCT01758237,COMPLETED,INTERVENTIONAL
NCT01628614,A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01628614,COMPLETED,OBSERVATIONAL
NCT03648814,Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT,https://clinicaltrials.gov/study/NCT03648814,RECRUITING,INTERVENTIONAL
NCT02989207,Surgical Approaches in Treating Uncontrolled Glaucoma in Black African and African-Caribbeans,https://clinicaltrials.gov/study/NCT02989207,UNKNOWN,INTERVENTIONAL
NCT04328207,Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits,https://clinicaltrials.gov/study/NCT04328207,RECRUITING,INTERVENTIONAL
NCT00441883,Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma,https://clinicaltrials.gov/study/NCT00441883,COMPLETED,INTERVENTIONAL
NCT00801437,Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.,https://clinicaltrials.gov/study/NCT00801437,COMPLETED,OBSERVATIONAL
NCT04519814,Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT),https://clinicaltrials.gov/study/NCT04519814,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00326014,A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.,https://clinicaltrials.gov/study/NCT00326014,COMPLETED,INTERVENTIONAL
NCT03613233,QoL Assessment in Traditional Glaucoma Surgery and MIGS.,https://clinicaltrials.gov/study/NCT03613233,UNKNOWN,INTERVENTIONAL
NCT00349414,Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma,https://clinicaltrials.gov/study/NCT00349414,UNKNOWN,INTERVENTIONAL
NCT01159314,Baerveldt Plate Area Comparison (BPAC),https://clinicaltrials.gov/study/NCT01159314,TERMINATED,INTERVENTIONAL
NCT00556114,A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging,https://clinicaltrials.gov/study/NCT00556114,COMPLETED,OBSERVATIONAL
NCT00338533,Endoscopic Goniotomy for Infantile Glaucoma,https://clinicaltrials.gov/study/NCT00338533,COMPLETED,INTERVENTIONAL
NCT05753137,A Clinical Trial of Acupuncture as Adjuvant Therapy for Glaucoma,https://clinicaltrials.gov/study/NCT05753137,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00676637,Glaucoma Adherence Study,https://clinicaltrials.gov/study/NCT00676637,COMPLETED,OBSERVATIONAL
NCT00652483,Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00652483,COMPLETED,INTERVENTIONAL
NCT03452033,H-1337 Ophthalmic Solution Phase 1/2,https://clinicaltrials.gov/study/NCT03452033,COMPLETED,INTERVENTIONAL
NCT00434707,Outcome of Small Pupil Phacotrabeculectomy in Persons With Glaucoma and Cataract,https://clinicaltrials.gov/study/NCT00434707,UNKNOWN,OBSERVATIONAL
NCT00452283,Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy,https://clinicaltrials.gov/study/NCT00452283,COMPLETED,OBSERVATIONAL
NCT03896633,Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt,https://clinicaltrials.gov/study/NCT03896633,COMPLETED,INTERVENTIONAL
NCT03273907,Post Approval Study of the CyPass System,https://clinicaltrials.gov/study/NCT03273907,TERMINATED,INTERVENTIONAL
NCT02908633,Safety and Efficacy of Three Variants of Canaloplasty With Phacoemulsification to Treat Glaucoma and Cataract,https://clinicaltrials.gov/study/NCT02908633,UNKNOWN,INTERVENTIONAL
NCT00626067,Study of Patient Use and Perception of the Travatan Dosing Aid,https://clinicaltrials.gov/study/NCT00626067,COMPLETED,INTERVENTIONAL
NCT00990743,Tolerance and Effect on Intraocular Pressure After Administration of SYL040012,https://clinicaltrials.gov/study/NCT00990743,COMPLETED,INTERVENTIONAL
NCT02990143,The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7),https://clinicaltrials.gov/study/NCT02990143,TERMINATED,INTERVENTIONAL
NCT04742283,Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04742283,COMPLETED,INTERVENTIONAL
NCT00661583,Use of Ranibizumab With Mitomycin C During Trabeculectomy,https://clinicaltrials.gov/study/NCT00661583,COMPLETED,INTERVENTIONAL
NCT05857267,Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety,https://clinicaltrials.gov/study/NCT05857267,RECRUITING,INTERVENTIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03469297,Early Feasibility Study of the Brown Glaucoma Implant in Patients With Severe Visual Impairment or No Light Perceived,https://clinicaltrials.gov/study/NCT03469297,COMPLETED,INTERVENTIONAL
NCT01338467,Glaucoma Treatment by Circular Cyclocoagulation Using High Intensity Focused Ultrasound With the EYEOP Medical Device,https://clinicaltrials.gov/study/NCT01338467,COMPLETED,INTERVENTIONAL
NCT01162356,Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study,https://clinicaltrials.gov/study/NCT01162356,COMPLETED,OBSERVATIONAL
NCT00221897,Diagnostic Innovations in Glaucoma Study,https://clinicaltrials.gov/study/NCT00221897,UNKNOWN,OBSERVATIONAL
NCT04830397,Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).,https://clinicaltrials.gov/study/NCT04830397,COMPLETED,INTERVENTIONAL
NCT04485897,Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring,https://clinicaltrials.gov/study/NCT04485897,RECRUITING,INTERVENTIONAL
NCT05469867,Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants,https://clinicaltrials.gov/study/NCT05469867,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00410267,Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells,https://clinicaltrials.gov/study/NCT00410267,TERMINATED,OBSERVATIONAL
NCT04422743,Effect of Citicoline/Homotaurine on PERG in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04422743,TERMINATED,INTERVENTIONAL
NCT06143943,Anterior Segment Anatomic Parameters for Risk Profiling of Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT06143943,COMPLETED,OBSERVATIONAL
NCT00672997,A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00672997,COMPLETED,INTERVENTIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT03160690,Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT03160690,UNKNOWN,OBSERVATIONAL
NCT01266343,Comparison of Anterior Chamber Paracentesis and Conventional Mannitol Infusion in Patients With Primary Acute Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT01266343,COMPLETED,OBSERVATIONAL
NCT02490267,Quality of Life in Children Glaucoma and Cataract,https://clinicaltrials.gov/study/NCT02490267,COMPLETED,OBSERVATIONAL
NCT01446497,Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01446497,UNKNOWN,INTERVENTIONAL
NCT00312403,Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1 MMP3 and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?,https://clinicaltrials.gov/study/NCT00312403,COMPLETED,INTERVENTIONAL
NCT02792803,A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT02792803,UNKNOWN,INTERVENTIONAL
NCT00803803,Dose Effects and Characteristics of Pilocarpine,https://clinicaltrials.gov/study/NCT00803803,COMPLETED,INTERVENTIONAL
NCT01640756,AqueSys Microfistula Implant in Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01640756,COMPLETED,INTERVENTIONAL
NCT00665756,Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00665756,UNKNOWN,INTERVENTIONAL
NCT05011747,Viscotrabeculotomy in Pediatric Glaucoma Following Cataract Surgery,https://clinicaltrials.gov/study/NCT05011747,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05340647,NorMIGS - a Study of Micro-invasive Glaucoma Surgery,https://clinicaltrials.gov/study/NCT05340647,RECRUITING,OBSERVATIONAL
NCT03159247,The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program,https://clinicaltrials.gov/study/NCT03159247,COMPLETED,INTERVENTIONAL
NCT03159247,The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program,https://clinicaltrials.gov/study/NCT03159247,COMPLETED,INTERVENTIONAL
NCT03159247,The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program,https://clinicaltrials.gov/study/NCT03159247,COMPLETED,INTERVENTIONAL
NCT03515187,Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops,https://clinicaltrials.gov/study/NCT03515187,UNKNOWN,INTERVENTIONAL
NCT03255785,Open-Angle Glaucoma Subjects With Cataract Treated With Cataract Surgery Plus One iStent and One iStent Supra,https://clinicaltrials.gov/study/NCT03255785,COMPLETED,INTERVENTIONAL
NCT04624685,iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study,https://clinicaltrials.gov/study/NCT04624685,UNKNOWN,OBSERVATIONAL
NCT05130385,High Resolution Optical Coherence Tomography,https://clinicaltrials.gov/study/NCT05130385,RECRUITING,OBSERVATIONAL
NCT05131087,A First-In-Human Clinical Trial to Evaluate the Safety Effectiveness and Surgical Characteristics of CADENCE in Patients With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT05131087,COMPLETED,INTERVENTIONAL
NCT04911387,iCare® Home vs Goldmann Applanation Tonometry,https://clinicaltrials.gov/study/NCT04911387,COMPLETED,OBSERVATIONAL
NCT01123785,A Dose-Escalation Study Designed to Evaluate the Tolerability Safety Pharmacokinetics (PK) and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01123785,COMPLETED,INTERVENTIONAL
NCT02507687,Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02507687,COMPLETED,INTERVENTIONAL
NCT05685485,Tied Tube Trial in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT05685485,RECRUITING,OBSERVATIONAL
NCT05685485,Tied Tube Trial in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT05685485,RECRUITING,OBSERVATIONAL
NCT00477685,Ologen (OculusGen)-Phacotrabeculectomy Historical Control Study in India,https://clinicaltrials.gov/study/NCT00477685,COMPLETED,OBSERVATIONAL
NCT00626847,How Does Your Genetic Make-up (Profile) Influence Your Glaucoma?,https://clinicaltrials.gov/study/NCT00626847,COMPLETED,OBSERVATIONAL
NCT05370287,Adaptive Optics Retinal Imaging,https://clinicaltrials.gov/study/NCT05370287,RECRUITING,INTERVENTIONAL
NCT01853085,A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons,https://clinicaltrials.gov/study/NCT01853085,COMPLETED,OBSERVATIONAL
NCT04910100,Nebivolol 0.5 1.0 or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension,https://clinicaltrials.gov/study/NCT04910100,COMPLETED,INTERVENTIONAL
NCT04910100,Nebivolol 0.5 1.0 or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension,https://clinicaltrials.gov/study/NCT04910100,COMPLETED,INTERVENTIONAL
NCT04743622,Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost,https://clinicaltrials.gov/study/NCT04743622,COMPLETED,INTERVENTIONAL
NCT04646122,Predicting Glaucoma Progression With Optical Coherence Tomography Structural and Angiographic Parameters.,https://clinicaltrials.gov/study/NCT04646122,UNKNOWN,OBSERVATIONAL
NCT04430647,Phaco-UCP Versus Phaco Alone for OAG and Cataract,https://clinicaltrials.gov/study/NCT04430647,COMPLETED,INTERVENTIONAL
NCT02178085,Ocular Blood Flow Assessment in Glaucoma,https://clinicaltrials.gov/study/NCT02178085,UNKNOWN,INTERVENTIONAL
NCT03611387,Artificial Intelligence Screening on Patients With Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT03611387,UNKNOWN,OBSERVATIONAL
NCT00803387,Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative,https://clinicaltrials.gov/study/NCT00803387,COMPLETED,OBSERVATIONAL
NCT01273285,Reproducibility of Nerve Fiber Layer Thickness Measurements in Patients With Glaucoma and Healthy Controls Using Spectral-Domain and Time-Domain OCT,https://clinicaltrials.gov/study/NCT01273285,TERMINATED,INTERVENTIONAL
NCT00121147,Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan,https://clinicaltrials.gov/study/NCT00121147,COMPLETED,INTERVENTIONAL
NCT04750447,Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C,https://clinicaltrials.gov/study/NCT04750447,RECRUITING,OBSERVATIONAL
NCT01027247,OculusGen™ Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: a Case-Control Study,https://clinicaltrials.gov/study/NCT01027247,COMPLETED,INTERVENTIONAL
NCT03944447,Outcomes Mandate National Integration With Cannabis as Medicine,https://clinicaltrials.gov/study/NCT03944447,RECRUITING,INTERVENTIONAL
NCT01908985,Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).,https://clinicaltrials.gov/study/NCT01908985,NO_LONGER_AVAILABLE,EXPANDED_ACCESS
NCT02105285,Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02105285,COMPLETED,INTERVENTIONAL
NCT01930487,The Effects of an Antioxidant Formulation on Ocular Blood Flow,https://clinicaltrials.gov/study/NCT01930487,COMPLETED,INTERVENTIONAL
NCT01298687,Divided Dose of TRAVATAN®,https://clinicaltrials.gov/study/NCT01298687,COMPLETED,INTERVENTIONAL
NCT03657147,Improving African American Glaucoma Patient Involvement in Visits and Outcomes,https://clinicaltrials.gov/study/NCT03657147,COMPLETED,INTERVENTIONAL
NCT00706056,A New View of Normal Tension Glaucoma: Autoregulation and Systemic Blood Pressure,https://clinicaltrials.gov/study/NCT00706056,COMPLETED,OBSERVATIONAL
NCT05455567,OCTA Study of Choroidal Vasculature in Open Angle Glaucoma Patients,https://clinicaltrials.gov/study/NCT05455567,COMPLETED,OBSERVATIONAL
NCT04468633,The Baerveldt Versus ClearPath Comparison Study,https://clinicaltrials.gov/study/NCT04468633,COMPLETED,INTERVENTIONAL
NCT03505567,Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100,https://clinicaltrials.gov/study/NCT03505567,COMPLETED,INTERVENTIONAL
NCT03759483,Diagnostic Efficacy of CNN in Differentiation of Visual Field,https://clinicaltrials.gov/study/NCT03759483,COMPLETED,OBSERVATIONAL
NCT01051583,Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT01051583,COMPLETED,INTERVENTIONAL
NCT01051583,Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT01051583,COMPLETED,INTERVENTIONAL
NCT01799707,Vision Restoration Training in Glaucoma,https://clinicaltrials.gov/study/NCT01799707,COMPLETED,INTERVENTIONAL
NCT01917383,A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01917383,COMPLETED,INTERVENTIONAL
NCT02512133,MIGS VS SLT Comparison in Glaucoma Patients,https://clinicaltrials.gov/study/NCT02512133,UNKNOWN,INTERVENTIONAL
NCT02049333,Cataract Surgery vs Cataract Surgery With ECPL for Treatment of Plateau Iris Configuration or Syndrome,https://clinicaltrials.gov/study/NCT02049333,COMPLETED,INTERVENTIONAL
NCT01299233,Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3,https://clinicaltrials.gov/study/NCT01299233,UNKNOWN,OBSERVATIONAL
NCT01563237,Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) Glaucoma Drainage Implant,https://clinicaltrials.gov/study/NCT01563237,COMPLETED,INTERVENTIONAL
NCT01923714,Impact of a Tolerability Switch to Dorzolamide/Timolol Preservative-free Fixed Combination on Ocular Surface Symptoms,https://clinicaltrials.gov/study/NCT01923714,COMPLETED,OBSERVATIONAL
NCT01814514,Safety Study of Aqueous Suppression After Ahmed Glaucoma Valve (AGV) Implantation,https://clinicaltrials.gov/study/NCT01814514,UNKNOWN,INTERVENTIONAL
NCT01076114,Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma,https://clinicaltrials.gov/study/NCT01076114,COMPLETED,OBSERVATIONAL
NCT02967614,KJ-TFC-004 Drug-drug Interaction Study,https://clinicaltrials.gov/study/NCT02967614,COMPLETED,INTERVENTIONAL
NCT01975714,Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European Multicentric Investigator-led Single Masked Study,https://clinicaltrials.gov/study/NCT01975714,COMPLETED,INTERVENTIONAL
NCT04284514,Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution,https://clinicaltrials.gov/study/NCT04284514,COMPLETED,INTERVENTIONAL
NCT01841437,Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry,https://clinicaltrials.gov/study/NCT01841437,COMPLETED,OBSERVATIONAL
NCT00286637,Novel Diagnostics for Ocular Structure,https://clinicaltrials.gov/study/NCT00286637,RECRUITING,OBSERVATIONAL
NCT00666237,Primary Tube Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT00666237,COMPLETED,INTERVENTIONAL
NCT00666237,Primary Tube Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT00666237,COMPLETED,INTERVENTIONAL
NCT00666237,Primary Tube Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT00666237,COMPLETED,INTERVENTIONAL
NCT05030714,Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study,https://clinicaltrials.gov/study/NCT05030714,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01340014,Patient Preference Comparison of AZARGA Versus COSOPT,https://clinicaltrials.gov/study/NCT01340014,COMPLETED,INTERVENTIONAL
NCT00487214,Internet-based Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma,https://clinicaltrials.gov/study/NCT00487214,COMPLETED,OBSERVATIONAL
NCT05954637,Correlation of Structure and Function in Glaucoma,https://clinicaltrials.gov/study/NCT05954637,RECRUITING,OBSERVATIONAL
NCT02629237,Satisfaction After Glaucoma Surgery in Rural China,https://clinicaltrials.gov/study/NCT02629237,WITHDRAWN,INTERVENTIONAL
NCT02061683,A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02061683,COMPLETED,INTERVENTIONAL
NCT02558400,Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02558400,COMPLETED,INTERVENTIONAL
NCT05885022,Feasibility Clinical Evaluation of the Calibreye System,https://clinicaltrials.gov/study/NCT05885022,RECRUITING,INTERVENTIONAL
NCT04214847,The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases,https://clinicaltrials.gov/study/NCT04214847,COMPLETED,INTERVENTIONAL
NCT05523622,Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices,https://clinicaltrials.gov/study/NCT05523622,RECRUITING,INTERVENTIONAL
NCT00981422,Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression,https://clinicaltrials.gov/study/NCT00981422,COMPLETED,OBSERVATIONAL
NCT04475900,Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics,https://clinicaltrials.gov/study/NCT04475900,COMPLETED,OBSERVATIONAL
NCT00708422,Effects of Travatan Z and Xalatan on Ocular Surface Health,https://clinicaltrials.gov/study/NCT00708422,COMPLETED,INTERVENTIONAL
NCT01033422,Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT01033422,COMPLETED,INTERVENTIONAL
NCT04295122,Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for Glaucoma Patients,https://clinicaltrials.gov/study/NCT04295122,UNKNOWN,INTERVENTIONAL
NCT04295122,Comparing the Effectiveness of Phacoemulsification + ECP Laser and Phacoemulsification Alone for Glaucoma Patients,https://clinicaltrials.gov/study/NCT04295122,UNKNOWN,INTERVENTIONAL
NCT05205122,Evaluation of Primary Congenital Glaucoma at Asyut University Hospital,https://clinicaltrials.gov/study/NCT05205122,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00406822,OculusGen-Glaucoma Historical Control Study in Taiwan,https://clinicaltrials.gov/study/NCT00406822,TERMINATED,INTERVENTIONAL
NCT00382122,Prevalence of Ocular Surface Disease in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00382122,COMPLETED,OBSERVATIONAL
NCT00362622,Determinants of Compliance With Glaucoma Therapy,https://clinicaltrials.gov/study/NCT00362622,COMPLETED,OBSERVATIONAL
NCT00856622,A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients,https://clinicaltrials.gov/study/NCT00856622,COMPLETED,INTERVENTIONAL
NCT01766947,IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy,https://clinicaltrials.gov/study/NCT01766947,WITHDRAWN,INTERVENTIONAL
NCT00348400,Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost,https://clinicaltrials.gov/study/NCT00348400,COMPLETED,INTERVENTIONAL
NCT01491867,Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect,https://clinicaltrials.gov/study/NCT01491867,COMPLETED,INTERVENTIONAL
NCT01629407,A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years,https://clinicaltrials.gov/study/NCT01629407,COMPLETED,OBSERVATIONAL
NCT04796883,A Study for Assessing the Safety of Hanita Glaucoma Shunt in Glaucoma Patients,https://clinicaltrials.gov/study/NCT04796883,COMPLETED,INTERVENTIONAL
NCT03647033,Phacoemulsification Versus Phacoemulsification With Micro-bypass Stent,https://clinicaltrials.gov/study/NCT03647033,COMPLETED,INTERVENTIONAL
NCT02613533,Water Drinking Test in Patients With Occludable Angle,https://clinicaltrials.gov/study/NCT02613533,COMPLETED,INTERVENTIONAL
NCT01726543,Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and Cataract,https://clinicaltrials.gov/study/NCT01726543,UNKNOWN,INTERVENTIONAL
NCT00670033,Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00670033,COMPLETED,INTERVENTIONAL
NCT05220007,Effect of Presbyopic Correction Lens on Humphrey Visual Field Testing in Patients With Multifocal Intraocular Lens,https://clinicaltrials.gov/study/NCT05220007,COMPLETED,INTERVENTIONAL
NCT04781283,Study Comparing the Kinetics of Endothelial Cell Loss Associated With the XEN® Implant Versus Traditional Filtering Surgery for Glaucoma,https://clinicaltrials.gov/study/NCT04781283,WITHDRAWN,INTERVENTIONAL
NCT04014933,Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System,https://clinicaltrials.gov/study/NCT04014933,COMPLETED,OBSERVATIONAL
NCT04143620,Triple Procedure for Dense Cataractus Neovascular Glaucoma Patients,https://clinicaltrials.gov/study/NCT04143620,COMPLETED,INTERVENTIONAL
NCT01908816,An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.,https://clinicaltrials.gov/study/NCT01908816,COMPLETED,INTERVENTIONAL
NCT01612416,Spectral Domain Optical Coherence Tomography Analysis for Glaucoma,https://clinicaltrials.gov/study/NCT01612416,COMPLETED,INTERVENTIONAL
NCT04072016,Study of the Beacon Aqueous Microshunt in Patients With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT04072016,TERMINATED,INTERVENTIONAL
NCT04524416,MINIject Global Long-Term Follow-up Study,https://clinicaltrials.gov/study/NCT04524416,RECRUITING,OBSERVATIONAL
NCT00061516,Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00061516,COMPLETED,INTERVENTIONAL
NCT01229982,A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01229982,COMPLETED,INTERVENTIONAL
NCT01510145,Efficacy of Changing to TRAVATAN® From Prior Therapy,https://clinicaltrials.gov/study/NCT01510145,COMPLETED,INTERVENTIONAL
NCT02570867,Functional Brain Changes of Primary Open-angle Glaucoma Patients,https://clinicaltrials.gov/study/NCT02570867,UNKNOWN,OBSERVATIONAL
NCT00820300,A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00820300,COMPLETED,INTERVENTIONAL
NCT00902200,A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP),https://clinicaltrials.gov/study/NCT00902200,COMPLETED,INTERVENTIONAL
NCT04092400,Study on Micro-invasive Glaucoma Surgical (MIGS) Devices,https://clinicaltrials.gov/study/NCT04092400,UNKNOWN,OBSERVATIONAL
NCT00522600,Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations,https://clinicaltrials.gov/study/NCT00522600,COMPLETED,OBSERVATIONAL
NCT00293800,A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00293800,COMPLETED,INTERVENTIONAL
NCT01433900,Switching From Preserved to Preserved-free Treatments for Glaucoma.,https://clinicaltrials.gov/study/NCT01433900,UNKNOWN,INTERVENTIONAL
NCT02554214,Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device,https://clinicaltrials.gov/study/NCT02554214,UNKNOWN,INTERVENTIONAL
NCT04695314,Foot Reflexology in Ocular Hypertensive and Glaucoma Patients,https://clinicaltrials.gov/study/NCT04695314,COMPLETED,INTERVENTIONAL
NCT04577300,Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma,https://clinicaltrials.gov/study/NCT04577300,RECRUITING,INTERVENTIONAL
NCT04131114,Glaucoma After Congenital And Infantile Cataract Surgery,https://clinicaltrials.gov/study/NCT04131114,UNKNOWN,OBSERVATIONAL
NCT03080714,Triton Agreement and Precision Study,https://clinicaltrials.gov/study/NCT03080714,COMPLETED,OBSERVATIONAL
NCT01978600,Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01978600,COMPLETED,INTERVENTIONAL
NCT03107000,Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy,https://clinicaltrials.gov/study/NCT03107000,COMPLETED,INTERVENTIONAL
NCT00675207,Comparison of Brimonidine Purite Dorzolamide and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs,https://clinicaltrials.gov/study/NCT00675207,COMPLETED,INTERVENTIONAL
NCT04339907,Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears),https://clinicaltrials.gov/study/NCT04339907,RECRUITING,INTERVENTIONAL
NCT01795014,Correlation of Orbital Cerebrospinal Fluid Pressure and Retinal Venous Outflow in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01795014,UNKNOWN,OBSERVATIONAL
NCT04036214,Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT),https://clinicaltrials.gov/study/NCT04036214,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT00449956,MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED),https://clinicaltrials.gov/study/NCT00449956,COMPLETED,INTERVENTIONAL
NCT00275756,Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans,https://clinicaltrials.gov/study/NCT00275756,WITHDRAWN,INTERVENTIONAL
NCT04687800,Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery,https://clinicaltrials.gov/study/NCT04687800,TERMINATED,INTERVENTIONAL
NCT03733600,Evaluation of the Xen Implant in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT03733600,COMPLETED,OBSERVATIONAL
NCT00781300,Intraocular Pressure With Loteprednol and Dexamethasone,https://clinicaltrials.gov/study/NCT00781300,COMPLETED,INTERVENTIONAL
NCT03090243,The Effects of Virtual Colonoscopy on Intraocular Pressure,https://clinicaltrials.gov/study/NCT03090243,UNKNOWN,OBSERVATIONAL
NCT05389267,Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.,https://clinicaltrials.gov/study/NCT05389267,RECRUITING,INTERVENTIONAL
NCT05717543,Imaging of Corneal and Crystalline by Near Infrared Retro-illumination,https://clinicaltrials.gov/study/NCT05717543,COMPLETED,INTERVENTIONAL
NCT03108443,Novel Markers for Detecting Early Progression of Glaucoma,https://clinicaltrials.gov/study/NCT03108443,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT04061343,The Effects of Changing Light Levels on Contrast Sensitivity in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT04061343,COMPLETED,OBSERVATIONAL
NCT03927443,A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03927443,WITHDRAWN,INTERVENTIONAL
NCT06053307,Treating Psychosocial Distress in Glaucoma,https://clinicaltrials.gov/study/NCT06053307,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00823043,A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs,https://clinicaltrials.gov/study/NCT00823043,COMPLETED,OBSERVATIONAL
NCT04521907,Correlative Study on Incidence and Risk Factors of Glaucoma-related Adverse Event at Various Durations After Congenital Cataract Surgery,https://clinicaltrials.gov/study/NCT04521907,UNKNOWN,OBSERVATIONAL
NCT01639807,Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP,https://clinicaltrials.gov/study/NCT01639807,UNKNOWN,INTERVENTIONAL
NCT01364207,The Effects of Caffeinated Coffee on Intraocular Pressure,https://clinicaltrials.gov/study/NCT01364207,COMPLETED,INTERVENTIONAL
NCT04943107,Effect of Antihypertensive Drugs on Glaucoma Patients,https://clinicaltrials.gov/study/NCT04943107,UNKNOWN,OBSERVATIONAL
NCT00300079,Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00300079,COMPLETED,INTERVENTIONAL
NCT04046809,Study of Neurotidine® Intake on Life Quality of Patients With Glaucoma,https://clinicaltrials.gov/study/NCT04046809,COMPLETED,INTERVENTIONAL
NCT02522039,Pupillary Response After Glaucoma Medication,https://clinicaltrials.gov/study/NCT02522039,COMPLETED,INTERVENTIONAL
NCT00902109,Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00902109,UNKNOWN,OBSERVATIONAL
NCT01983579,TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection,https://clinicaltrials.gov/study/NCT01983579,TERMINATED,INTERVENTIONAL
NCT02375009,Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty,https://clinicaltrials.gov/study/NCT02375009,COMPLETED,INTERVENTIONAL
NCT00327509,mRNA Expression in Lymphocytes of Glaucoma Patients,https://clinicaltrials.gov/study/NCT00327509,COMPLETED,OBSERVATIONAL
NCT04585100,FM101 Safety Tolerability Efficacy Study in the Patients With Ocular Hypertension,https://clinicaltrials.gov/study/NCT04585100,UNKNOWN,INTERVENTIONAL
NCT04647214,18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA),https://clinicaltrials.gov/study/NCT04647214,RECRUITING,OBSERVATIONAL
NCT05159414,Study of Application of Pulse Electrical Stimulation Around Eye in Glaucoma Patients,https://clinicaltrials.gov/study/NCT05159414,COMPLETED,INTERVENTIONAL
NCT01168414,A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01168414,COMPLETED,INTERVENTIONAL
NCT01298700,Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01298700,COMPLETED,INTERVENTIONAL
NCT03686072,Cataract Surgery Combined With Endoscopic Goniosynechialysis for Advanced Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT03686072,COMPLETED,INTERVENTIONAL
NCT00570362,Systemic Glutathione Level in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT00570362,COMPLETED,OBSERVATIONAL
NCT01252862,Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents,https://clinicaltrials.gov/study/NCT01252862,COMPLETED,INTERVENTIONAL
NCT04273438,Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.,https://clinicaltrials.gov/study/NCT04273438,UNKNOWN,OBSERVATIONAL
NCT01845038,Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01845038,COMPLETED,INTERVENTIONAL
NCT04586738,Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT04586738,UNKNOWN,INTERVENTIONAL
NCT03852810,Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT03852810,COMPLETED,OBSERVATIONAL
NCT02105272,Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02105272,COMPLETED,INTERVENTIONAL
NCT00751062,A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia,https://clinicaltrials.gov/study/NCT00751062,COMPLETED,INTERVENTIONAL
NCT00348062,A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00348062,COMPLETED,INTERVENTIONAL
NCT00862472,Safety and Efficacy Study of DuoTrav APS Versus DuoTrav,https://clinicaltrials.gov/study/NCT00862472,WITHDRAWN,INTERVENTIONAL
NCT00320762,Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital,https://clinicaltrials.gov/study/NCT00320762,COMPLETED,INTERVENTIONAL
NCT05247762,Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05247762,RECRUITING,INTERVENTIONAL
NCT04024072,To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes,https://clinicaltrials.gov/study/NCT04024072,COMPLETED,INTERVENTIONAL
NCT06016972,Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients,https://clinicaltrials.gov/study/NCT06016972,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00371072,Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma,https://clinicaltrials.gov/study/NCT00371072,COMPLETED,INTERVENTIONAL
NCT01408472,NT-501 CNTF Implant for Glaucoma: Safety Neuroprotection and Neuroenhancement,https://clinicaltrials.gov/study/NCT01408472,COMPLETED,INTERVENTIONAL
NCT04898387,Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.,https://clinicaltrials.gov/study/NCT04898387,COMPLETED,INTERVENTIONAL
NCT03654885,XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS),https://clinicaltrials.gov/study/NCT03654885,COMPLETED,INTERVENTIONAL
NCT03278587,Village-Integrated Eye Worker Trial II - Pilot,https://clinicaltrials.gov/study/NCT03278587,COMPLETED,INTERVENTIONAL
NCT03278587,Village-Integrated Eye Worker Trial II - Pilot,https://clinicaltrials.gov/study/NCT03278587,COMPLETED,INTERVENTIONAL
NCT02876185,Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital,https://clinicaltrials.gov/study/NCT02876185,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT03192085,Comparison of SITA-Standard Compared to SITA-Fast Visual Fields.,https://clinicaltrials.gov/study/NCT03192085,UNKNOWN,INTERVENTIONAL
NCT03192085,Comparison of SITA-Standard Compared to SITA-Fast Visual Fields.,https://clinicaltrials.gov/study/NCT03192085,UNKNOWN,INTERVENTIONAL
NCT01528787,Study of AR-13324 in Patients With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT01528787,COMPLETED,INTERVENTIONAL
NCT04943185,A Prospective Single Surgeon Randomized Control Study Comparing ab Interno XEN Gel Microstent Implantation vs Closed Conjunctiva ab Externo Implantation Performed at the Slit Lamp for the Treatment of Uncontrolled Glaucoma,https://clinicaltrials.gov/study/NCT04943185,RECRUITING,INTERVENTIONAL
NCT00981786,24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol,https://clinicaltrials.gov/study/NCT00981786,COMPLETED,INTERVENTIONAL
NCT00304785,Latanoprost Versus Fotil,https://clinicaltrials.gov/study/NCT00304785,COMPLETED,INTERVENTIONAL
NCT00693485,Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy,https://clinicaltrials.gov/study/NCT00693485,COMPLETED,INTERVENTIONAL
NCT01384487,Nidek RS3000 Comparative Study,https://clinicaltrials.gov/study/NCT01384487,COMPLETED,OBSERVATIONAL
NCT00607685,5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy,https://clinicaltrials.gov/study/NCT00607685,COMPLETED,INTERVENTIONAL
NCT00607685,5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy,https://clinicaltrials.gov/study/NCT00607685,COMPLETED,INTERVENTIONAL
NCT01906151,IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients Before and After LPI,https://clinicaltrials.gov/study/NCT01906151,WITHDRAWN,INTERVENTIONAL
NCT06016712,The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes,https://clinicaltrials.gov/study/NCT06016712,RECRUITING,INTERVENTIONAL
NCT04703712,Lens Extraction Combined With Goniosynechialysis Versus Trabeculectomy,https://clinicaltrials.gov/study/NCT04703712,RECRUITING,INTERVENTIONAL
NCT04434612,Effect of OXSIGHT Smart Glasses on Patients With Advanced Glaucoma,https://clinicaltrials.gov/study/NCT04434612,UNKNOWN,INTERVENTIONAL
NCT02020512,A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02020512,COMPLETED,INTERVENTIONAL
NCT00321386,Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT00321386,UNKNOWN,OBSERVATIONAL
NCT00321386,Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT00321386,UNKNOWN,OBSERVATIONAL
NCT01895686,Comparison of Gonioscopy With Cirrus and Visante,https://clinicaltrials.gov/study/NCT01895686,COMPLETED,OBSERVATIONAL
NCT02327312,Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT02327312,TERMINATED,INTERVENTIONAL
NCT00491712,Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection,https://clinicaltrials.gov/study/NCT00491712,UNKNOWN,INTERVENTIONAL
NCT00651612,Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00651612,COMPLETED,INTERVENTIONAL
NCT00799682,Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®,https://clinicaltrials.gov/study/NCT00799682,COMPLETED,INTERVENTIONAL
NCT04232982,The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis,https://clinicaltrials.gov/study/NCT04232982,RECRUITING,INTERVENTIONAL
NCT01305616,Effect of Yellow-Tinted Intraocular Lens on Standard Automated Perimetry (SAP) and Short-wavelength Automated Perimetry (SWAP) in Patients With and Without Glaucoma,https://clinicaltrials.gov/study/NCT01305616,COMPLETED,INTERVENTIONAL
NCT00347893,The Efficacy of Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00347893,UNKNOWN,OBSERVATIONAL
NCT00402493,Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops,https://clinicaltrials.gov/study/NCT00402493,COMPLETED,INTERVENTIONAL
NCT02708082,Glaucoma HFA / OCT Specificity Study,https://clinicaltrials.gov/study/NCT02708082,UNKNOWN,OBSERVATIONAL
NCT03098316,Metabolomics in Surgical Ophthalmological Patients,https://clinicaltrials.gov/study/NCT03098316,UNKNOWN,OBSERVATIONAL
NCT05299593,24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective Open Study of 3 Months Duration.,https://clinicaltrials.gov/study/NCT05299593,RECRUITING,INTERVENTIONAL
NCT01174420,Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany,https://clinicaltrials.gov/study/NCT01174420,UNKNOWN,INTERVENTIONAL
NCT00626782,Lucentis Versus Mitomycin C During Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00626782,COMPLETED,INTERVENTIONAL
NCT00626782,Lucentis Versus Mitomycin C During Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00626782,COMPLETED,INTERVENTIONAL
NCT05163093,Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular,https://clinicaltrials.gov/study/NCT05163093,RECRUITING,OBSERVATIONAL
NCT01000220,Evaluation of Omeprazole Effect on Glaucoma,https://clinicaltrials.gov/study/NCT01000220,UNKNOWN,INTERVENTIONAL
NCT03642782,Evaluation of the Electroretinogram Pattern (Diopsys® NOVA System) for the Early Diagnosis of Glaucoma,https://clinicaltrials.gov/study/NCT03642782,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT06076720,Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision,https://clinicaltrials.gov/study/NCT06076720,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00767793,A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650),https://clinicaltrials.gov/study/NCT00767793,COMPLETED,INTERVENTIONAL
NCT02679482,Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT02679482,UNKNOWN,OBSERVATIONAL
NCT01843920,The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble,https://clinicaltrials.gov/study/NCT01843920,COMPLETED,INTERVENTIONAL
NCT01228149,COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy,https://clinicaltrials.gov/study/NCT01228149,COMPLETED,INTERVENTIONAL
NCT01314326,Advanced Imaging for Glaucoma Study,https://clinicaltrials.gov/study/NCT01314326,COMPLETED,OBSERVATIONAL
NCT01318252,AL-54478 Proof of Concept Study,https://clinicaltrials.gov/study/NCT01318252,COMPLETED,INTERVENTIONAL
NCT04461249,Comparison Between Latanoprost  Travoprost and Tafluprost in Reducing IOP Fluctuation in POAG Patients,https://clinicaltrials.gov/study/NCT04461249,COMPLETED,OBSERVATIONAL
NCT03267849,Lamina Cribrosa Depth Change With Change in Eye Pressure,https://clinicaltrials.gov/study/NCT03267849,RECRUITING,INTERVENTIONAL
NCT02955849,A Trial of China Laser and Surgery Study Glaucoma in Rural China,https://clinicaltrials.gov/study/NCT02955849,COMPLETED,INTERVENTIONAL
NCT00961649,Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination,https://clinicaltrials.gov/study/NCT00961649,TERMINATED,INTERVENTIONAL
NCT05075226,Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma,https://clinicaltrials.gov/study/NCT05075226,UNKNOWN,OBSERVATIONAL
NCT03972852,Establishment of an Anaesthetic Protocol for Examinations for Children With Glaucoma or Suspected Glaucoma,https://clinicaltrials.gov/study/NCT03972852,UNKNOWN,OBSERVATIONAL
NCT03590249,Effects of a Single Osteopathic Manipulative Treatment (OMT) on Intraocular Pressure (IOP) Reduction,https://clinicaltrials.gov/study/NCT03590249,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT00306852,Tube Versus Trabeculectomy (TVT) Study,https://clinicaltrials.gov/study/NCT00306852,COMPLETED,INTERVENTIONAL
NCT00306852,Tube Versus Trabeculectomy (TVT) Study,https://clinicaltrials.gov/study/NCT00306852,COMPLETED,INTERVENTIONAL
NCT01302249,AR-12286 in Combination With Latanoprost,https://clinicaltrials.gov/study/NCT01302249,COMPLETED,INTERVENTIONAL
NCT02784249,A Comparison of Two Ab Interno Procedures in the Treatment of Glaucoma in Patients Undergoing Cataract Extraction,https://clinicaltrials.gov/study/NCT02784249,COMPLETED,INTERVENTIONAL
NCT04020705,The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma,https://clinicaltrials.gov/study/NCT04020705,COMPLETED,INTERVENTIONAL
NCT00272363,Clinical and Molecular Studies in Families With Glaucoma and Related Diseases,https://clinicaltrials.gov/study/NCT00272363,COMPLETED,OBSERVATIONAL
NCT02863705,Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG),https://clinicaltrials.gov/study/NCT02863705,COMPLETED,INTERVENTIONAL
NCT03548805,Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03548805,COMPLETED,INTERVENTIONAL
NCT02713152,Prevalence of Obstructive Sleep Apnoea in Glaucoma,https://clinicaltrials.gov/study/NCT02713152,COMPLETED,OBSERVATIONAL
NCT02713152,Prevalence of Obstructive Sleep Apnoea in Glaucoma,https://clinicaltrials.gov/study/NCT02713152,COMPLETED,OBSERVATIONAL
NCT00327405,Results of Ocular Compression and Suture Release in Trabeculectomy and Combined Surgery,https://clinicaltrials.gov/study/NCT00327405,COMPLETED,OBSERVATIONAL
NCT00603005,Adherence Improvement in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00603005,COMPLETED,INTERVENTIONAL
NCT00001152,Pigment Dispersion Syndrome With and Without Glaucoma,https://clinicaltrials.gov/study/NCT00001152,COMPLETED,OBSERVATIONAL
NCT00570726,Treatment of Failing Blebs With Ranibizumab,https://clinicaltrials.gov/study/NCT00570726,COMPLETED,INTERVENTIONAL
NCT03889652,Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction,https://clinicaltrials.gov/study/NCT03889652,COMPLETED,OBSERVATIONAL
NCT02959593,The Effects of Visior on Ocular Hemodynamics,https://clinicaltrials.gov/study/NCT02959593,COMPLETED,INTERVENTIONAL
NCT06128720,Hyperbaric Oxygen Therapy for Optic Neuropathies,https://clinicaltrials.gov/study/NCT06128720,RECRUITING,INTERVENTIONAL
NCT03257020,The Diagnostic Performance of BMO-MRW and RNFL Thickness and Their Combinational Index Using Artificial Neural Network,https://clinicaltrials.gov/study/NCT03257020,COMPLETED,OBSERVATIONAL
NCT01021982,Evaluation of Objective Perimetry Using Pupillometer,https://clinicaltrials.gov/study/NCT01021982,COMPLETED,OBSERVATIONAL
NCT01021982,Evaluation of Objective Perimetry Using Pupillometer,https://clinicaltrials.gov/study/NCT01021982,COMPLETED,OBSERVATIONAL
NCT04118920,Safety of Topical Insulin Drops for Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04118920,RECRUITING,INTERVENTIONAL
NCT03534882,Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03534882,COMPLETED,INTERVENTIONAL
NCT05624593,P200TE and Predicate Agreement and Precision Study,https://clinicaltrials.gov/study/NCT05624593,RECRUITING,INTERVENTIONAL
NCT05279716,Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl,https://clinicaltrials.gov/study/NCT05279716,RECRUITING,INTERVENTIONAL
NCT01357616,Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01357616,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT02390245,Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study,https://clinicaltrials.gov/study/NCT02390245,COMPLETED,INTERVENTIONAL
NCT01012245,Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom,https://clinicaltrials.gov/study/NCT01012245,COMPLETED,OBSERVATIONAL
NCT05474716,The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA,https://clinicaltrials.gov/study/NCT05474716,COMPLETED,INTERVENTIONAL
NCT01709916,Comparing Diurnal Fluctuations in Intra Ocular Pressure Measured in Same Day Versus Different Days in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01709916,COMPLETED,OBSERVATIONAL
NCT00753168,Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00753168,COMPLETED,INTERVENTIONAL
NCT05822245,A Study of PER-001 in Participants With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05822245,RECRUITING,INTERVENTIONAL
NCT05670015,Ocular Changes With Alpha-2 Receptor Agonist.,https://clinicaltrials.gov/study/NCT05670015,RECRUITING,INTERVENTIONAL
NCT01693315,Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01693315,COMPLETED,INTERVENTIONAL
NCT01362868,Water Drinking Test During Intraocular Pressure Fluctuation (IOP) Monitoring,https://clinicaltrials.gov/study/NCT01362868,TERMINATED,INTERVENTIONAL
NCT00762645,Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG),https://clinicaltrials.gov/study/NCT00762645,COMPLETED,INTERVENTIONAL
NCT00721968,Safety and Efficacy of the GTS400 Stent in Conjunction With Cataract,https://clinicaltrials.gov/study/NCT00721968,COMPLETED,INTERVENTIONAL
NCT00804115,The International Collaborative Exfoliation Syndrome Treatment Study,https://clinicaltrials.gov/study/NCT00804115,UNKNOWN,INTERVENTIONAL
NCT01551550,Shunt Tube Exposure Prevention Study,https://clinicaltrials.gov/study/NCT01551550,COMPLETED,INTERVENTIONAL
NCT01551550,Shunt Tube Exposure Prevention Study,https://clinicaltrials.gov/study/NCT01551550,COMPLETED,INTERVENTIONAL
NCT01551550,Shunt Tube Exposure Prevention Study,https://clinicaltrials.gov/study/NCT01551550,COMPLETED,INTERVENTIONAL
NCT01551550,Shunt Tube Exposure Prevention Study,https://clinicaltrials.gov/study/NCT01551550,COMPLETED,INTERVENTIONAL
NCT03844945,Efficacy and Systemic Safety of Netarsudil 0.01% 0.02% 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan,https://clinicaltrials.gov/study/NCT03844945,COMPLETED,INTERVENTIONAL
NCT05116345,DEXTENZA for the Treatment of Pain and Inflammation Following Surgical Trabeculectomy and Ahmed Valve Procedures,https://clinicaltrials.gov/study/NCT05116345,UNKNOWN,INTERVENTIONAL
NCT02993445,Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension,https://clinicaltrials.gov/study/NCT02993445,COMPLETED,INTERVENTIONAL
NCT01017068,Aqueous Mushroom Extract and Intraocular Pressure,https://clinicaltrials.gov/study/NCT01017068,UNKNOWN,INTERVENTIONAL
NCT00523250,Ocular Hypotensive Efficacy of AR-102,https://clinicaltrials.gov/study/NCT00523250,COMPLETED,INTERVENTIONAL
NCT02434250,Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy,https://clinicaltrials.gov/study/NCT02434250,COMPLETED,INTERVENTIONAL
NCT03506568,A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications,https://clinicaltrials.gov/study/NCT03506568,COMPLETED,INTERVENTIONAL
NCT03506568,A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications,https://clinicaltrials.gov/study/NCT03506568,COMPLETED,INTERVENTIONAL
NCT03506568,A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications,https://clinicaltrials.gov/study/NCT03506568,COMPLETED,INTERVENTIONAL
NCT03798145,Surgical Retinotomy for the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT03798145,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04110015,Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis,https://clinicaltrials.gov/study/NCT04110015,TERMINATED,OBSERVATIONAL
NCT01978015,Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG,https://clinicaltrials.gov/study/NCT01978015,COMPLETED,INTERVENTIONAL
NCT01535768,Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves,https://clinicaltrials.gov/study/NCT01535768,UNKNOWN,INTERVENTIONAL
NCT04405245,Study to Assess the Efficacy Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04405245,COMPLETED,INTERVENTIONAL
NCT05062668,Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05062668,RECRUITING,OBSERVATIONAL
NCT01416415,Glaucoma Eye Drop Instillation: Impact of Education,https://clinicaltrials.gov/study/NCT01416415,TERMINATED,INTERVENTIONAL
NCT03125850,Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients,https://clinicaltrials.gov/study/NCT03125850,COMPLETED,INTERVENTIONAL
NCT01309204,Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01309204,COMPLETED,INTERVENTIONAL
NCT00823706,Prevalence of Angle Closure in Caucasian Hyperopes,https://clinicaltrials.gov/study/NCT00823706,UNKNOWN,OBSERVATIONAL
NCT06023927,Obstructive Sleep Apnea as a Risk Factor for Normal Tension Glaucoma and a Crucial Step in Preventing Blindness,https://clinicaltrials.gov/study/NCT06023927,NOT_YET_RECRUITING,OBSERVATIONAL
NCT05209204,Anterior Chamber Angle Examination in Angle Closure Suspect Patients,https://clinicaltrials.gov/study/NCT05209204,COMPLETED,OBSERVATIONAL
NCT01319604,SENSIMED Triggerfish,https://clinicaltrials.gov/study/NCT01319604,COMPLETED,INTERVENTIONAL
NCT02870504,Clinical Study of LPI on Different Sites of Iris,https://clinicaltrials.gov/study/NCT02870504,UNKNOWN,INTERVENTIONAL
NCT04673604,From Preserved to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy,https://clinicaltrials.gov/study/NCT04673604,COMPLETED,INTERVENTIONAL
NCT01342406,Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics,https://clinicaltrials.gov/study/NCT01342406,COMPLETED,OBSERVATIONAL
NCT01460017,Comparison Between Deep Sclerectomy and Traditional Trabeculotomy & Trabeculectomy in Congenital Glaucoma,https://clinicaltrials.gov/study/NCT01460017,UNKNOWN,INTERVENTIONAL
NCT03289806,Effects of DHA on Post-operative Fibrosis of Trabulectomy Blebs in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT03289806,UNKNOWN,OBSERVATIONAL
NCT01254006,Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients,https://clinicaltrials.gov/study/NCT01254006,COMPLETED,INTERVENTIONAL
NCT01254006,Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients,https://clinicaltrials.gov/study/NCT01254006,COMPLETED,INTERVENTIONAL
NCT01254006,Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients,https://clinicaltrials.gov/study/NCT01254006,COMPLETED,INTERVENTIONAL
NCT02247804,Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02247804,COMPLETED,INTERVENTIONAL
NCT03133117,Deficits Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma),https://clinicaltrials.gov/study/NCT03133117,TERMINATED,INTERVENTIONAL
NCT00751127,A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00751127,COMPLETED,INTERVENTIONAL
NCT04595227,Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device,https://clinicaltrials.gov/study/NCT04595227,UNKNOWN,OBSERVATIONAL
NCT01493427,Efficacy of Changing to TRAVATAN® From Prior Therapy,https://clinicaltrials.gov/study/NCT01493427,COMPLETED,INTERVENTIONAL
NCT01722604,Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt,https://clinicaltrials.gov/study/NCT01722604,COMPLETED,INTERVENTIONAL
NCT05973305,Comparative Study of Dorzol Eye Drops 20 mg/ml Versus Trusopt® Eye Drops 20 mg/ml,https://clinicaltrials.gov/study/NCT05973305,COMPLETED,INTERVENTIONAL
NCT05466526,Microinvasive Glaucoma Surgery -The Lowering Effect of Intraocular Pressure on Glaucoma Patients With High Frequency Deep Sclerotomy,https://clinicaltrials.gov/study/NCT05466526,RECRUITING,INTERVENTIONAL
NCT00486252,Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®,https://clinicaltrials.gov/study/NCT00486252,COMPLETED,OBSERVATIONAL
NCT02471105,Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml,https://clinicaltrials.gov/study/NCT02471105,UNKNOWN,INTERVENTIONAL
NCT01987752,Safety and Efficacy of Combigan® Ophthalmic Solution in Korea,https://clinicaltrials.gov/study/NCT01987752,COMPLETED,OBSERVATIONAL
NCT01252849,Purpose of This Study is to Evaluate the Safety and Efficacy of One Two or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects,https://clinicaltrials.gov/study/NCT01252849,COMPLETED,INTERVENTIONAL
NCT00709449,An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration Primary Open Angle Glaucoma and Healthy Control Subjects,https://clinicaltrials.gov/study/NCT00709449,COMPLETED,INTERVENTIONAL
NCT02627352,How Safe and Effective is Micropulse Transscleral Cyclophotocoagulation in Patients With Uncontrolled Glaucoma?,https://clinicaltrials.gov/study/NCT02627352,COMPLETED,INTERVENTIONAL
NCT00853905,Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?,https://clinicaltrials.gov/study/NCT00853905,COMPLETED,INTERVENTIONAL
NCT01444105,Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT01444105,COMPLETED,INTERVENTIONAL
NCT06078605,Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients,https://clinicaltrials.gov/study/NCT06078605,RECRUITING,INTERVENTIONAL
NCT00451152,Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00451152,COMPLETED,INTERVENTIONAL
NCT04455126,Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma,https://clinicaltrials.gov/study/NCT04455126,COMPLETED,INTERVENTIONAL
NCT03318705,Testing Latest Version of NidekRS3000Adv,https://clinicaltrials.gov/study/NCT03318705,COMPLETED,OBSERVATIONAL
NCT01462526,The Detection of Glaucoma Using Pupillography,https://clinicaltrials.gov/study/NCT01462526,COMPLETED,OBSERVATIONAL
NCT02789293,Glaucoma Treatment Using Focused Ultrasound in Open Angle Glaucoma Patients,https://clinicaltrials.gov/study/NCT02789293,COMPLETED,INTERVENTIONAL
NCT00047593,Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98,https://clinicaltrials.gov/study/NCT00047593,COMPLETED,INTERVENTIONAL
NCT01343082,DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01343082,COMPLETED,INTERVENTIONAL
NCT01527682,Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma,https://clinicaltrials.gov/study/NCT01527682,COMPLETED,INTERVENTIONAL
NCT04417920,Express Implant Versus Trabeculectomy After Late Failure Trabeculectomy,https://clinicaltrials.gov/study/NCT04417920,COMPLETED,INTERVENTIONAL
NCT03850782,Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03850782,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02526693,Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects?,https://clinicaltrials.gov/study/NCT02526693,COMPLETED,INTERVENTIONAL
NCT04302220,Myopic Optic Neuropathy in Chinese High Myopia Population,https://clinicaltrials.gov/study/NCT04302220,RECRUITING,OBSERVATIONAL
NCT01067482,The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes,https://clinicaltrials.gov/study/NCT01067482,COMPLETED,OBSERVATIONAL
NCT05576493,Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT05576493,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT05654493,Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients,https://clinicaltrials.gov/study/NCT05654493,RECRUITING,OBSERVATIONAL
NCT00824720,Safety and Efficacy of a Glaucoma Drug Delivery System,https://clinicaltrials.gov/study/NCT00824720,COMPLETED,INTERVENTIONAL
NCT02639975,First-in-human Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers,https://clinicaltrials.gov/study/NCT02639975,COMPLETED,INTERVENTIONAL
NCT04421859,Augmented Reality Mobile Application for Glaucoma Education in the South Bronx,https://clinicaltrials.gov/study/NCT04421859,COMPLETED,INTERVENTIONAL
NCT03587454,Feasibility of Teleglaucoma Versus Conventional Clinical Evaluation for Diagnostic Accuracy and Management Recommendations in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT03587454,COMPLETED,INTERVENTIONAL
NCT01923454,Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure,https://clinicaltrials.gov/study/NCT01923454,COMPLETED,INTERVENTIONAL
NCT04563559,PREFERENTIAL Study,https://clinicaltrials.gov/study/NCT04563559,WITHDRAWN,INTERVENTIONAL
NCT03758859,CLARITY Imaging Study,https://clinicaltrials.gov/study/NCT03758859,UNKNOWN,INTERVENTIONAL
NCT03751059,NSAID vs Steroid in Trabeculectomy Wound Management,https://clinicaltrials.gov/study/NCT03751059,UNKNOWN,INTERVENTIONAL
NCT00332059,Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332059,COMPLETED,INTERVENTIONAL
NCT04868175,Interval Intraocular Pressure in Intravitreal Injection Study,https://clinicaltrials.gov/study/NCT04868175,COMPLETED,INTERVENTIONAL
NCT05548959,Outflow Facility AIT vs Microshunt,https://clinicaltrials.gov/study/NCT05548959,COMPLETED,INTERVENTIONAL
NCT04215575,Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases,https://clinicaltrials.gov/study/NCT04215575,COMPLETED,INTERVENTIONAL
NCT03639675,Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injection is Also Studied,https://clinicaltrials.gov/study/NCT03639675,COMPLETED,INTERVENTIONAL
NCT05992415,New York City Eye Study (NYCES),https://clinicaltrials.gov/study/NCT05992415,NOT_YET_RECRUITING,INTERVENTIONAL
NCT06066645,Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone,https://clinicaltrials.gov/study/NCT06066645,RECRUITING,INTERVENTIONAL
NCT03365245,Partial Least Squares Regression Modelling for Glaucoma Detection,https://clinicaltrials.gov/study/NCT03365245,COMPLETED,INTERVENTIONAL
NCT05752045,OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases,https://clinicaltrials.gov/study/NCT05752045,RECRUITING,INTERVENTIONAL
NCT05752045,OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases,https://clinicaltrials.gov/study/NCT05752045,RECRUITING,INTERVENTIONAL
NCT05752045,OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases,https://clinicaltrials.gov/study/NCT05752045,RECRUITING,INTERVENTIONAL
NCT05451745,Glaucoma Following Pediatric Cataract Surgery,https://clinicaltrials.gov/study/NCT05451745,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT02539745,Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02539745,COMPLETED,OBSERVATIONAL
NCT03967145,Turkish Version of the Glaucoma Quality of Life-15 Questionnaire,https://clinicaltrials.gov/study/NCT03967145,COMPLETED,OBSERVATIONAL
NCT02710916,SD-OCT Multimodal Analysis in GLaucoma,https://clinicaltrials.gov/study/NCT02710916,COMPLETED,INTERVENTIONAL
NCT02084745,Timing of Glaucoma Drainage Device With Boston Keratoprosthesis,https://clinicaltrials.gov/study/NCT02084745,RECRUITING,INTERVENTIONAL
NCT00280345,Autoimmune Dysregulation in Pigmentary Glaucoma,https://clinicaltrials.gov/study/NCT00280345,COMPLETED,INTERVENTIONAL
NCT00308945,Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00308945,COMPLETED,INTERVENTIONAL
NCT02921568,Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes,https://clinicaltrials.gov/study/NCT02921568,UNKNOWN,INTERVENTIONAL
NCT04401982,Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects,https://clinicaltrials.gov/study/NCT04401982,COMPLETED,OBSERVATIONAL
NCT04296916,Effect of Lowering IOP in Glaucoma Suspects With HM,https://clinicaltrials.gov/study/NCT04296916,RECRUITING,INTERVENTIONAL
NCT00727168,Screening for Glaucoma in Namil Area South Korea,https://clinicaltrials.gov/study/NCT00727168,COMPLETED,OBSERVATIONAL
NCT00471068,Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00471068,TERMINATED,INTERVENTIONAL
NCT04354545,Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications,https://clinicaltrials.gov/study/NCT04354545,RECRUITING,OBSERVATIONAL
NCT05405868,Nicotinamide in Glaucoma,https://clinicaltrials.gov/study/NCT05405868,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04635020,Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group,https://clinicaltrials.gov/study/NCT04635020,RECRUITING,INTERVENTIONAL
NCT01520116,Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension,https://clinicaltrials.gov/study/NCT01520116,UNKNOWN,INTERVENTIONAL
NCT00141882,Memantine in Patients With Chronic Glaucoma,https://clinicaltrials.gov/study/NCT00141882,COMPLETED,INTERVENTIONAL
NCT02835482,Effect of Elevated Intraocular Pressure in Glaucoma Patients During Femtolaser Cataract Surgery,https://clinicaltrials.gov/study/NCT02835482,TERMINATED,INTERVENTIONAL
NCT04542616,Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT04542616,RECRUITING,INTERVENTIONAL
NCT01053416,Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser Iridotomy,https://clinicaltrials.gov/study/NCT01053416,COMPLETED,INTERVENTIONAL
NCT00637130,Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost,https://clinicaltrials.gov/study/NCT00637130,COMPLETED,INTERVENTIONAL
NCT04629521,Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent,https://clinicaltrials.gov/study/NCT04629521,COMPLETED,INTERVENTIONAL
NCT06078592,Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive,https://clinicaltrials.gov/study/NCT06078592,COMPLETED,INTERVENTIONAL
NCT01422525,Changes of the Peripapillary Retinal Nerve Fiber Layer After Filtration Surgery in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01422525,TERMINATED,OBSERVATIONAL
NCT05251792,Macular Pigment Optical Density in Primary Angle-closure Disease,https://clinicaltrials.gov/study/NCT05251792,RECRUITING,OBSERVATIONAL
NCT01020721,The Genetic Characteristics in South Korean Patients With Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT01020721,UNKNOWN,OBSERVATIONAL
NCT00454025,Intraocular Pressure (IOP) Changes Associated With Muslim Prayer Postural Changes,https://clinicaltrials.gov/study/NCT00454025,TERMINATED,OBSERVATIONAL
NCT00527592,A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00527592,COMPLETED,INTERVENTIONAL
NCT03352492,Effect of Peripheral Laser Iridotomy Placement on Post-operative Visual Function,https://clinicaltrials.gov/study/NCT03352492,UNKNOWN,INTERVENTIONAL
NCT05557721,Uddevalla Skövde Transscleral Micropulse Study,https://clinicaltrials.gov/study/NCT05557721,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT01510392,CEI Van Outreach Screening Study,https://clinicaltrials.gov/study/NCT01510392,COMPLETED,OBSERVATIONAL
NCT03104621,Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients,https://clinicaltrials.gov/study/NCT03104621,COMPLETED,INTERVENTIONAL
NCT02207621,Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02207621,COMPLETED,INTERVENTIONAL
NCT00465621,Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00465621,COMPLETED,INTERVENTIONAL
NCT03766425,Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.,https://clinicaltrials.gov/study/NCT03766425,COMPLETED,INTERVENTIONAL
NCT00772330,Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms,https://clinicaltrials.gov/study/NCT00772330,COMPLETED,INTERVENTIONAL
NCT04465630,A Prospective Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04465630,TERMINATED,INTERVENTIONAL
NCT05052242,Evaluation of Ocular Biometry in PACD With Two Swept Source Optical Coherence Tomography Devices,https://clinicaltrials.gov/study/NCT05052242,COMPLETED,OBSERVATIONAL
NCT02822742,A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study,https://clinicaltrials.gov/study/NCT02822742,COMPLETED,INTERVENTIONAL
NCT00342342,Family Studies of Eye Traits,https://clinicaltrials.gov/study/NCT00342342,COMPLETED,OBSERVATIONAL
NCT01794442,Study on the Oxygen Saturation in Pulsating and Non-pulsating Central Retinal Veins,https://clinicaltrials.gov/study/NCT01794442,UNKNOWN,OBSERVATIONAL
NCT02512042,Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes,https://clinicaltrials.gov/study/NCT02512042,COMPLETED,INTERVENTIONAL
NCT03373942,The Effect of Pseudoexfoliation on Choroidal Thickness in Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03373942,COMPLETED,OBSERVATIONAL
NCT01287442,Evaluation of Filtering Blebs Using the Wuerzburg Bleb Classification Score Compared to Other Clinical Findings e.g. the Intraocular Pressure (IOP),https://clinicaltrials.gov/study/NCT01287442,COMPLETED,OBSERVATIONAL
NCT00346489,Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C,https://clinicaltrials.gov/study/NCT00346489,COMPLETED,INTERVENTIONAL
NCT00846989,Efficacy Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00846989,COMPLETED,INTERVENTIONAL
NCT02083289,A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG),https://clinicaltrials.gov/study/NCT02083289,COMPLETED,INTERVENTIONAL
NCT01936389,A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma,https://clinicaltrials.gov/study/NCT01936389,COMPLETED,INTERVENTIONAL
NCT05543889,Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists,https://clinicaltrials.gov/study/NCT05543889,NOT_YET_RECRUITING,OBSERVATIONAL
NCT00061542,Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00061542,COMPLETED,INTERVENTIONAL
NCT01042665,Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus Placebo,https://clinicaltrials.gov/study/NCT01042665,COMPLETED,OBSERVATIONAL
NCT06000865,Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE,https://clinicaltrials.gov/study/NCT06000865,NOT_YET_RECRUITING,INTERVENTIONAL
NCT06000865,Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE,https://clinicaltrials.gov/study/NCT06000865,NOT_YET_RECRUITING,INTERVENTIONAL
NCT06000865,Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE,https://clinicaltrials.gov/study/NCT06000865,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02023242,Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes,https://clinicaltrials.gov/study/NCT02023242,COMPLETED,INTERVENTIONAL
NCT00934089,A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329,https://clinicaltrials.gov/study/NCT00934089,COMPLETED,INTERVENTIONAL
NCT00468988,Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers,https://clinicaltrials.gov/study/NCT00468988,COMPLETED,INTERVENTIONAL
NCT04863365,A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04863365,UNKNOWN,INTERVENTIONAL
NCT05876689,Swept Source OCT Imaging With the DREAM VG-OCT,https://clinicaltrials.gov/study/NCT05876689,RECRUITING,OBSERVATIONAL
NCT03800589,Assessment of Effectiveness Ex-Press Surgery Modification,https://clinicaltrials.gov/study/NCT03800589,COMPLETED,INTERVENTIONAL
NCT00775489,Nasal Steroids in Controlled Glaucoma,https://clinicaltrials.gov/study/NCT00775489,COMPLETED,INTERVENTIONAL
NCT00567788,Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study,https://clinicaltrials.gov/study/NCT00567788,UNKNOWN,INTERVENTIONAL
NCT01443988,Subjects With Open-angle Glaucoma Pseudoexfoliative Glaucoma or Ocular Hypertension Naïve to Medical and Surgical Therapy Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost,https://clinicaltrials.gov/study/NCT01443988,COMPLETED,INTERVENTIONAL
NCT05241938,PSLT Compared to Prostaglandin Analogue Eye Drops,https://clinicaltrials.gov/study/NCT05241938,RECRUITING,INTERVENTIONAL
NCT01417689,Eyedrop Instillation Technique,https://clinicaltrials.gov/study/NCT01417689,UNKNOWN,INTERVENTIONAL
NCT04700189,A FIH Trial of the STREAMLINE™ SURGICAL SYSTEM,https://clinicaltrials.gov/study/NCT04700189,COMPLETED,INTERVENTIONAL
NCT04900142,Micropulsed Laser Trabeculoplasty Using Different Parameters,https://clinicaltrials.gov/study/NCT04900142,UNKNOWN,INTERVENTIONAL
NCT05162989,iCare HOME2 Clinical Trial,https://clinicaltrials.gov/study/NCT05162989,COMPLETED,INTERVENTIONAL
NCT00311389,A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00311389,COMPLETED,INTERVENTIONAL
NCT01956942,Micropulse Laser Trabeculoplasty (MLT) Versus Selective Laser Trabeculoplasty (SLT) for Treatment of Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01956942,COMPLETED,INTERVENTIONAL
NCT01222065,Polarization Sensitive Retinal Tomography for Glaucoma Diagnosis,https://clinicaltrials.gov/study/NCT01222065,COMPLETED,OBSERVATIONAL
NCT00444665,Examining The Efficacy Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy,https://clinicaltrials.gov/study/NCT00444665,COMPLETED,INTERVENTIONAL
NCT04651530,Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT04651530,RECRUITING,INTERVENTIONAL
NCT04129021,Multimodal Ophthalmic Imaging,https://clinicaltrials.gov/study/NCT04129021,UNKNOWN,INTERVENTIONAL
NCT05283031,The Water Drinking Test in Glaucoma Study,https://clinicaltrials.gov/study/NCT05283031,RECRUITING,OBSERVATIONAL
NCT00405431,Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?,https://clinicaltrials.gov/study/NCT00405431,COMPLETED,INTERVENTIONAL
NCT00051142,A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT00051142,COMPLETED,INTERVENTIONAL
NCT02613442,Factors Affecting Aqueous Humor Outflow Facility in Patients With Uveitis,https://clinicaltrials.gov/study/NCT02613442,WITHDRAWN,OBSERVATIONAL
NCT05316142,Any Unique Identifier Assigned to the Protocol by the Sponsor,https://clinicaltrials.gov/study/NCT05316142,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00956865,Community Glaucoma Screening Follow-up,https://clinicaltrials.gov/study/NCT00956865,COMPLETED,INTERVENTIONAL
NCT04052165,IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient,https://clinicaltrials.gov/study/NCT04052165,COMPLETED,INTERVENTIONAL
NCT04052165,IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient,https://clinicaltrials.gov/study/NCT04052165,COMPLETED,INTERVENTIONAL
NCT04052165,IOP Reduction and Complications of Polymethyl Methacrylate GDD on Glaucoma Patient,https://clinicaltrials.gov/study/NCT04052165,COMPLETED,INTERVENTIONAL
NCT01687465,A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01687465,UNKNOWN,INTERVENTIONAL
NCT03595865,Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy,https://clinicaltrials.gov/study/NCT03595865,UNKNOWN,INTERVENTIONAL
NCT03609125,Cord Blood Serum in the Treatment of Neuro-Degenerative Ophthalmic Diseases. 1-Glaucoma,https://clinicaltrials.gov/study/NCT03609125,UNKNOWN,INTERVENTIONAL
NCT04380025,Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT04380025,UNKNOWN,INTERVENTIONAL
NCT03293992,A Study of the Safety Tolerability Pharmacokinetics and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03293992,COMPLETED,INTERVENTIONAL
NCT04515030,Changes of Trace Elements in Aqueous Humor Blood and Tears and Analysis of Related Factors,https://clinicaltrials.gov/study/NCT04515030,COMPLETED,OBSERVATIONAL
NCT05113121,Correlation Between Pupil Size and Ocular Signs of Pseudoexfoliation Syndrome,https://clinicaltrials.gov/study/NCT05113121,COMPLETED,OBSERVATIONAL
NCT04645992,Effect of Combining Yoga to TENS on Diabetic Glaucoma,https://clinicaltrials.gov/study/NCT04645992,UNKNOWN,INTERVENTIONAL
NCT02047630,Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02047630,TERMINATED,INTERVENTIONAL
NCT01484392,Determinants of Compliance With Glaucoma Therapy,https://clinicaltrials.gov/study/NCT01484392,COMPLETED,OBSERVATIONAL
NCT06120621,Combined VCST With Phacoemulsification Versus Phacoemulsification in Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT06120621,COMPLETED,INTERVENTIONAL
NCT04079725,Iris Tissue in Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT04079725,UNKNOWN,INTERVENTIONAL
NCT03611530,CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03611530,UNKNOWN,INTERVENTIONAL
NCT04054830,Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.,https://clinicaltrials.gov/study/NCT04054830,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00326092,A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00326092,COMPLETED,INTERVENTIONAL
NCT04323930,eyeWatch vs. Trabeculectomy RCT (evT),https://clinicaltrials.gov/study/NCT04323930,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT03870230,Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects,https://clinicaltrials.gov/study/NCT03870230,RECRUITING,INTERVENTIONAL
NCT00000125,Ocular Hypertension Treatment Study (OHTS),https://clinicaltrials.gov/study/NCT00000125,COMPLETED,INTERVENTIONAL
NCT04896125,Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study,https://clinicaltrials.gov/study/NCT04896125,UNKNOWN,OBSERVATIONAL
NCT03959592,Macular Pigment and Visual Performance in Glaucoma Patients,https://clinicaltrials.gov/study/NCT03959592,TERMINATED,INTERVENTIONAL
NCT03959592,Macular Pigment and Visual Performance in Glaucoma Patients,https://clinicaltrials.gov/study/NCT03959592,TERMINATED,INTERVENTIONAL
NCT03959592,Macular Pigment and Visual Performance in Glaucoma Patients,https://clinicaltrials.gov/study/NCT03959592,TERMINATED,INTERVENTIONAL
NCT00741130,Corrected Measurement of the Retinal Nerve Fiber Layer Thickness by Optic Disc Configuration With the Cirrus HD OCT,https://clinicaltrials.gov/study/NCT00741130,UNKNOWN,OBSERVATIONAL
NCT04297930,Treatment Outcomes of a Novel Glaucoma Tube Shunt Implant for Intraocular Pressure Control in Eyes With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT04297930,COMPLETED,OBSERVATIONAL
NCT01749930,Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01749930,COMPLETED,INTERVENTIONAL
NCT03894631,Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure,https://clinicaltrials.gov/study/NCT03894631,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00406042,The Role of Steroids Following Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00406042,COMPLETED,INTERVENTIONAL
NCT00273442,Assessing Cosopt Switch Patients,https://clinicaltrials.gov/study/NCT00273442,COMPLETED,INTERVENTIONAL
NCT02785042,Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3),https://clinicaltrials.gov/study/NCT02785042,TERMINATED,INTERVENTIONAL
NCT04141865,Effect of Xen Implantation on the Aqueous Humor Proteome,https://clinicaltrials.gov/study/NCT04141865,TERMINATED,OBSERVATIONAL
NCT02598765,Micro vs. Standard Trabeculectomy Study,https://clinicaltrials.gov/study/NCT02598765,UNKNOWN,INTERVENTIONAL
NCT02598765,Micro vs. Standard Trabeculectomy Study,https://clinicaltrials.gov/study/NCT02598765,UNKNOWN,INTERVENTIONAL
NCT04967989,Clarifying the Optimal Application of SLT Therapy Trial,https://clinicaltrials.gov/study/NCT04967989,RECRUITING,INTERVENTIONAL
NCT01105065,Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma,https://clinicaltrials.gov/study/NCT01105065,COMPLETED,INTERVENTIONAL
NCT03188042,A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma,https://clinicaltrials.gov/study/NCT03188042,COMPLETED,INTERVENTIONAL
NCT04460365,European Nutrition in Glaucoma Management Trial,https://clinicaltrials.gov/study/NCT04460365,COMPLETED,INTERVENTIONAL
NCT00766389,Retinal Nerve Fiber Layer Thickness Analysis With Cirrus HD OCT Versus Stratus Optical Coherence Tomography (OCT),https://clinicaltrials.gov/study/NCT00766389,UNKNOWN,OBSERVATIONAL
NCT04702789,Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.,https://clinicaltrials.gov/study/NCT04702789,TERMINATED,INTERVENTIONAL
NCT02805231,Associations of Vitamin D Receptor ApaI and Tru9I Polymorphisms With the Risk of Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02805231,COMPLETED,OBSERVATIONAL
NCT03966365,Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®,https://clinicaltrials.gov/study/NCT03966365,COMPLETED,INTERVENTIONAL
NCT05949242,Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent,https://clinicaltrials.gov/study/NCT05949242,RECRUITING,INTERVENTIONAL
NCT00347789,Effectiveness of a Procedure for Previously Failed Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00347789,COMPLETED,OBSERVATIONAL
NCT02165631,The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure,https://clinicaltrials.gov/study/NCT02165631,COMPLETED,OBSERVATIONAL
NCT01864642,Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects,https://clinicaltrials.gov/study/NCT01864642,COMPLETED,INTERVENTIONAL
NCT05332665,AS-OCT Evaluation of Iridocorneal Angle of Patients of Angle Closure Glaucoma After Phacoemulsification,https://clinicaltrials.gov/study/NCT05332665,RECRUITING,OBSERVATIONAL
NCT00576342,Patient Preference Study,https://clinicaltrials.gov/study/NCT00576342,COMPLETED,INTERVENTIONAL
NCT02959242,Dresden Glaucoma and Treatment Study (DGTS),https://clinicaltrials.gov/study/NCT02959242,RECRUITING,OBSERVATIONAL
NCT00638742,A Phase 1 Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.,https://clinicaltrials.gov/study/NCT00638742,COMPLETED,INTERVENTIONAL
NCT02366065,Does Oral Acetaminophen Lower Intraocular Pressure?,https://clinicaltrials.gov/study/NCT02366065,COMPLETED,INTERVENTIONAL
NCT03928665,Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea,https://clinicaltrials.gov/study/NCT03928665,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT06124521,Community Based Treatment for (ComBaT) Glaucoma,https://clinicaltrials.gov/study/NCT06124521,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00372931,A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00372931,COMPLETED,INTERVENTIONAL
NCT03187821,Comparison of Superior vs Nasal/Temporal Laser Peripheral Iridotomy in Primary Angle Closure,https://clinicaltrials.gov/study/NCT03187821,COMPLETED,INTERVENTIONAL
NCT06154330,Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas,https://clinicaltrials.gov/study/NCT06154330,RECRUITING,OBSERVATIONAL
NCT03394521,Progression of Disease in Patients Newly Diagnosed With Glaucoma and Glaucoma Suspects Participating in the GATE Study,https://clinicaltrials.gov/study/NCT03394521,COMPLETED,OBSERVATIONAL
NCT00765921,Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma,https://clinicaltrials.gov/study/NCT00765921,COMPLETED,INTERVENTIONAL
NCT00838721,Evaluation of Pascal Laser Trabeculoplaty,https://clinicaltrials.gov/study/NCT00838721,COMPLETED,INTERVENTIONAL
NCT04145830,UCP Glaucoma Treatment for Primary Glaucoma in China,https://clinicaltrials.gov/study/NCT04145830,COMPLETED,INTERVENTIONAL
NCT01409421,RESEARCH PROTOCOL: Glaucoma Treatment Adherence and Persistence,https://clinicaltrials.gov/study/NCT01409421,COMPLETED,INTERVENTIONAL
NCT06112431,New York City SIGHT Study-2,https://clinicaltrials.gov/study/NCT06112431,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04918121,A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery,https://clinicaltrials.gov/study/NCT04918121,RECRUITING,INTERVENTIONAL
NCT05686421,Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations,https://clinicaltrials.gov/study/NCT05686421,COMPLETED,INTERVENTIONAL
NCT02901730,Clinical Study of LPI With Different Laser Wavelengths,https://clinicaltrials.gov/study/NCT02901730,UNKNOWN,INTERVENTIONAL
NCT04157530,Clinical Evaluation of Acupuncture in Treating Glaucoma,https://clinicaltrials.gov/study/NCT04157530,COMPLETED,INTERVENTIONAL
NCT05235321,Automated Applanation Tonometry,https://clinicaltrials.gov/study/NCT05235321,RECRUITING,INTERVENTIONAL
NCT00303121,Compliance and Administration Technique in Topical Drug Therapy of Glaucoma,https://clinicaltrials.gov/study/NCT00303121,COMPLETED,OBSERVATIONAL
NCT01228721,Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy Controls,https://clinicaltrials.gov/study/NCT01228721,TERMINATED,INTERVENTIONAL
NCT03077789,Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France,https://clinicaltrials.gov/study/NCT03077789,UNKNOWN,INTERVENTIONAL
NCT02599688,Open Label Extension of LipoLat-CS202,https://clinicaltrials.gov/study/NCT02599688,COMPLETED,OBSERVATIONAL
NCT00224289,Effect of Age on Latanoprost 0.005% in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT00224289,COMPLETED,INTERVENTIONAL
NCT03494465,Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma,https://clinicaltrials.gov/study/NCT03494465,COMPLETED,INTERVENTIONAL
NCT04683289,Visco-Circumferential-Suture-Trabeculotomy Versus Trabeculotomy,https://clinicaltrials.gov/study/NCT04683289,COMPLETED,INTERVENTIONAL
NCT02928289,Randomized Study of the Safety and Effectiveness of the Sight Sciences VISCO™360 Viscosurgical System Versus SLT in Primary Open Angle Glaucoma (VISCO360 Study),https://clinicaltrials.gov/study/NCT02928289,TERMINATED,INTERVENTIONAL
NCT01446588,Ocular Hypertension And Yoga Study,https://clinicaltrials.gov/study/NCT01446588,WITHDRAWN,INTERVENTIONAL
NCT00573638,Effects of Xal-Ease on Patient Compliance With Xalatan,https://clinicaltrials.gov/study/NCT00573638,UNKNOWN,INTERVENTIONAL
NCT03689088,Sensing Contact Lens-based Device for 24-hour Monitoring of Intraocular Pressure,https://clinicaltrials.gov/study/NCT03689088,COMPLETED,INTERVENTIONAL
NCT03323138,Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT03323138,UNKNOWN,INTERVENTIONAL
NCT01308788,Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow,https://clinicaltrials.gov/study/NCT01308788,COMPLETED,OBSERVATIONAL
NCT01906138,An Open Label Study Assessing the 24-hour Intraocular Pressure Pattern in PAC and PACG Patients Before and After Laser Peripheral Iridotomy,https://clinicaltrials.gov/study/NCT01906138,COMPLETED,INTERVENTIONAL
NCT04651231,Punch Trabeculectomy Versus Classic Trabeculectomy,https://clinicaltrials.gov/study/NCT04651231,COMPLETED,INTERVENTIONAL
NCT00346931,Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure,https://clinicaltrials.gov/study/NCT00346931,TERMINATED,INTERVENTIONAL
NCT01836042,Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort,https://clinicaltrials.gov/study/NCT01836042,COMPLETED,OBSERVATIONAL
NCT00758342,Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG),https://clinicaltrials.gov/study/NCT00758342,TERMINATED,INTERVENTIONAL
NCT06120842,Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution,https://clinicaltrials.gov/study/NCT06120842,RECRUITING,INTERVENTIONAL
NCT03268031,Artificial Intelligence-assissted Glaucoma Evaluation,https://clinicaltrials.gov/study/NCT03268031,COMPLETED,OBSERVATIONAL
NCT00541242,Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00541242,COMPLETED,INTERVENTIONAL
NCT00716742,Safety and Efficacy Study of Bimatoprost Latanoprost and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG),https://clinicaltrials.gov/study/NCT00716742,COMPLETED,OBSERVATIONAL
NCT03506542,Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C,https://clinicaltrials.gov/study/NCT03506542,COMPLETED,INTERVENTIONAL
NCT02014142,A Phase 2 Single-Masked Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT02014142,COMPLETED,INTERVENTIONAL
NCT02524431,The Changes Within the Cells of the Drainage System of the Eye in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT02524431,WITHDRAWN,INTERVENTIONAL
NCT00384631,Intravitreal Bevacizumab for Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT00384631,COMPLETED,INTERVENTIONAL
NCT03109665,Glaucoma Within Northern Ireland Cohort for the Longitudinal Study of Ageing,https://clinicaltrials.gov/study/NCT03109665,COMPLETED,OBSERVATIONAL
NCT02108288,Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers,https://clinicaltrials.gov/study/NCT02108288,COMPLETED,INTERVENTIONAL
NCT03338088,Evaluation of Adherence to Clinical Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT03338088,UNKNOWN,OBSERVATIONAL
NCT02862938,Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration,https://clinicaltrials.gov/study/NCT02862938,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01628588,Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01628588,COMPLETED,OBSERVATIONAL
NCT01410188,Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01410188,COMPLETED,INTERVENTIONAL
NCT01704989,The Laser in Pseudoexfoliation (LIP) Study,https://clinicaltrials.gov/study/NCT01704989,UNKNOWN,INTERVENTIONAL
NCT02014389,Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer,https://clinicaltrials.gov/study/NCT02014389,RECRUITING,OBSERVATIONAL
NCT00476138,Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma,https://clinicaltrials.gov/study/NCT00476138,UNKNOWN,INTERVENTIONAL
NCT02162043,Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for Glaucoma,https://clinicaltrials.gov/study/NCT02162043,COMPLETED,OBSERVATIONAL
NCT01426867,A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination Brinzolamide 1% and Brimonidine 0.2%,https://clinicaltrials.gov/study/NCT01426867,COMPLETED,INTERVENTIONAL
NCT02613143,Zonulo-hyaloido-vitrectomy for Malignant Glaucoma,https://clinicaltrials.gov/study/NCT02613143,UNKNOWN,OBSERVATIONAL
NCT04406467,Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach,https://clinicaltrials.gov/study/NCT04406467,COMPLETED,OBSERVATIONAL
NCT00150267,A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00150267,COMPLETED,INTERVENTIONAL
NCT01216943,Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01216943,COMPLETED,INTERVENTIONAL
NCT05041543,Safety and Tolerability of NTX-101 in Korean Healthy Volunteers,https://clinicaltrials.gov/study/NCT05041543,COMPLETED,INTERVENTIONAL
NCT02143843,An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product,https://clinicaltrials.gov/study/NCT02143843,COMPLETED,INTERVENTIONAL
NCT00300443,Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00300443,COMPLETED,INTERVENTIONAL
NCT04648943,The Effect of Trabeculectomy & Ex-PRESS Glaucoma Drainage Implant on the Corneal Biomechanical Properties,https://clinicaltrials.gov/study/NCT04648943,COMPLETED,INTERVENTIONAL
NCT00707421,Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes,https://clinicaltrials.gov/study/NCT00707421,COMPLETED,INTERVENTIONAL
NCT00287521,A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00287521,COMPLETED,INTERVENTIONAL
NCT05156021,A Study on the Treatment Strategy of NVG Secondary to PDR,https://clinicaltrials.gov/study/NCT05156021,COMPLETED,INTERVENTIONAL
NCT00273221,Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT00273221,UNKNOWN,INTERVENTIONAL
NCT03715231,NIDEK Gonioscope GS-1 for Glaucoma,https://clinicaltrials.gov/study/NCT03715231,COMPLETED,INTERVENTIONAL
NCT00449631,Multidrug Resistance After Trabeculectomy With Mitomycin C,https://clinicaltrials.gov/study/NCT00449631,COMPLETED,OBSERVATIONAL
NCT01514721,Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy,https://clinicaltrials.gov/study/NCT01514721,TERMINATED,INTERVENTIONAL
NCT05328921,Effects of Systemic Drugs on Intraocular Pressure,https://clinicaltrials.gov/study/NCT05328921,RECRUITING,OBSERVATIONAL
NCT01943721,A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01943721,COMPLETED,INTERVENTIONAL
NCT01769521,Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG,https://clinicaltrials.gov/study/NCT01769521,COMPLETED,INTERVENTIONAL
NCT02558712,Technology-based Eye Care Services (TECS) Compare,https://clinicaltrials.gov/study/NCT02558712,COMPLETED,INTERVENTIONAL
NCT05906212,Anterior Lens Capsule as a Spacer in the Deep Sclerectomy _ Phacoemulsification,https://clinicaltrials.gov/study/NCT05906212,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00472810,Ologen (OculusGen)-Glaucoma MMC Control in Pakistan,https://clinicaltrials.gov/study/NCT00472810,COMPLETED,INTERVENTIONAL
NCT00980473,Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT00980473,UNKNOWN,INTERVENTIONAL
NCT01136473,Mechanism of Aphakic and Pseudophakic Glaucoma in Pediatric Patients,https://clinicaltrials.gov/study/NCT01136473,COMPLETED,OBSERVATIONAL
NCT01887873,Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy,https://clinicaltrials.gov/study/NCT01887873,COMPLETED,INTERVENTIONAL
NCT02874846,Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution,https://clinicaltrials.gov/study/NCT02874846,COMPLETED,INTERVENTIONAL
NCT00918346,Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation,https://clinicaltrials.gov/study/NCT00918346,COMPLETED,INTERVENTIONAL
NCT01525173,A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT01525173,COMPLETED,INTERVENTIONAL
NCT04334473,IOP and Ocular Biometrics Changes After Phacoemulsification in Glaucoma Patients and Controls,https://clinicaltrials.gov/study/NCT04334473,COMPLETED,INTERVENTIONAL
NCT02129673,A Phase 1/2 Multicenter Randomized Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02129673,COMPLETED,INTERVENTIONAL
NCT01481077,A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT01481077,COMPLETED,INTERVENTIONAL
NCT04632329,Negative Pressure Applied by the Equinox MPD for Severe Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04632329,COMPLETED,INTERVENTIONAL
NCT03958929,Impact of an Educational Video on Satisfaction After Glaucoma Surgery,https://clinicaltrials.gov/study/NCT03958929,SUSPENDED,INTERVENTIONAL
NCT03648229,African Glaucoma Laser Trial,https://clinicaltrials.gov/study/NCT03648229,WITHDRAWN,INTERVENTIONAL
NCT03648229,African Glaucoma Laser Trial,https://clinicaltrials.gov/study/NCT03648229,WITHDRAWN,INTERVENTIONAL
NCT02785029,Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1),https://clinicaltrials.gov/study/NCT02785029,TERMINATED,INTERVENTIONAL
NCT02614651,AUgmented REality for the Visually Impaired - Part 1,https://clinicaltrials.gov/study/NCT02614651,COMPLETED,INTERVENTIONAL
NCT02250612,SYL040012 Treatment for Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02250612,COMPLETED,INTERVENTIONAL
NCT02822612,The EASE Study - Human Factor and Usability Testing of a Binocular OCT System,https://clinicaltrials.gov/study/NCT02822612,COMPLETED,OBSERVATIONAL
NCT04590651,Cataract Surgery in Patients With Pseudoexfoliation and Pseudoexfoliation Glaucoma,https://clinicaltrials.gov/study/NCT04590651,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT02474238,Comparing Nd:YAG Laser and Sequential Double Frequency YAG-Nd:YAG Laser Iridotomy,https://clinicaltrials.gov/study/NCT02474238,COMPLETED,INTERVENTIONAL
NCT00698438,Comparison Of Trabeculectomy Versus The Ex-PRESS Miniature Glaucoma Device In The Same Patient: A Prospective Randomized Study,https://clinicaltrials.gov/study/NCT00698438,COMPLETED,INTERVENTIONAL
NCT00650338,Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00650338,COMPLETED,INTERVENTIONAL
NCT06144138,Impact of Breathing Exercises and Meditation on Reducing Stress and Improving Quality of Life of Glaucoma Patients: An Electronic Pilot Feasibility Study,https://clinicaltrials.gov/study/NCT06144138,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00485238,ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function,https://clinicaltrials.gov/study/NCT00485238,UNKNOWN,INTERVENTIONAL
NCT02623738,A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-,https://clinicaltrials.gov/study/NCT02623738,COMPLETED,INTERVENTIONAL
NCT02757677,Evaluation of Blood Flow Characteristics in Glaucoma Using Optical Coherence Tomography Angiography (OCT-A).,https://clinicaltrials.gov/study/NCT02757677,TERMINATED,OBSERVATIONAL
NCT03466177,Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease,https://clinicaltrials.gov/study/NCT03466177,RECRUITING,OBSERVATIONAL
NCT05924477,Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial,https://clinicaltrials.gov/study/NCT05924477,RECRUITING,INTERVENTIONAL
NCT05924477,Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial,https://clinicaltrials.gov/study/NCT05924477,RECRUITING,INTERVENTIONAL
NCT05924477,Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial,https://clinicaltrials.gov/study/NCT05924477,RECRUITING,INTERVENTIONAL
NCT03933631,Pilocarpine Use After Kahook Goniotomy,https://clinicaltrials.gov/study/NCT03933631,RECRUITING,INTERVENTIONAL
NCT03362931,Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT03362931,COMPLETED,INTERVENTIONAL
NCT03921931,Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study,https://clinicaltrials.gov/study/NCT03921931,RECRUITING,INTERVENTIONAL
NCT01247831,The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular Rigidity,https://clinicaltrials.gov/study/NCT01247831,COMPLETED,INTERVENTIONAL
NCT01026831,Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED),https://clinicaltrials.gov/study/NCT01026831,COMPLETED,INTERVENTIONAL
NCT02077231,Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients,https://clinicaltrials.gov/study/NCT02077231,COMPLETED,INTERVENTIONAL
NCT01669031,Randomized Controlled Trial on Visual Field Training,https://clinicaltrials.gov/study/NCT01669031,UNKNOWN,INTERVENTIONAL
NCT05043831,Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial,https://clinicaltrials.gov/study/NCT05043831,WITHDRAWN,INTERVENTIONAL
NCT01540331,Efficacy And Safety of Pneumatic Trabeculoplasty,https://clinicaltrials.gov/study/NCT01540331,COMPLETED,INTERVENTIONAL
NCT05530031,UBM Guided Site and Extent of Trabeculotomy in Pediatric Glaucoma,https://clinicaltrials.gov/study/NCT05530031,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04426331,Vouchers to Increase Uptake of Already Free Eye Care,https://clinicaltrials.gov/study/NCT04426331,COMPLETED,INTERVENTIONAL
NCT00175786,Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT00175786,COMPLETED,OBSERVATIONAL
NCT05273385,Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05273385,RECRUITING,INTERVENTIONAL
NCT05273385,Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05273385,RECRUITING,INTERVENTIONAL
NCT05035394,Swedish Microinvasive Glaucoma Surgery Study (SMIGS),https://clinicaltrials.gov/study/NCT05035394,RECRUITING,INTERVENTIONAL
NCT02151318,Culturing TM Cells From Primary Open-angle Glaucoma Patient Biopsies,https://clinicaltrials.gov/study/NCT02151318,UNKNOWN,OBSERVATIONAL
NCT05104294,Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05104294,COMPLETED,OBSERVATIONAL
NCT01511094,Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications,https://clinicaltrials.gov/study/NCT01511094,UNKNOWN,INTERVENTIONAL
NCT04234932,Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation,https://clinicaltrials.gov/study/NCT04234932,UNKNOWN,INTERVENTIONAL
NCT01510132,Travacom Post Marketing Surveillance Study,https://clinicaltrials.gov/study/NCT01510132,WITHDRAWN,INTERVENTIONAL
NCT00000132,Early Manifest Glaucoma Trial (EMGT),https://clinicaltrials.gov/study/NCT00000132,UNKNOWN,INTERVENTIONAL
NCT04562402,Phaco-ECP vs Phaco Alone in Primary Angle Closure,https://clinicaltrials.gov/study/NCT04562402,UNKNOWN,INTERVENTIONAL
NCT01488032,Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma,https://clinicaltrials.gov/study/NCT01488032,COMPLETED,OBSERVATIONAL
NCT00773877,Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients,https://clinicaltrials.gov/study/NCT00773877,UNKNOWN,OBSERVATIONAL
NCT06061718,Travoprost Intraocular Implant in Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT06061718,RECRUITING,INTERVENTIONAL
NCT00152932,Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide,https://clinicaltrials.gov/study/NCT00152932,UNKNOWN,INTERVENTIONAL
NCT05955118,Hydrus Microstent as a Quality of Life Consideration,https://clinicaltrials.gov/study/NCT05955118,RECRUITING,OBSERVATIONAL
NCT05543018,Effect of Intraocular Tamponade on Visual Perception,https://clinicaltrials.gov/study/NCT05543018,RECRUITING,INTERVENTIONAL
NCT02300818,Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion.,https://clinicaltrials.gov/study/NCT02300818,UNKNOWN,INTERVENTIONAL
NCT00767494,Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT,https://clinicaltrials.gov/study/NCT00767494,TERMINATED,INTERVENTIONAL
NCT04010994,Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation,https://clinicaltrials.gov/study/NCT04010994,UNKNOWN,INTERVENTIONAL
NCT05973318,Comparative Study of Dorzotimol Eye Drops 20 mg/mL + 5 mg/mL Versus Cosopt® Eye Drops 20 mg/mL + 5 mg/mL,https://clinicaltrials.gov/study/NCT05973318,COMPLETED,INTERVENTIONAL
NCT05704777,Exercise Intervention in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05704777,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05704777,Exercise Intervention in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05704777,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05704777,Exercise Intervention in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05704777,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02226094,Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02226094,TERMINATED,INTERVENTIONAL
NCT00868894,Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00868894,COMPLETED,INTERVENTIONAL
NCT03235232,BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension,https://clinicaltrials.gov/study/NCT03235232,RECRUITING,INTERVENTIONAL
NCT05697094,Impact of Meditation on Improving Quality of Life Among Glaucoma Patients: An Electronic Pilot Feasibility Study,https://clinicaltrials.gov/study/NCT05697094,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04064918,Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity,https://clinicaltrials.gov/study/NCT04064918,WITHDRAWN,INTERVENTIONAL
NCT05159960,Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial,https://clinicaltrials.gov/study/NCT05159960,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT04536129,Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure,https://clinicaltrials.gov/study/NCT04536129,COMPLETED,INTERVENTIONAL
NCT00143429,Corneal Versus Conjunctival Delivery Using a Delivery Device,https://clinicaltrials.gov/study/NCT00143429,WITHDRAWN,INTERVENTIONAL
NCT05730478,Comparison Between Anterior Segment Optical Coherence Tomography and Ultrasound Bio Microscopy Parameters in Glaucoma Assessment,https://clinicaltrials.gov/study/NCT05730478,NOT_YET_RECRUITING,OBSERVATIONAL
NCT00557232,Intraocular Bevacizumab (Avastin) for Rubeosis Iridis,https://clinicaltrials.gov/study/NCT00557232,COMPLETED,INTERVENTIONAL
NCT00832832,Eyelid Closure in Glaucoma Therapy,https://clinicaltrials.gov/study/NCT00832832,COMPLETED,INTERVENTIONAL
NCT03417453,Eye Drop Dispensers: Safety Efficacy and Comfort.,https://clinicaltrials.gov/study/NCT03417453,UNKNOWN,INTERVENTIONAL
NCT01936129,Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure,https://clinicaltrials.gov/study/NCT01936129,UNKNOWN,INTERVENTIONAL
NCT02697318,Evaluation of a New Method for Instilling Eye Drops,https://clinicaltrials.gov/study/NCT02697318,COMPLETED,INTERVENTIONAL
NCT05264818,Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05264818,RECRUITING,OBSERVATIONAL
NCT01115218,The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy,https://clinicaltrials.gov/study/NCT01115218,COMPLETED,OBSERVATIONAL
NCT02325518,Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution,https://clinicaltrials.gov/study/NCT02325518,COMPLETED,INTERVENTIONAL
NCT00821002,A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS),https://clinicaltrials.gov/study/NCT00821002,COMPLETED,INTERVENTIONAL
NCT05913232,Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT05913232,RECRUITING,INTERVENTIONAL
NCT00307918,Acupuncture for Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT00307918,TERMINATED,INTERVENTIONAL
NCT01175902,Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01175902,COMPLETED,INTERVENTIONAL
NCT03187418,Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma,https://clinicaltrials.gov/study/NCT03187418,COMPLETED,INTERVENTIONAL
NCT00650702,Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00650702,COMPLETED,INTERVENTIONAL
NCT02868502,Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02868502,UNKNOWN,OBSERVATIONAL
NCT01855802,Greek Physicians Perceptions Regarding Generics Prescribing in Glaucoma,https://clinicaltrials.gov/study/NCT01855802,COMPLETED,OBSERVATIONAL
NCT00811694,Neurovascular Coupling in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00811694,TERMINATED,OBSERVATIONAL
NCT02209961,Combined Ex-PRESS Implantation Alone or With Phacoemulsification for Glaucoma Associated With Cataract,https://clinicaltrials.gov/study/NCT02209961,UNKNOWN,OBSERVATIONAL
NCT01737853,Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01737853,COMPLETED,OBSERVATIONAL
NCT05439161,XEN Glaucoma Gel Stent Versus Trabeculectomy,https://clinicaltrials.gov/study/NCT05439161,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00448929,Ologen (OculusGen)-Glaucoma Case Control Trial in India,https://clinicaltrials.gov/study/NCT00448929,COMPLETED,INTERVENTIONAL
NCT00468429,Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery,https://clinicaltrials.gov/study/NCT00468429,UNKNOWN,INTERVENTIONAL
NCT01767753,IOP Fluctuations in Patients With Primary Open-angle Glaucoma Before and After Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT01767753,COMPLETED,INTERVENTIONAL
NCT01494753,Pharmacokinetics Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01494753,COMPLETED,INTERVENTIONAL
NCT02388360,The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02388360,COMPLETED,INTERVENTIONAL
NCT00404729,Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases,https://clinicaltrials.gov/study/NCT00404729,COMPLETED,INTERVENTIONAL
NCT03021629,Comparison of Vitamin D Status and Vitamin D Receptor Polymorphisms in Patients With High Myopia and Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03021629,COMPLETED,OBSERVATIONAL
NCT00279253,Effects of Intravenous Clonidine on Ocular Blood Flow and Intraocular Pressure,https://clinicaltrials.gov/study/NCT00279253,COMPLETED,INTERVENTIONAL
NCT01682460,Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01682460,COMPLETED,INTERVENTIONAL
NCT04769453,Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty,https://clinicaltrials.gov/study/NCT04769453,TERMINATED,INTERVENTIONAL
NCT00503360,Tolerability Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension,https://clinicaltrials.gov/study/NCT00503360,COMPLETED,INTERVENTIONAL
NCT00913029,Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG),https://clinicaltrials.gov/study/NCT00913029,COMPLETED,INTERVENTIONAL
NCT00887029,A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00887029,COMPLETED,INTERVENTIONAL
NCT00481494,Personality Characteristics and Compliance With Antiglaucoma Medication,https://clinicaltrials.gov/study/NCT00481494,UNKNOWN,OBSERVATIONAL
NCT01798732,PIO Laser Sclerectomy IOP SLT Sclerectomy,https://clinicaltrials.gov/study/NCT01798732,COMPLETED,INTERVENTIONAL
NCT03150160,Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT03150160,COMPLETED,INTERVENTIONAL
NCT04957329,Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells,https://clinicaltrials.gov/study/NCT04957329,RECRUITING,INTERVENTIONAL
NCT05371977,Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT05371977,RECRUITING,INTERVENTIONAL
NCT01310777,Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01310777,COMPLETED,INTERVENTIONAL
NCT00967694,Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers,https://clinicaltrials.gov/study/NCT00967694,COMPLETED,INTERVENTIONAL
NCT00967694,Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers,https://clinicaltrials.gov/study/NCT00967694,COMPLETED,INTERVENTIONAL
NCT03151577,Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent,https://clinicaltrials.gov/study/NCT03151577,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00906594,Additive Intra-ocular Pressure Reduction Effect of Fixed Combination of Maleate Timolol 0.5%/Dorzolamide 2% on Monotherapy With Latanoprost in Patients With Elevated Intra-ocular Pressure,https://clinicaltrials.gov/study/NCT00906594,COMPLETED,INTERVENTIONAL
NCT00196677,Study of Glaucoma Treatment With Food Additives,https://clinicaltrials.gov/study/NCT00196677,TERMINATED,INTERVENTIONAL
NCT02656394,Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101,https://clinicaltrials.gov/study/NCT02656394,COMPLETED,INTERVENTIONAL
NCT03106532,Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT03106532,COMPLETED,INTERVENTIONAL
NCT04318132,Agreement and Precision Study of the Nidek Mirante,https://clinicaltrials.gov/study/NCT04318132,COMPLETED,INTERVENTIONAL
NCT01166594,Use of Bevacizumab in Trabeculectomy Surgery,https://clinicaltrials.gov/study/NCT01166594,COMPLETED,INTERVENTIONAL
NCT03402802,Steroid Eyedrop Adherence After Trabeculectomy,https://clinicaltrials.gov/study/NCT03402802,COMPLETED,OBSERVATIONAL
NCT01632423,A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01632423,COMPLETED,OBSERVATIONAL
NCT02628223,180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma,https://clinicaltrials.gov/study/NCT02628223,COMPLETED,INTERVENTIONAL
NCT04448223,A Clinical Study to Evaluate the Efficacy and Safety of CKD-351,https://clinicaltrials.gov/study/NCT04448223,UNKNOWN,INTERVENTIONAL
NCT05563623,The Beijing Angle Closure Progression Study,https://clinicaltrials.gov/study/NCT05563623,RECRUITING,OBSERVATIONAL
NCT03798223,Optimal Treatment Protocol for Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT03798223,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT05726058,Ocular Blood Flow Imaging for Glaucoma Assessment,https://clinicaltrials.gov/study/NCT05726058,RECRUITING,INTERVENTIONAL
NCT05726058,Ocular Blood Flow Imaging for Glaucoma Assessment,https://clinicaltrials.gov/study/NCT05726058,RECRUITING,INTERVENTIONAL
NCT02173223,A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt,https://clinicaltrials.gov/study/NCT02173223,UNKNOWN,INTERVENTIONAL
NCT00834223,A Prospective Multicenter Open-label Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG),https://clinicaltrials.gov/study/NCT00834223,COMPLETED,INTERVENTIONAL
NCT04943458,Application of Innovative Non-Invasive Neuroprotective Technology in Cardiac Surgery and Ophthalmology,https://clinicaltrials.gov/study/NCT04943458,RECRUITING,OBSERVATIONAL
NCT00945958,Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00945958,COMPLETED,INTERVENTIONAL
NCT02862158,Frequency Doubling Technology (FDT) Mobile Visual Field Testing,https://clinicaltrials.gov/study/NCT02862158,UNKNOWN,INTERVENTIONAL
NCT05625958,Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT05625958,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01471158,Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT01471158,COMPLETED,INTERVENTIONAL
NCT00314158,A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00314158,COMPLETED,INTERVENTIONAL
NCT04254458,Corneal Densitometry in Acute Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT04254458,COMPLETED,OBSERVATIONAL
NCT03605823,Pars Plana Ex-Press Shunt in Vitrectomized Eyes,https://clinicaltrials.gov/study/NCT03605823,UNKNOWN,INTERVENTIONAL
NCT04000828,Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy,https://clinicaltrials.gov/study/NCT04000828,COMPLETED,INTERVENTIONAL
NCT05943184,Cognitive Behavioral Nursing Model,https://clinicaltrials.gov/study/NCT05943184,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03138928,An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation,https://clinicaltrials.gov/study/NCT03138928,COMPLETED,OBSERVATIONAL
NCT00047528,Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41,https://clinicaltrials.gov/study/NCT00047528,COMPLETED,INTERVENTIONAL
NCT01301378,Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube,https://clinicaltrials.gov/study/NCT01301378,TERMINATED,INTERVENTIONAL
NCT05940623,Impact of Home Intraocular Pressure Telemonitoring on Intraocular Pressure Control and Glaucoma Progression,https://clinicaltrials.gov/study/NCT05940623,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00524758,Oculusgen (Ologen) Glaucoma MMC Control in Estonia,https://clinicaltrials.gov/study/NCT00524758,COMPLETED,INTERVENTIONAL
NCT06012058,Glaucoma Screening With Artificial Intelligence,https://clinicaltrials.gov/study/NCT06012058,RECRUITING,INTERVENTIONAL
NCT05557058,GORE Glaucoma Drainage Implant Clinical Study,https://clinicaltrials.gov/study/NCT05557058,RECRUITING,INTERVENTIONAL
NCT00773123,Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma.,https://clinicaltrials.gov/study/NCT00773123,UNKNOWN,OBSERVATIONAL
NCT03391518,Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy,https://clinicaltrials.gov/study/NCT03391518,UNKNOWN,INTERVENTIONAL
NCT04949802,Glaucoma Surgery Using the ViaLase Laser System,https://clinicaltrials.gov/study/NCT04949802,COMPLETED,INTERVENTIONAL
NCT02945202,Influence of Trabeculectomy and Phaco-trabeculectomy on Corneal Astigmatism,https://clinicaltrials.gov/study/NCT02945202,UNKNOWN,INTERVENTIONAL
NCT01746602,Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects,https://clinicaltrials.gov/study/NCT01746602,TERMINATED,INTERVENTIONAL
NCT03483402,Micropulse Laser Trabeculoplasty as Adjunctive Treatment in Patients With Pseudoexfoliation Glaucoma,https://clinicaltrials.gov/study/NCT03483402,COMPLETED,INTERVENTIONAL
NCT00863018,Corneal Endothelium After Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00863018,COMPLETED,OBSERVATIONAL
NCT04396002,Glaucoma Visual Field Loss and Their Association With Life Space in Older Adults,https://clinicaltrials.gov/study/NCT04396002,RECRUITING,OBSERVATIONAL
NCT02731118,Antisecretory Factor (AF) Effects on Intraocular-pressure,https://clinicaltrials.gov/study/NCT02731118,TERMINATED,INTERVENTIONAL
NCT03927118,Effect of Dexamethasone Implant on Optic Disc,https://clinicaltrials.gov/study/NCT03927118,COMPLETED,OBSERVATIONAL
NCT01731002,Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT01731002,COMPLETED,INTERVENTIONAL
NCT01272102,Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma,https://clinicaltrials.gov/study/NCT01272102,COMPLETED,OBSERVATIONAL
NCT03525132,Study of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV),https://clinicaltrials.gov/study/NCT03525132,UNKNOWN,INTERVENTIONAL
NCT00347802,Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%,https://clinicaltrials.gov/study/NCT00347802,COMPLETED,INTERVENTIONAL
NCT01461278,Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT01461278,COMPLETED,INTERVENTIONAL
NCT03216902,A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study,https://clinicaltrials.gov/study/NCT03216902,COMPLETED,INTERVENTIONAL
NCT01229202,Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery,https://clinicaltrials.gov/study/NCT01229202,UNKNOWN,INTERVENTIONAL
NCT01806402,Evaluation of OCT Measurements,https://clinicaltrials.gov/study/NCT01806402,COMPLETED,OBSERVATIONAL
NCT02088528,The Ghana Primary Tube Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT02088528,UNKNOWN,INTERVENTIONAL
NCT02088528,The Ghana Primary Tube Versus Trabeculectomy Study,https://clinicaltrials.gov/study/NCT02088528,UNKNOWN,INTERVENTIONAL
NCT01987323,Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension,https://clinicaltrials.gov/study/NCT01987323,COMPLETED,INTERVENTIONAL
NCT00350428,Laser Iridotomy Versus Phacoemulsification in Acute Angle Closure,https://clinicaltrials.gov/study/NCT00350428,COMPLETED,INTERVENTIONAL
NCT05449041,Bulbicam Validation on Glaucoma- and Cataract Patients,https://clinicaltrials.gov/study/NCT05449041,RECRUITING,OBSERVATIONAL
NCT02665884,Diurnal Fluctuations of Intraocular Pressure in EX-Press Valve Blebs in Glaucoma Patients,https://clinicaltrials.gov/study/NCT02665884,UNKNOWN,OBSERVATIONAL
NCT02700984,A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial,https://clinicaltrials.gov/study/NCT02700984,COMPLETED,INTERVENTIONAL
NCT04737928,Prospective Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution),https://clinicaltrials.gov/study/NCT04737928,COMPLETED,INTERVENTIONAL
NCT00869141,Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma,https://clinicaltrials.gov/study/NCT00869141,COMPLETED,INTERVENTIONAL
NCT03194828,Real-time Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03194828,TERMINATED,INTERVENTIONAL
NCT03194828,Real-time Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03194828,TERMINATED,INTERVENTIONAL
NCT03194828,Real-time Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03194828,TERMINATED,INTERVENTIONAL
NCT03194828,Real-time Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03194828,TERMINATED,INTERVENTIONAL
NCT03194828,Real-time Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03194828,TERMINATED,INTERVENTIONAL
NCT03604328,Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03604328,COMPLETED,INTERVENTIONAL
NCT00346541,Role of Polymorphisms in the IL-1 Gene Cluster,https://clinicaltrials.gov/study/NCT00346541,COMPLETED,OBSERVATIONAL
NCT02604953,Comparing SD-tVEP and PERG Tests Between Patients With Glaucoma Patients With High Eye Pressure and Normal Patients,https://clinicaltrials.gov/study/NCT02604953,COMPLETED,OBSERVATIONAL
NCT01292460,Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies,https://clinicaltrials.gov/study/NCT01292460,COMPLETED,INTERVENTIONAL
NCT02982629,Improving Access to Eye Care in Glaucoma Patients,https://clinicaltrials.gov/study/NCT02982629,COMPLETED,INTERVENTIONAL
NCT00273429,Cosopt Versus Xalatan,https://clinicaltrials.gov/study/NCT00273429,COMPLETED,INTERVENTIONAL
NCT00680329,Glaucoma Adherence Study Spain,https://clinicaltrials.gov/study/NCT00680329,COMPLETED,OBSERVATIONAL
NCT05451329,A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT05451329,COMPLETED,INTERVENTIONAL
NCT03145129,PAIR Study-PAP And IOP Relationship: Study 2,https://clinicaltrials.gov/study/NCT03145129,COMPLETED,OBSERVATIONAL
NCT05446077,Quantitatively Analysis of Fundus Structure Characteristics in Glaucoma Following Congenital Cataract Surgery,https://clinicaltrials.gov/study/NCT05446077,COMPLETED,OBSERVATIONAL
NCT00193960,The Results of Ahmed Valve Operations,https://clinicaltrials.gov/study/NCT00193960,UNKNOWN,OBSERVATIONAL
NCT01347229,SENSIMED Triggerfish® in Sitting and Supine Position,https://clinicaltrials.gov/study/NCT01347229,COMPLETED,INTERVENTIONAL
NCT01217853,24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry,https://clinicaltrials.gov/study/NCT01217853,COMPLETED,OBSERVATIONAL
NCT03886753,Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products,https://clinicaltrials.gov/study/NCT03886753,TERMINATED,OBSERVATIONAL
NCT02822729,A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study,https://clinicaltrials.gov/study/NCT02822729,COMPLETED,INTERVENTIONAL
NCT03450629,Evaluation of Safety and Efficacy of PDP-716,https://clinicaltrials.gov/study/NCT03450629,COMPLETED,INTERVENTIONAL
NCT04352660,Subconjunctival Versus Direct Mitomycin C in Trabeculectomy,https://clinicaltrials.gov/study/NCT04352660,COMPLETED,INTERVENTIONAL
NCT01136460,Genetic Testing in Primary Congenital Glaucoma Patients,https://clinicaltrials.gov/study/NCT01136460,UNKNOWN,OBSERVATIONAL
NCT00061529,A Phase III Study of Brimonidine Tartrate Ophthalmic Solution 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00061529,COMPLETED,INTERVENTIONAL
NCT00351429,Study of PGA Suture in Ophthalmology,https://clinicaltrials.gov/study/NCT00351429,COMPLETED,INTERVENTIONAL
NCT01517477,One Two or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects,https://clinicaltrials.gov/study/NCT01517477,COMPLETED,INTERVENTIONAL
NCT01711177,Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01711177,COMPLETED,INTERVENTIONAL
NCT00799994,Does Lowering Eye Pressure Affect the Results Obtained From Objective Visual Field Testing?,https://clinicaltrials.gov/study/NCT00799994,COMPLETED,OBSERVATIONAL
NCT05180994,Topical Infliximab in Eyes With Penetrating Keratoplasty,https://clinicaltrials.gov/study/NCT05180994,RECRUITING,INTERVENTIONAL
NCT05180994,Topical Infliximab in Eyes With Penetrating Keratoplasty,https://clinicaltrials.gov/study/NCT05180994,RECRUITING,INTERVENTIONAL
NCT05180994,Topical Infliximab in Eyes With Penetrating Keratoplasty,https://clinicaltrials.gov/study/NCT05180994,RECRUITING,INTERVENTIONAL
NCT05180994,Topical Infliximab in Eyes With Penetrating Keratoplasty,https://clinicaltrials.gov/study/NCT05180994,RECRUITING,INTERVENTIONAL
NCT05180994,Topical Infliximab in Eyes With Penetrating Keratoplasty,https://clinicaltrials.gov/study/NCT05180994,RECRUITING,INTERVENTIONAL
NCT02228577,Safety and Performance Study of the CyPass System Applier Model 241,https://clinicaltrials.gov/study/NCT02228577,COMPLETED,OBSERVATIONAL
NCT00832377,COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED),https://clinicaltrials.gov/study/NCT00832377,COMPLETED,INTERVENTIONAL
NCT02090777,Health Coaching for Glaucoma Patients,https://clinicaltrials.gov/study/NCT02090777,COMPLETED,INTERVENTIONAL
NCT02246777,Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients,https://clinicaltrials.gov/study/NCT02246777,COMPLETED,INTERVENTIONAL
NCT02141594,Posterior Pole Asymmetry Analysis (PPAA) for Early Glaucoma,https://clinicaltrials.gov/study/NCT02141594,COMPLETED,OBSERVATIONAL
NCT00051194,A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00051194,COMPLETED,INTERVENTIONAL
NCT05206877,Topical Insulin for Glaucoma,https://clinicaltrials.gov/study/NCT05206877,RECRUITING,INTERVENTIONAL
NCT00690794,Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00690794,COMPLETED,INTERVENTIONAL
NCT01342094,DE-111 Against Timolol Ophthalmic Solution 0.5%,https://clinicaltrials.gov/study/NCT01342094,COMPLETED,INTERVENTIONAL
NCT02356094,Posterior Cornea in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02356094,UNKNOWN,OBSERVATIONAL
NCT00798694,How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?,https://clinicaltrials.gov/study/NCT00798694,COMPLETED,INTERVENTIONAL
NCT06071494,The Effect Of Tropical Fruits In Patients With Primary Glaucoma,https://clinicaltrials.gov/study/NCT06071494,NOT_YET_RECRUITING,INTERVENTIONAL
NCT03858894,Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6,https://clinicaltrials.gov/study/NCT03858894,COMPLETED,INTERVENTIONAL
NCT04647929,Comparison of Surgical Treatment Options for Primary Congenital and Developmental Glaucomas,https://clinicaltrials.gov/study/NCT04647929,WITHDRAWN,INTERVENTIONAL
NCT00317577,Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma,https://clinicaltrials.gov/study/NCT00317577,COMPLETED,INTERVENTIONAL
NCT00551902,Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes,https://clinicaltrials.gov/study/NCT00551902,WITHDRAWN,INTERVENTIONAL
NCT05925894,Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.,https://clinicaltrials.gov/study/NCT05925894,COMPLETED,INTERVENTIONAL
NCT04433702,Effect of Negative Pressure on Pattern Electroretinography Readings,https://clinicaltrials.gov/study/NCT04433702,UNKNOWN,INTERVENTIONAL
NCT00330577,24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00330577,COMPLETED,INTERVENTIONAL
NCT04141891,Advancing Understanding of Transportation Options,https://clinicaltrials.gov/study/NCT04141891,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01568008,Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01568008,COMPLETED,OBSERVATIONAL
NCT04242108,Diagnostic Performance of Deep Learning for Angle Closure,https://clinicaltrials.gov/study/NCT04242108,UNKNOWN,OBSERVATIONAL
NCT02419508,SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA),https://clinicaltrials.gov/study/NCT02419508,COMPLETED,INTERVENTIONAL
NCT00143208,Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.,https://clinicaltrials.gov/study/NCT00143208,COMPLETED,INTERVENTIONAL
NCT00430209,Neurovascular Coupling in Eyes of Glaucoma Patients,https://clinicaltrials.gov/study/NCT00430209,COMPLETED,OBSERVATIONAL
NCT05790408,Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR),https://clinicaltrials.gov/study/NCT05790408,TERMINATED,INTERVENTIONAL
NCT00485108,Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00485108,COMPLETED,INTERVENTIONAL
NCT00485108,Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00485108,COMPLETED,INTERVENTIONAL
NCT03560609,Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus,https://clinicaltrials.gov/study/NCT03560609,RECRUITING,INTERVENTIONAL
NCT00481208,Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00481208,COMPLETED,OBSERVATIONAL
NCT00901108,Trabectome Versus Trabeculectomy With Mitomycin C in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00901108,TERMINATED,INTERVENTIONAL
NCT02379208,Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02379208,UNKNOWN,OBSERVATIONAL
NCT05626491,Electrical Stimulation for the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT05626491,RECRUITING,INTERVENTIONAL
NCT05626491,Electrical Stimulation for the Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT05626491,RECRUITING,INTERVENTIONAL
NCT03631108,Feasibility Study and Preliminary Application Study on Iris OCTA,https://clinicaltrials.gov/study/NCT03631108,UNKNOWN,OBSERVATIONAL
NCT04271709,Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT),https://clinicaltrials.gov/study/NCT04271709,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02207491,Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02207491,COMPLETED,INTERVENTIONAL
NCT01217606,Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01217606,COMPLETED,INTERVENTIONAL
NCT03387306,Serum Bilirubin Levels in Normal-tension Glaucoma,https://clinicaltrials.gov/study/NCT03387306,COMPLETED,OBSERVATIONAL
NCT01125306,Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients Treated With Xalatan or Xalacom,https://clinicaltrials.gov/study/NCT01125306,UNKNOWN,INTERVENTIONAL
NCT05999006,Safety and Feasibility of the ELIOS System in POAG Patients,https://clinicaltrials.gov/study/NCT05999006,RECRUITING,INTERVENTIONAL
NCT00652106,Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00652106,COMPLETED,INTERVENTIONAL
NCT05695027,Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study,https://clinicaltrials.gov/study/NCT05695027,RECRUITING,INTERVENTIONAL
NCT02017327,Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose,https://clinicaltrials.gov/study/NCT02017327,COMPLETED,INTERVENTIONAL
NCT00803504,Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00803504,COMPLETED,OBSERVATIONAL
NCT04440527,Intraocular Pressure After Preserflo / Innfocus Microshunt Implantation vs Trabeculectomy,https://clinicaltrials.gov/study/NCT04440527,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05022004,A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT05022004,COMPLETED,INTERVENTIONAL
NCT01297517,Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%,https://clinicaltrials.gov/study/NCT01297517,COMPLETED,INTERVENTIONAL
NCT03931317,Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity,https://clinicaltrials.gov/study/NCT03931317,COMPLETED,INTERVENTIONAL
NCT05566626,Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera,https://clinicaltrials.gov/study/NCT05566626,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT04676126,Augmented Macular Pigment-containing Nutraceutical and Central Visual Function,https://clinicaltrials.gov/study/NCT04676126,WITHDRAWN,INTERVENTIONAL
NCT02867527,Prospective Constitution of Database Gathering Data of Patients Suffering From Glaucoma Followed at University Hospital of Grenoble,https://clinicaltrials.gov/study/NCT02867527,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT01749904,Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01749904,COMPLETED,INTERVENTIONAL
NCT00538304,A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00538304,COMPLETED,INTERVENTIONAL
NCT00069706,Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00069706,COMPLETED,INTERVENTIONAL
NCT01254604,Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002),https://clinicaltrials.gov/study/NCT01254604,COMPLETED,INTERVENTIONAL
NCT01346904,a 3.0T Magnetic Resonance Imaging Study,https://clinicaltrials.gov/study/NCT01346904,UNKNOWN,OBSERVATIONAL
NCT00828906,DuoTrav® Eye Drops As Replacement Therapy Program,https://clinicaltrials.gov/study/NCT00828906,COMPLETED,INTERVENTIONAL
NCT06135727,Screening Protocol,https://clinicaltrials.gov/study/NCT06135727,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT00372827,Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00372827,COMPLETED,INTERVENTIONAL
NCT05111106,Symfony Intraocular Lens Retrospective Chart Review,https://clinicaltrials.gov/study/NCT05111106,COMPLETED,OBSERVATIONAL
NCT01927406,The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.,https://clinicaltrials.gov/study/NCT01927406,WITHDRAWN,INTERVENTIONAL
NCT00706927,Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00706927,COMPLETED,INTERVENTIONAL
NCT04890106,Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT04890106,COMPLETED,INTERVENTIONAL
NCT05042609,A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma,https://clinicaltrials.gov/study/NCT05042609,COMPLETED,INTERVENTIONAL
NCT04857827,A Study to Evaluate Safety and Tolerability of QLS-101 in NTG,https://clinicaltrials.gov/study/NCT04857827,COMPLETED,INTERVENTIONAL
NCT04920227,Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04920227,UNKNOWN,INTERVENTIONAL
NCT01253109,Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients,https://clinicaltrials.gov/study/NCT01253109,TERMINATED,OBSERVATIONAL
NCT01253109,Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients,https://clinicaltrials.gov/study/NCT01253109,TERMINATED,OBSERVATIONAL
NCT01915706,The Effect of Scheduled Ripcord Removal on the Outcomes of Baerveldt 350 Implants,https://clinicaltrials.gov/study/NCT01915706,COMPLETED,INTERVENTIONAL
NCT02526706,Using a Type of Blue Dye to Observe Bleb Function During Cataract Surgery,https://clinicaltrials.gov/study/NCT02526706,COMPLETED,INTERVENTIONAL
NCT04773106,Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery,https://clinicaltrials.gov/study/NCT04773106,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01862627,Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy,https://clinicaltrials.gov/study/NCT01862627,COMPLETED,OBSERVATIONAL
NCT03445806,IOP Monitoring After Trabeculectomy Using iCare Home,https://clinicaltrials.gov/study/NCT03445806,TERMINATED,OBSERVATIONAL
NCT05527106,Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05527106,COMPLETED,INTERVENTIONAL
NCT02628327,Factors Influencing Patient Satisfaction in a Glaucoma Population,https://clinicaltrials.gov/study/NCT02628327,COMPLETED,OBSERVATIONAL
NCT01255306,The Influence of Silicone Oil on Nerve Fiber Layer Thickness After Pars Plana Vitrectomy,https://clinicaltrials.gov/study/NCT01255306,COMPLETED,OBSERVATIONAL
NCT00238563,Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery,https://clinicaltrials.gov/study/NCT00238563,WITHDRAWN,INTERVENTIONAL
NCT02776449,Pressure Difference Between Brain and Eye: a Possible Cause to Normal Tension Glaucoma.,https://clinicaltrials.gov/study/NCT02776449,COMPLETED,OBSERVATIONAL
NCT00140049,A 12week Randomized Evaluator-Masked Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma,https://clinicaltrials.gov/study/NCT00140049,COMPLETED,INTERVENTIONAL
NCT03750149,Reading Analysis in Ophthalmologic Patients,https://clinicaltrials.gov/study/NCT03750149,UNKNOWN,INTERVENTIONAL
NCT02742649,A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02742649,COMPLETED,INTERVENTIONAL
NCT04178863,CATS Tonometer IOP Reduction Latanoprost Verses Timolol,https://clinicaltrials.gov/study/NCT04178863,UNKNOWN,INTERVENTIONAL
NCT00744705,Normative Database of the Retinal Nerve Fiber Layer Thickness Measured by the Cirrus HD OCT in Asians,https://clinicaltrials.gov/study/NCT00744705,UNKNOWN,OBSERVATIONAL
NCT03691649,A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study,https://clinicaltrials.gov/study/NCT03691649,COMPLETED,INTERVENTIONAL
NCT03014349,Water Drinking Test and Its Reproducibility in Goldmann Applanation Tonometry and Pneumatic Tonometry,https://clinicaltrials.gov/study/NCT03014349,COMPLETED,OBSERVATIONAL
NCT02990663,The Effect of Antihypertensive Medication Timing on Morbidity and Mortality,https://clinicaltrials.gov/study/NCT02990663,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02990663,The Effect of Antihypertensive Medication Timing on Morbidity and Mortality,https://clinicaltrials.gov/study/NCT02990663,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02990663,The Effect of Antihypertensive Medication Timing on Morbidity and Mortality,https://clinicaltrials.gov/study/NCT02990663,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT06054763,Buyang Huanwu Decoction and Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT06054763,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01452009,Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution 0.004%,https://clinicaltrials.gov/study/NCT01452009,WITHDRAWN,INTERVENTIONAL
NCT00338208,Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot,https://clinicaltrials.gov/study/NCT00338208,COMPLETED,INTERVENTIONAL
NCT03233308,Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT03233308,COMPLETED,INTERVENTIONAL
NCT04610008,Optic Nerve Head Shape as a Predictor of the Formation of Acquired Pits of the Optic Nerve (APONs),https://clinicaltrials.gov/study/NCT04610008,COMPLETED,OBSERVATIONAL
NCT05539508,Role of Peripheral Vision in Scene Perception (PERISCE),https://clinicaltrials.gov/study/NCT05539508,NOT_YET_RECRUITING,OBSERVATIONAL
NCT02174991,A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention,https://clinicaltrials.gov/study/NCT02174991,UNKNOWN,INTERVENTIONAL
NCT05564091,Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05564091,RECRUITING,INTERVENTIONAL
NCT01564108,The LIMO Study Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema,https://clinicaltrials.gov/study/NCT01564108,COMPLETED,INTERVENTIONAL
NCT05115708,Kahook Dual Blade Ab-interno Trabeculotomy Versus ab Externo Viscotrabeculotomy in Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT05115708,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01719809,An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation,https://clinicaltrials.gov/study/NCT01719809,TERMINATED,OBSERVATIONAL
NCT01188291,Retinal Nerve Fiber Layer Thickness Measurements in Patients With Sleep Apnea Syndrome,https://clinicaltrials.gov/study/NCT01188291,COMPLETED,OBSERVATIONAL
NCT01262209,Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01262209,COMPLETED,INTERVENTIONAL
NCT01227291,SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg,https://clinicaltrials.gov/study/NCT01227291,COMPLETED,INTERVENTIONAL
NCT04495491,Predicting the Effect of Laser Peripheral Iridotomy,https://clinicaltrials.gov/study/NCT04495491,UNKNOWN,OBSERVATIONAL
NCT04630808,MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04630808,RECRUITING,INTERVENTIONAL
NCT01291108,Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01291108,COMPLETED,INTERVENTIONAL
NCT02828891,Analysis of Translaminar Pressure Gradient Using Noninvasive Cerebrospinal Fluid Pressure Monitoring,https://clinicaltrials.gov/study/NCT02828891,WITHDRAWN,INTERVENTIONAL
NCT02765308,Aqueous Humor Dynamics and Hypertensive Uveitis,https://clinicaltrials.gov/study/NCT02765308,COMPLETED,OBSERVATIONAL
NCT00966108,SENSIMED Triggerfish Discomfort During IOP Monitoring,https://clinicaltrials.gov/study/NCT00966108,COMPLETED,OBSERVATIONAL
NCT01881126,An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01881126,COMPLETED,INTERVENTIONAL
NCT04622605,Hydrus Microstent and Lens Extraction for the Treatment of Primary Angle-Closure Glaucoma,https://clinicaltrials.gov/study/NCT04622605,COMPLETED,INTERVENTIONAL
NCT02988752,Comparison Between an Electronic Mobile Device and Optical Coherence Tomography to Determine Cup-to-disc Ratio,https://clinicaltrials.gov/study/NCT02988752,UNKNOWN,INTERVENTIONAL
NCT05690152,Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test,https://clinicaltrials.gov/study/NCT05690152,RECRUITING,INTERVENTIONAL
NCT01687426,Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01687426,COMPLETED,INTERVENTIONAL
NCT04342052,Glaucoma After Congenital Cataract Surgery,https://clinicaltrials.gov/study/NCT04342052,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT05626426,Electrical Stimulation for the Treatment of Optic Neuropathies,https://clinicaltrials.gov/study/NCT05626426,RECRUITING,INTERVENTIONAL
NCT05626426,Electrical Stimulation for the Treatment of Optic Neuropathies,https://clinicaltrials.gov/study/NCT05626426,RECRUITING,INTERVENTIONAL
NCT03965052,Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®,https://clinicaltrials.gov/study/NCT03965052,COMPLETED,INTERVENTIONAL
NCT02531152,28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02531152,COMPLETED,INTERVENTIONAL
NCT05231252,The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.,https://clinicaltrials.gov/study/NCT05231252,COMPLETED,INTERVENTIONAL
NCT02622191,Analysis of the Eye in Patients With Primary Open-Angle Glaucoma and a Visual Field Defect in One Eye,https://clinicaltrials.gov/study/NCT02622191,COMPLETED,INTERVENTIONAL
NCT01020071,Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study,https://clinicaltrials.gov/study/NCT01020071,COMPLETED,INTERVENTIONAL
NCT02121171,Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT02121171,UNKNOWN,INTERVENTIONAL
NCT00076271,Evaluation and Treatment of Pediatric Developmental and Genetic Eye Diseases,https://clinicaltrials.gov/study/NCT00076271,COMPLETED,OBSERVATIONAL
NCT01051739,Variability in Perimetry Study,https://clinicaltrials.gov/study/NCT01051739,COMPLETED,OBSERVATIONAL
NCT01284439,Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma,https://clinicaltrials.gov/study/NCT01284439,UNKNOWN,INTERVENTIONAL
NCT02612571,Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players,https://clinicaltrials.gov/study/NCT02612571,COMPLETED,OBSERVATIONAL
NCT00867971,Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?,https://clinicaltrials.gov/study/NCT00867971,UNKNOWN,OBSERVATIONAL
NCT01461291,Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT01461291,COMPLETED,INTERVENTIONAL
NCT05236439,Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05236439,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03529591,Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT?,https://clinicaltrials.gov/study/NCT03529591,COMPLETED,INTERVENTIONAL
NCT05583591,Prospective Randomized Controlled Study Comparing Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05583591,RECRUITING,INTERVENTIONAL
NCT00347191,Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments.,https://clinicaltrials.gov/study/NCT00347191,COMPLETED,OBSERVATIONAL
NCT01064505,Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients,https://clinicaltrials.gov/study/NCT01064505,COMPLETED,INTERVENTIONAL
NCT05160805,A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05160805,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01300949,Spaeth/Richman Contrast Sensitivity Test,https://clinicaltrials.gov/study/NCT01300949,COMPLETED,INTERVENTIONAL
NCT04161963,Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery,https://clinicaltrials.gov/study/NCT04161963,UNKNOWN,OBSERVATIONAL
NCT00230763,Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure,https://clinicaltrials.gov/study/NCT00230763,COMPLETED,INTERVENTIONAL
NCT01384149,EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA,https://clinicaltrials.gov/study/NCT01384149,COMPLETED,INTERVENTIONAL
NCT04761705,Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04761705,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02653963,Triamcinolone for Ahmed Glaucoma Valve,https://clinicaltrials.gov/study/NCT02653963,COMPLETED,INTERVENTIONAL
NCT01802463,Study on Ocular Blood Flow and the Orbital Cerebrospinal Fluid Pressure in Glaucoma,https://clinicaltrials.gov/study/NCT01802463,COMPLETED,OBSERVATIONAL
NCT00000149,Collaborative Initial Glaucoma Treatment Study (CIGTS),https://clinicaltrials.gov/study/NCT00000149,UNKNOWN,INTERVENTIONAL
NCT03318549,Evaluation of Visual and Task Performance,https://clinicaltrials.gov/study/NCT03318549,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT02972749,Modifiable Factors and Glaucoma - RCT,https://clinicaltrials.gov/study/NCT02972749,COMPLETED,INTERVENTIONAL
NCT05044793,A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System,https://clinicaltrials.gov/study/NCT05044793,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT06030193,Qlaris Phase 2 Study in NTG Patients,https://clinicaltrials.gov/study/NCT06030193,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01281020,Adherence With Fixed Versus Unfixed Glaucoma Therapy,https://clinicaltrials.gov/study/NCT01281020,COMPLETED,OBSERVATIONAL
NCT01114893,Travoprost Five Day Posology Study,https://clinicaltrials.gov/study/NCT01114893,COMPLETED,INTERVENTIONAL
NCT01297920,Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%,https://clinicaltrials.gov/study/NCT01297920,COMPLETED,INTERVENTIONAL
NCT04024293,Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry,https://clinicaltrials.gov/study/NCT04024293,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02006693,Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants,https://clinicaltrials.gov/study/NCT02006693,COMPLETED,INTERVENTIONAL
NCT03478293,iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications,https://clinicaltrials.gov/study/NCT03478293,TERMINATED,INTERVENTIONAL
NCT00772993,Efficacy of Retinal Nerve Fiber Layer (RNFL) / Retinal Thickness Ratio by Cirrus OCT Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma,https://clinicaltrials.gov/study/NCT00772993,UNKNOWN,OBSERVATIONAL
NCT04245163,Development and Implementation of an Educational Program to Enhance Adherence to Glaucoma Treatment,https://clinicaltrials.gov/study/NCT04245163,UNKNOWN,INTERVENTIONAL
NCT01931904,Eye Pressure Lowering Surgery,https://clinicaltrials.gov/study/NCT01931904,RECRUITING,OBSERVATIONAL
NCT00108017,Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED),https://clinicaltrials.gov/study/NCT00108017,COMPLETED,INTERVENTIONAL
NCT02154217,Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures,https://clinicaltrials.gov/study/NCT02154217,COMPLETED,INTERVENTIONAL
NCT01774227,the Pops-titration Versus the Slow-coagulation Cyclophotocoagulation in Treatment of Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01774227,COMPLETED,INTERVENTIONAL
NCT04075227,Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium,https://clinicaltrials.gov/study/NCT04075227,COMPLETED,INTERVENTIONAL
NCT02873806,Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents,https://clinicaltrials.gov/study/NCT02873806,COMPLETED,INTERVENTIONAL
NCT05352906,Accuracy of Handheld and Non-contact Tonometry,https://clinicaltrials.gov/study/NCT05352906,RECRUITING,INTERVENTIONAL
NCT00761709,Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00761709,COMPLETED,INTERVENTIONAL
NCT02624427,Goldmann Applanation Tonometry Dynamic Contour Tonometry and Corvis ST Tonometer,https://clinicaltrials.gov/study/NCT02624427,COMPLETED,INTERVENTIONAL
NCT05338606,Expanded Access to Bimatoprost (Durysta),https://clinicaltrials.gov/study/NCT05338606,AVAILABLE,EXPANDED_ACCESS
NCT05315206,Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution,https://clinicaltrials.gov/study/NCT05315206,RECRUITING,INTERVENTIONAL
NCT00047606,Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32,https://clinicaltrials.gov/study/NCT00047606,TERMINATED,INTERVENTIONAL
NCT01965106,Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG),https://clinicaltrials.gov/study/NCT01965106,COMPLETED,INTERVENTIONAL
NCT02914509,Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT,https://clinicaltrials.gov/study/NCT02914509,COMPLETED,INTERVENTIONAL
NCT04035239,Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT04035239,COMPLETED,INTERVENTIONAL
NCT05801471,Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression,https://clinicaltrials.gov/study/NCT05801471,RECRUITING,OBSERVATIONAL
NCT05902871,Direct Selective Laser Trabeculoplasty in a Ethnic Chinese Population,https://clinicaltrials.gov/study/NCT05902871,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01493271,A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01493271,COMPLETED,INTERVENTIONAL
NCT01087671,Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops,https://clinicaltrials.gov/study/NCT01087671,COMPLETED,INTERVENTIONAL
NCT01062971,Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide,https://clinicaltrials.gov/study/NCT01062971,COMPLETED,INTERVENTIONAL
NCT02730871,Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®,https://clinicaltrials.gov/study/NCT02730871,TERMINATED,INTERVENTIONAL
NCT02003391,Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure,https://clinicaltrials.gov/study/NCT02003391,COMPLETED,INTERVENTIONAL
NCT04747808,Study of LL-BMT1 in Patients With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT04747808,COMPLETED,INTERVENTIONAL
NCT01925391,The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops,https://clinicaltrials.gov/study/NCT01925391,COMPLETED,INTERVENTIONAL
NCT01016691,Safety and Efficacy of a Drug Delivery System in Glaucoma,https://clinicaltrials.gov/study/NCT01016691,COMPLETED,INTERVENTIONAL
NCT01191008,Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01191008,COMPLETED,OBSERVATIONAL
NCT00687791,Oculusgen (Ologen) Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: A Case-Control Study,https://clinicaltrials.gov/study/NCT00687791,UNKNOWN,INTERVENTIONAL
NCT02179008,Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02179008,COMPLETED,INTERVENTIONAL
NCT00596791,Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops,https://clinicaltrials.gov/study/NCT00596791,COMPLETED,INTERVENTIONAL
NCT02658071,Measurement of Ocular Tensional Fluctuation by Triggerfish Lens Before and After Cataract Surgery in Patients With Exfoliative Glaucoma,https://clinicaltrials.gov/study/NCT02658071,UNKNOWN,OBSERVATIONAL
NCT04037917,First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute,https://clinicaltrials.gov/study/NCT04037917,TERMINATED,INTERVENTIONAL
NCT03558126,Silicone Tube for the Surgical Treatment of Glaucoma,https://clinicaltrials.gov/study/NCT03558126,COMPLETED,INTERVENTIONAL
NCT00972426,A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT00972426,COMPLETED,INTERVENTIONAL
NCT02801617,Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02801617,TERMINATED,INTERVENTIONAL
NCT00382226,IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy,https://clinicaltrials.gov/study/NCT00382226,COMPLETED,INTERVENTIONAL
NCT05159817,Study of an Interposition Supraciliary Implant in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05159817,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT01319617,SENSIMED Triggerfish Safety and Tolerability,https://clinicaltrials.gov/study/NCT01319617,COMPLETED,INTERVENTIONAL
NCT00878917,Equivalence Study of Dorzolamide 2% Eye Drops Solution,https://clinicaltrials.gov/study/NCT00878917,COMPLETED,INTERVENTIONAL
NCT00707226,Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes,https://clinicaltrials.gov/study/NCT00707226,COMPLETED,OBSERVATIONAL
NCT02914626,Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study,https://clinicaltrials.gov/study/NCT02914626,UNKNOWN,INTERVENTIONAL
NCT00347126,Results of Mass Switch From Latanoprost to Travoprost,https://clinicaltrials.gov/study/NCT00347126,COMPLETED,OBSERVATIONAL
NCT00262626,The Canadian Glaucoma Study,https://clinicaltrials.gov/study/NCT00262626,TERMINATED,INTERVENTIONAL
NCT00262626,The Canadian Glaucoma Study,https://clinicaltrials.gov/study/NCT00262626,TERMINATED,INTERVENTIONAL
NCT00262626,The Canadian Glaucoma Study,https://clinicaltrials.gov/study/NCT00262626,TERMINATED,INTERVENTIONAL
NCT00262626,The Canadian Glaucoma Study,https://clinicaltrials.gov/study/NCT00262626,TERMINATED,INTERVENTIONAL
NCT00262626,The Canadian Glaucoma Study,https://clinicaltrials.gov/study/NCT00262626,TERMINATED,INTERVENTIONAL
NCT02891317,Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma,https://clinicaltrials.gov/study/NCT02891317,TERMINATED,OBSERVATIONAL
NCT02891317,Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma,https://clinicaltrials.gov/study/NCT02891317,TERMINATED,OBSERVATIONAL
NCT03567226,Leveraging WeChat Social-Media and Messaging Platform to Increase Physical Activity in Chinese Glaucoma Patients,https://clinicaltrials.gov/study/NCT03567226,COMPLETED,INTERVENTIONAL
NCT05973617,Development of an IT Tool Able to Identify Ocular Conditions,https://clinicaltrials.gov/study/NCT05973617,WITHDRAWN,OBSERVATIONAL
NCT04515017,Evaluation of Filtering Bleb After Glaucoma Surgery by AS-OCTA,https://clinicaltrials.gov/study/NCT04515017,UNKNOWN,OBSERVATIONAL
NCT01864317,Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging,https://clinicaltrials.gov/study/NCT01864317,TERMINATED,INTERVENTIONAL
NCT03612817,Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing,https://clinicaltrials.gov/study/NCT03612817,COMPLETED,INTERVENTIONAL
NCT00691717,Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00691717,COMPLETED,INTERVENTIONAL
NCT01027039,Will Listening to Music Make it Easier to Take a Visual Field Test?,https://clinicaltrials.gov/study/NCT01027039,COMPLETED,OBSERVATIONAL
NCT01351779,The Effect of Body Posture on Intraocular Pressure in Progressive Glaucoma,https://clinicaltrials.gov/study/NCT01351779,UNKNOWN,OBSERVATIONAL
NCT04719871,Vitreous Detachment and Glaucoma Progression,https://clinicaltrials.gov/study/NCT04719871,UNKNOWN,OBSERVATIONAL
NCT00691639,Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP),https://clinicaltrials.gov/study/NCT00691639,COMPLETED,OBSERVATIONAL
NCT01330979,24-hour Efficacy of AR-12286,https://clinicaltrials.gov/study/NCT01330979,COMPLETED,INTERVENTIONAL
NCT04005079,Pilocarpine After Combined Cataract/Trabectome Surgery,https://clinicaltrials.gov/study/NCT04005079,WITHDRAWN,INTERVENTIONAL
NCT01539239,Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON),https://clinicaltrials.gov/study/NCT01539239,COMPLETED,INTERVENTIONAL
NCT00759239,Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00759239,COMPLETED,INTERVENTIONAL
NCT04846179,To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA,https://clinicaltrials.gov/study/NCT04846179,UNKNOWN,INTERVENTIONAL
NCT01664039,An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®,https://clinicaltrials.gov/study/NCT01664039,COMPLETED,INTERVENTIONAL
NCT01303939,Does Glaucoma Cause Loss of Brain Function?,https://clinicaltrials.gov/study/NCT01303939,COMPLETED,INTERVENTIONAL
NCT01711879,Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT01711879,COMPLETED,INTERVENTIONAL
NCT01390779,Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor,https://clinicaltrials.gov/study/NCT01390779,COMPLETED,INTERVENTIONAL
NCT00657579,Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00657579,COMPLETED,INTERVENTIONAL
NCT00466479,Brimonidine vs ALTP in Progressing Human Glaucoma,https://clinicaltrials.gov/study/NCT00466479,COMPLETED,INTERVENTIONAL
NCT01060579,Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT01060579,COMPLETED,INTERVENTIONAL
NCT04220879,Study on Intraocular Structural Parameters and Surgical Effect Before and After the Onset of Malignant Glaucoma,https://clinicaltrials.gov/study/NCT04220879,UNKNOWN,OBSERVATIONAL
NCT00326079,A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2,https://clinicaltrials.gov/study/NCT00326079,UNKNOWN,INTERVENTIONAL
NCT00570479,Prophylactic Anecortave Acetate in Patients With a Retisert Implant,https://clinicaltrials.gov/study/NCT00570479,COMPLETED,INTERVENTIONAL
NCT02656979,Blood Flow of Ophthalmic Artery and Glaucoma,https://clinicaltrials.gov/study/NCT02656979,UNKNOWN,INTERVENTIONAL
NCT02097979,The Impact of a Brief Educational Intervention on Glaucoma Adherence,https://clinicaltrials.gov/study/NCT02097979,COMPLETED,INTERVENTIONAL
NCT04452279,Ocular Surface Disease Changes After iStent or iStent Inject Implantation With Phacoemulsification,https://clinicaltrials.gov/study/NCT04452279,COMPLETED,INTERVENTIONAL
NCT04709679,Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation,https://clinicaltrials.gov/study/NCT04709679,TERMINATED,INTERVENTIONAL
NCT03047239,TF for the Prediction of Visual Field Progression,https://clinicaltrials.gov/study/NCT03047239,WITHDRAWN,INTERVENTIONAL
NCT01868126,Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01868126,COMPLETED,INTERVENTIONAL
NCT00539526,Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues,https://clinicaltrials.gov/study/NCT00539526,COMPLETED,INTERVENTIONAL
NCT01742104,Multicentric Observational Study on Quality of Life in Glaucoma,https://clinicaltrials.gov/study/NCT01742104,COMPLETED,OBSERVATIONAL
NCT02609204,Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG),https://clinicaltrials.gov/study/NCT02609204,COMPLETED,INTERVENTIONAL
NCT01151904,Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients,https://clinicaltrials.gov/study/NCT01151904,TERMINATED,INTERVENTIONAL
NCT00855517,A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00855517,WITHDRAWN,INTERVENTIONAL
NCT04596826,The Effect of Dronabinol on Ocular Hemodynamics in Patients With Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04596826,RECRUITING,INTERVENTIONAL
NCT01369771,The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma,https://clinicaltrials.gov/study/NCT01369771,COMPLETED,INTERVENTIONAL
NCT01369771,The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma,https://clinicaltrials.gov/study/NCT01369771,COMPLETED,INTERVENTIONAL
NCT01658839,Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients,https://clinicaltrials.gov/study/NCT01658839,COMPLETED,INTERVENTIONAL
NCT02627339,Building a Database of Results From People Without Eye Problems,https://clinicaltrials.gov/study/NCT02627339,COMPLETED,OBSERVATIONAL
NCT03210571,Clinical Investigation of the eyeWatch Glaucoma Drainage Device,https://clinicaltrials.gov/study/NCT03210571,COMPLETED,INTERVENTIONAL
NCT00314171,A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00314171,COMPLETED,INTERVENTIONAL
NCT05232539,Efficiency of Intraoperative Optical Coherence Tomography (iOCT),https://clinicaltrials.gov/study/NCT05232539,RECRUITING,INTERVENTIONAL
NCT00760539,Safety and Efficacy of Travoprost/Timolol BAC-free,https://clinicaltrials.gov/study/NCT00760539,COMPLETED,INTERVENTIONAL
NCT02659709,Interest in Electronic Applications for Patients With Glaucoma,https://clinicaltrials.gov/study/NCT02659709,COMPLETED,OBSERVATIONAL
NCT00804063,Serum Citrate in Diagnosis and Follow-up for Glaucoma,https://clinicaltrials.gov/study/NCT00804063,COMPLETED,OBSERVATIONAL
NCT00735449,Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects,https://clinicaltrials.gov/study/NCT00735449,COMPLETED,INTERVENTIONAL
NCT04899063,Excimer Laser Trabeculostomy Glaucoma Treatment Study,https://clinicaltrials.gov/study/NCT04899063,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT05895617,Assessment of the Occuity PM1 Pachymeter,https://clinicaltrials.gov/study/NCT05895617,COMPLETED,OBSERVATIONAL
NCT05895617,Assessment of the Occuity PM1 Pachymeter,https://clinicaltrials.gov/study/NCT05895617,COMPLETED,OBSERVATIONAL
NCT00168363,Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00168363,COMPLETED,INTERVENTIONAL
NCT01210963,Central Corneal Thickness With SENSIMED Triggerfish,https://clinicaltrials.gov/study/NCT01210963,COMPLETED,OBSERVATIONAL
NCT05900063,Evaluation of the Efficacy of Selecta Laser Trabeculoplasty in Patients Undergoing Filtering Surgery,https://clinicaltrials.gov/study/NCT05900063,COMPLETED,OBSERVATIONAL
NCT02396316,Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients,https://clinicaltrials.gov/study/NCT02396316,COMPLETED,INTERVENTIONAL
NCT05432245,MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract,https://clinicaltrials.gov/study/NCT05432245,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT04609345,Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients,https://clinicaltrials.gov/study/NCT04609345,UNKNOWN,OBSERVATIONAL
NCT02639845,Eye Drop Application Monitor Pilot Study,https://clinicaltrials.gov/study/NCT02639845,UNKNOWN,OBSERVATIONAL
NCT02639845,Eye Drop Application Monitor Pilot Study,https://clinicaltrials.gov/study/NCT02639845,UNKNOWN,OBSERVATIONAL
NCT02639845,Eye Drop Application Monitor Pilot Study,https://clinicaltrials.gov/study/NCT02639845,UNKNOWN,OBSERVATIONAL
NCT00698945,Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG),https://clinicaltrials.gov/study/NCT00698945,COMPLETED,INTERVENTIONAL
NCT01064817,PRM-151 in the Prevention of Scarring Following Trabeculectomy,https://clinicaltrials.gov/study/NCT01064817,COMPLETED,INTERVENTIONAL
NCT00751049,A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom,https://clinicaltrials.gov/study/NCT00751049,COMPLETED,INTERVENTIONAL
NCT05446363,Glaucoma Telemedicine Screening,https://clinicaltrials.gov/study/NCT05446363,RECRUITING,OBSERVATIONAL
NCT01254149,IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic,https://clinicaltrials.gov/study/NCT01254149,COMPLETED,OBSERVATIONAL
NCT00333463,Compliance With Once Daily Glaucoma Medication,https://clinicaltrials.gov/study/NCT00333463,COMPLETED,OBSERVATIONAL
NCT00333463,Compliance With Once Daily Glaucoma Medication,https://clinicaltrials.gov/study/NCT00333463,COMPLETED,OBSERVATIONAL
NCT00376363,Ahmed Versus Baerveldt Comparison Study,https://clinicaltrials.gov/study/NCT00376363,COMPLETED,INTERVENTIONAL
NCT00376363,Ahmed Versus Baerveldt Comparison Study,https://clinicaltrials.gov/study/NCT00376363,COMPLETED,INTERVENTIONAL
NCT01633775,Re-Trabeculectomy Versus Ahmed Glaucoma Valve Implantation in Secondary Surgical Management of Patients With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01633775,COMPLETED,OBSERVATIONAL
NCT03419975,A Multi-center Randomized Blinded Evaluator Active Control Parallel Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients,https://clinicaltrials.gov/study/NCT03419975,COMPLETED,INTERVENTIONAL
NCT03626675,Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy,https://clinicaltrials.gov/study/NCT03626675,UNKNOWN,INTERVENTIONAL
NCT00168350,Memantine in Patients With Chronic Glaucoma,https://clinicaltrials.gov/study/NCT00168350,COMPLETED,INTERVENTIONAL
NCT02102750,A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02102750,COMPLETED,INTERVENTIONAL
NCT01370850,Clinical Validation Study of RTVue Features,https://clinicaltrials.gov/study/NCT01370850,COMPLETED,OBSERVATIONAL
NCT00334750,Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada,https://clinicaltrials.gov/study/NCT00334750,COMPLETED,OBSERVATIONAL
NCT00332345,Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332345,COMPLETED,INTERVENTIONAL
NCT01560975,IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure,https://clinicaltrials.gov/study/NCT01560975,COMPLETED,INTERVENTIONAL
NCT03868254,Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT),https://clinicaltrials.gov/study/NCT03868254,COMPLETED,OBSERVATIONAL
NCT05575154,ISNT Rule in Normal Population,https://clinicaltrials.gov/study/NCT05575154,NOT_YET_RECRUITING,OBSERVATIONAL
NCT01297803,Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery,https://clinicaltrials.gov/study/NCT01297803,UNKNOWN,INTERVENTIONAL
NCT01126203,Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT01126203,COMPLETED,INTERVENTIONAL
NCT03850054,AADI Glaucoma Shunt - a Quality Control Study,https://clinicaltrials.gov/study/NCT03850054,TERMINATED,OBSERVATIONAL
NCT03748654,Feasibility of Visual Field Testing With a Virtual Reality Headset,https://clinicaltrials.gov/study/NCT03748654,SUSPENDED,INTERVENTIONAL
NCT04682054,Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics,https://clinicaltrials.gov/study/NCT04682054,UNKNOWN,INTERVENTIONAL
NCT02144103,Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration,https://clinicaltrials.gov/study/NCT02144103,UNKNOWN,INTERVENTIONAL
NCT04888156,Impact of Self-tonometry on Glaucoma Treatment Decision.,https://clinicaltrials.gov/study/NCT04888156,COMPLETED,OBSERVATIONAL
NCT00651859,Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00651859,COMPLETED,INTERVENTIONAL
NCT02235454,SDOCT-GMPE Software,https://clinicaltrials.gov/study/NCT02235454,COMPLETED,INTERVENTIONAL
NCT04615403,Study of Exchange of Travoprost Intraocular Implant,https://clinicaltrials.gov/study/NCT04615403,COMPLETED,INTERVENTIONAL
NCT01162603,Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP),https://clinicaltrials.gov/study/NCT01162603,COMPLETED,INTERVENTIONAL
NCT02600403,Are There Changes in the Nerve Fiber Layer (NFL) After Lowering of Eye Pressure?,https://clinicaltrials.gov/study/NCT02600403,COMPLETED,OBSERVATIONAL
NCT05130554,XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05130554,UNKNOWN,INTERVENTIONAL
NCT02313259,The Impact of Ocular Diseases on Driving: a Prospective Study,https://clinicaltrials.gov/study/NCT02313259,COMPLETED,OBSERVATIONAL
NCT03822559,A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03822559,COMPLETED,INTERVENTIONAL
NCT01209975,Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT01209975,UNKNOWN,OBSERVATIONAL
NCT05352854,Morphological Changes of Ciliary Body and Trabecular Meshwork,https://clinicaltrials.gov/study/NCT05352854,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00912054,DuoTrav APS Versus XALACOM® in Ocular Surface Health,https://clinicaltrials.gov/study/NCT00912054,TERMINATED,INTERVENTIONAL
NCT02585375,Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT,https://clinicaltrials.gov/study/NCT02585375,RECRUITING,INTERVENTIONAL
NCT02057575,Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT02057575,COMPLETED,INTERVENTIONAL
NCT02868190,Two Second-Generation Trabecular Micro-bypass Stents to Treat Glaucoma Subjects on One Hypotensive Medication,https://clinicaltrials.gov/study/NCT02868190,COMPLETED,INTERVENTIONAL
NCT05542290,Implantation of Capsular Tension Ring in Primary Angle Closure Patients With Zonular Laxity or Dialysis,https://clinicaltrials.gov/study/NCT05542290,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00719290,Primary Angle Closure Glaucoma and Aqueous Dynamics,https://clinicaltrials.gov/study/NCT00719290,COMPLETED,INTERVENTIONAL
NCT01920867,Stem Cell Ophthalmology Treatment Study,https://clinicaltrials.gov/study/NCT01920867,UNKNOWN,INTERVENTIONAL
NCT05605743,Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure,https://clinicaltrials.gov/study/NCT05605743,RECRUITING,INTERVENTIONAL
NCT00825890,The High Cup/Disc Ratio in Children,https://clinicaltrials.gov/study/NCT00825890,COMPLETED,OBSERVATIONAL
NCT02448875,Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT02448875,COMPLETED,INTERVENTIONAL
NCT00047554,Study of TRAVATAN in Subjects With Iris Pigmentation Changes,https://clinicaltrials.gov/study/NCT00047554,TERMINATED,OBSERVATIONAL
NCT00893490,Ahmed Glaucoma Valve Alone With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma,https://clinicaltrials.gov/study/NCT00893490,UNKNOWN,INTERVENTIONAL
NCT00538590,Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00538590,COMPLETED,INTERVENTIONAL
NCT01023997,Central Corneal Thickness in Glaucoma,https://clinicaltrials.gov/study/NCT01023997,COMPLETED,OBSERVATIONAL
NCT02764697,Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients,https://clinicaltrials.gov/study/NCT02764697,COMPLETED,INTERVENTIONAL
NCT05150197,Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease,https://clinicaltrials.gov/study/NCT05150197,RECRUITING,INTERVENTIONAL
NCT03131167,Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03131167,COMPLETED,INTERVENTIONAL
NCT01455467,Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT01455467,COMPLETED,INTERVENTIONAL
NCT04944290,To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes,https://clinicaltrials.gov/study/NCT04944290,COMPLETED,INTERVENTIONAL
NCT02014597,Human Optokinetic Contrast Device (HOCD) to Measure Visual Function and Identify Patients With and Without Glaucoma,https://clinicaltrials.gov/study/NCT02014597,TERMINATED,INTERVENTIONAL
NCT02839590,Aqueous Dynamics and Glaucoma Surgeries,https://clinicaltrials.gov/study/NCT02839590,UNKNOWN,OBSERVATIONAL
NCT01243567,Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated,https://clinicaltrials.gov/study/NCT01243567,COMPLETED,INTERVENTIONAL
NCT04703959,Glaucoma and Sleep Quality,https://clinicaltrials.gov/study/NCT04703959,UNKNOWN,OBSERVATIONAL
NCT05400759,Clinical Outcomes of the Implementation of Diurnal IOP Curve to 1500 Patients - A Cohort Study.,https://clinicaltrials.gov/study/NCT05400759,COMPLETED,OBSERVATIONAL
NCT01580254,Efficacy and Safety of Three Different Latanoprost 0005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01580254,UNKNOWN,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT03201354,Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery,https://clinicaltrials.gov/study/NCT03201354,COMPLETED,INTERVENTIONAL
NCT00739154,Protective Effect of Phenytoin on Glaucoma,https://clinicaltrials.gov/study/NCT00739154,UNKNOWN,OBSERVATIONAL
NCT05673954,Glaucoma Assessment Via Reading Ability,https://clinicaltrials.gov/study/NCT05673954,NOT_YET_RECRUITING,OBSERVATIONAL
NCT04164459,Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.,https://clinicaltrials.gov/study/NCT04164459,UNKNOWN,INTERVENTIONAL
NCT02674854,Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02674854,COMPLETED,INTERVENTIONAL
NCT04670575,Vivity Outcomes in Patients With Early Stage Glaucoma,https://clinicaltrials.gov/study/NCT04670575,UNKNOWN,OBSERVATIONAL
NCT00792259,Topcon 3D OCT-1000 Optical Coherence Tomography System,https://clinicaltrials.gov/study/NCT00792259,COMPLETED,OBSERVATIONAL
NCT05593354,MicroPulse TLT - UK Study,https://clinicaltrials.gov/study/NCT05593354,NOT_YET_RECRUITING,OBSERVATIONAL
NCT00798759,Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN,https://clinicaltrials.gov/study/NCT00798759,COMPLETED,INTERVENTIONAL
NCT03114059,5 Years Long Term Results After Standalone CyPass-Implantation,https://clinicaltrials.gov/study/NCT03114059,COMPLETED,OBSERVATIONAL
NCT00716859,A Phase 3 Prospective Randomized Double-Masked 12-Week Parallel Group Study In Pediatric Subjects With Glaucoma.,https://clinicaltrials.gov/study/NCT00716859,COMPLETED,INTERVENTIONAL
NCT02617459,Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02617459,COMPLETED,INTERVENTIONAL
NCT01166659,Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy,https://clinicaltrials.gov/study/NCT01166659,COMPLETED,INTERVENTIONAL
NCT04619654,Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04619654,COMPLETED,INTERVENTIONAL
NCT02042703,Imaging Lens Deposits in Exfoliation Syndrome,https://clinicaltrials.gov/study/NCT02042703,TERMINATED,OBSERVATIONAL
NCT00957190,The DIOXXACT Trial(Diurnal IOP and OBF Xalatan vs Xalatan And Cosopt Trial),https://clinicaltrials.gov/study/NCT00957190,COMPLETED,INTERVENTIONAL
NCT04454190,Development and Validation of a Model to Predict Fast Progression in Glaucoma,https://clinicaltrials.gov/study/NCT04454190,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT04709497,Surgery for Primary Congenital Glaucoma in Neonates,https://clinicaltrials.gov/study/NCT04709497,UNKNOWN,INTERVENTIONAL
NCT00800267,A Study of Glaucoma or Ocular Hypertension in Patients Within the United States,https://clinicaltrials.gov/study/NCT00800267,COMPLETED,INTERVENTIONAL
NCT00620256,Adjunctive Study of AL-37807 Ophthalmic Suspension,https://clinicaltrials.gov/study/NCT00620256,COMPLETED,INTERVENTIONAL
NCT04003090,Citicoline Concentration in Human Vitreous,https://clinicaltrials.gov/study/NCT04003090,COMPLETED,INTERVENTIONAL
NCT01711190,Astigmatism Post-trabeculectomy,https://clinicaltrials.gov/study/NCT01711190,COMPLETED,OBSERVATIONAL
NCT02444767,Bimatoprost Ocular Insert Pharmacokinetic Study,https://clinicaltrials.gov/study/NCT02444767,COMPLETED,INTERVENTIONAL
NCT05165290,Prospective Double-masked Randomized Multi-center Active-controlled Parallel-group 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT05165290,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00478790,Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital,https://clinicaltrials.gov/study/NCT00478790,UNKNOWN,INTERVENTIONAL
NCT00950690,Efficacy and Tolerability of Xalatan in Patients,https://clinicaltrials.gov/study/NCT00950690,COMPLETED,OBSERVATIONAL
NCT01957267,Functional and Structural Imaging for Glaucoma,https://clinicaltrials.gov/study/NCT01957267,RECRUITING,OBSERVATIONAL
NCT03657797,Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03657797,COMPLETED,INTERVENTIONAL
NCT04503590,Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study,https://clinicaltrials.gov/study/NCT04503590,COMPLETED,INTERVENTIONAL
NCT04303897,Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT04303897,COMPLETED,OBSERVATIONAL
NCT03016156,Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma,https://clinicaltrials.gov/study/NCT03016156,RECRUITING,INTERVENTIONAL
NCT04503356,OMNI in Open-angle Glaucoma Treatment,https://clinicaltrials.gov/study/NCT04503356,UNKNOWN,INTERVENTIONAL
NCT02328456,Effect of SMS Reminder and Free Eye Drops on Follow-up Adherence After Trabeculectomy Surgery in Rural China,https://clinicaltrials.gov/study/NCT02328456,COMPLETED,INTERVENTIONAL
NCT00465803,A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00465803,COMPLETED,INTERVENTIONAL
NCT02526654,Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects,https://clinicaltrials.gov/study/NCT02526654,COMPLETED,INTERVENTIONAL
NCT01312454,Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C,https://clinicaltrials.gov/study/NCT01312454,TERMINATED,INTERVENTIONAL
NCT05498103,Use of Methazolamide to Lower Intraocular Pressure,https://clinicaltrials.gov/study/NCT05498103,RECRUITING,INTERVENTIONAL
NCT01159756,To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular Pressure,https://clinicaltrials.gov/study/NCT01159756,COMPLETED,INTERVENTIONAL
NCT01886456,IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients,https://clinicaltrials.gov/study/NCT01886456,UNKNOWN,INTERVENTIONAL
NCT01922154,Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT01922154,COMPLETED,INTERVENTIONAL
NCT00343603,Tracking Optical Coherence Tomography,https://clinicaltrials.gov/study/NCT00343603,COMPLETED,OBSERVATIONAL
NCT01883856,Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves,https://clinicaltrials.gov/study/NCT01883856,COMPLETED,INTERVENTIONAL
NCT05875090,Glaucoma Portugal Screening Trial,https://clinicaltrials.gov/study/NCT05875090,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT05875090,Glaucoma Portugal Screening Trial,https://clinicaltrials.gov/study/NCT05875090,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT05875090,Glaucoma Portugal Screening Trial,https://clinicaltrials.gov/study/NCT05875090,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT05875090,Glaucoma Portugal Screening Trial,https://clinicaltrials.gov/study/NCT05875090,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT05898997,Regulation of Intraocular Pressure in Glaucoma Patients by Acupressure,https://clinicaltrials.gov/study/NCT05898997,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02846090,Dexmedetomidine as an Additive to Local Anaesthesia to Decrease Intraocular Pressure in Glaucoma Surgery,https://clinicaltrials.gov/study/NCT02846090,UNKNOWN,INTERVENTIONAL
NCT01456390,Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents,https://clinicaltrials.gov/study/NCT01456390,COMPLETED,INTERVENTIONAL
NCT02744690,Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia,https://clinicaltrials.gov/study/NCT02744690,WITHDRAWN,INTERVENTIONAL
NCT03076697,Smartphone Screening for Eye Diseases,https://clinicaltrials.gov/study/NCT03076697,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT03076697,Smartphone Screening for Eye Diseases,https://clinicaltrials.gov/study/NCT03076697,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT02355990,Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study,https://clinicaltrials.gov/study/NCT02355990,COMPLETED,INTERVENTIONAL
NCT05674890,SmartSystem Virtual Reality Headset Perimeter Versus Humphrey HFA-III Perimeter,https://clinicaltrials.gov/study/NCT05674890,RECRUITING,INTERVENTIONAL
NCT01111890,Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01111890,COMPLETED,INTERVENTIONAL
NCT00928590,Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00928590,COMPLETED,INTERVENTIONAL
NCT06045390,An App-based Instructional Platform to Improve Eye Drop Recall,https://clinicaltrials.gov/study/NCT06045390,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00701597,Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT00701597,COMPLETED,INTERVENTIONAL
NCT00854256,Trabeculectomy Versus Canaloplasty to Treat Glaucoma,https://clinicaltrials.gov/study/NCT00854256,UNKNOWN,INTERVENTIONAL
NCT03220490,Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops,https://clinicaltrials.gov/study/NCT03220490,UNKNOWN,INTERVENTIONAL
NCT04931290,Supracapsular Ahmed Glaucoma Valve Plate Delivery Technique for Management of Encapsulated Bleb in Pediatric Patients,https://clinicaltrials.gov/study/NCT04931290,COMPLETED,INTERVENTIONAL
NCT02054403,Angle Closure (Glaucoma) in Caucasians,https://clinicaltrials.gov/study/NCT02054403,UNKNOWN,OBSERVATIONAL
NCT00061503,Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00061503,COMPLETED,INTERVENTIONAL
NCT00320203,Anecortave Acetate in Patients With Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT00320203,COMPLETED,INTERVENTIONAL
NCT05136950,Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation,https://clinicaltrials.gov/study/NCT05136950,RECRUITING,INTERVENTIONAL
NCT00047515,Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69,https://clinicaltrials.gov/study/NCT00047515,COMPLETED,INTERVENTIONAL
NCT01840215,Study on the Impact of Ocular Anesthetic Procedures in Ocular Blood Flow,https://clinicaltrials.gov/study/NCT01840215,COMPLETED,OBSERVATIONAL
NCT01818115,Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery.,https://clinicaltrials.gov/study/NCT01818115,COMPLETED,INTERVENTIONAL
NCT02287545,Biomechanical Changes After Trabeculectomy,https://clinicaltrials.gov/study/NCT02287545,COMPLETED,OBSERVATIONAL
NCT04593745,Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids,https://clinicaltrials.gov/study/NCT04593745,RECRUITING,INTERVENTIONAL
NCT00051168,A Long-term Safety Study of Once-daily Travatan,https://clinicaltrials.gov/study/NCT00051168,COMPLETED,INTERVENTIONAL
NCT02231515,ProspectiveRandomizedControlled Study to Assess EfficacySafety and Tolerability of SLT vs. PLT in Patients With POAG,https://clinicaltrials.gov/study/NCT02231515,TERMINATED,INTERVENTIONAL
NCT02647515,Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT02647515,COMPLETED,INTERVENTIONAL
NCT04671550,The Value of Visual Field Examination in Driving Licence.,https://clinicaltrials.gov/study/NCT04671550,UNKNOWN,OBSERVATIONAL
NCT02855450,Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT02855450,COMPLETED,INTERVENTIONAL
NCT04116450,MicrocatheterTrabeculotomy in Primary Congenital Glaucoma,https://clinicaltrials.gov/study/NCT04116450,COMPLETED,INTERVENTIONAL
NCT03488550,Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03488550,COMPLETED,INTERVENTIONAL
NCT01733550,ICare Self-tonometry - A Head-to-head Comparison to the Gold Standard Goldmann Tonometer,https://clinicaltrials.gov/study/NCT01733550,UNKNOWN,OBSERVATIONAL
NCT01677507,Glaucoma Biomarkers,https://clinicaltrials.gov/study/NCT01677507,COMPLETED,INTERVENTIONAL
NCT01677507,Glaucoma Biomarkers,https://clinicaltrials.gov/study/NCT01677507,COMPLETED,INTERVENTIONAL
NCT01677507,Glaucoma Biomarkers,https://clinicaltrials.gov/study/NCT01677507,COMPLETED,INTERVENTIONAL
NCT00453024,Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures,https://clinicaltrials.gov/study/NCT00453024,UNKNOWN,INTERVENTIONAL
NCT01025024,Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients,https://clinicaltrials.gov/study/NCT01025024,COMPLETED,OBSERVATIONAL
NCT01025024,Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients,https://clinicaltrials.gov/study/NCT01025024,COMPLETED,OBSERVATIONAL
NCT01898624,Specified Drug Use-results Survey of Betanis Tablets,https://clinicaltrials.gov/study/NCT01898624,COMPLETED,OBSERVATIONAL
NCT00551395,Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion,https://clinicaltrials.gov/study/NCT00551395,TERMINATED,INTERVENTIONAL
NCT02655432,Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population,https://clinicaltrials.gov/study/NCT02655432,WITHDRAWN,OBSERVATIONAL
NCT06144918,Phase 2 Placebo-Controlled Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure,https://clinicaltrials.gov/study/NCT06144918,RECRUITING,INTERVENTIONAL
NCT05506423,Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes,https://clinicaltrials.gov/study/NCT05506423,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT05039684,Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins,https://clinicaltrials.gov/study/NCT05039684,RECRUITING,OBSERVATIONAL
NCT01887223,Transconjunctival Needling Revision Versus Medical Treatment,https://clinicaltrials.gov/study/NCT01887223,COMPLETED,INTERVENTIONAL
NCT01087684,Response to SLT vs. ALT in Patients Under 60 Years of Age,https://clinicaltrials.gov/study/NCT01087684,COMPLETED,INTERVENTIONAL
NCT01840202,Ocular Blood Flow in Glaucoma Patients - the Leuven Eye Study,https://clinicaltrials.gov/study/NCT01840202,COMPLETED,OBSERVATIONAL
NCT00940823,The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma,https://clinicaltrials.gov/study/NCT00940823,COMPLETED,INTERVENTIONAL
NCT05231928,A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome,https://clinicaltrials.gov/study/NCT05231928,RECRUITING,INTERVENTIONAL
NCT03584958,Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries,https://clinicaltrials.gov/study/NCT03584958,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT03584958,Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries,https://clinicaltrials.gov/study/NCT03584958,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT01105923,Study of an Intervention to Improve Problem List Accuracy and Use,https://clinicaltrials.gov/study/NCT01105923,UNKNOWN,INTERVENTIONAL
NCT00323284,A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00323284,COMPLETED,INTERVENTIONAL
NCT00332384,Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332384,COMPLETED,INTERVENTIONAL
NCT00444184,24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost,https://clinicaltrials.gov/study/NCT00444184,COMPLETED,INTERVENTIONAL
NCT01430923,Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost,https://clinicaltrials.gov/study/NCT01430923,UNKNOWN,INTERVENTIONAL
NCT01417858,Intraocular Pressure Control After Anterior Segment Laser - Comparison Between 2 Drugs,https://clinicaltrials.gov/study/NCT01417858,UNKNOWN,INTERVENTIONAL
NCT03423758,Investigating the Genetic Basis of Pseudoexfoliation Syndrome Angle-closure Glaucoma and Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT03423758,RECRUITING,OBSERVATIONAL
NCT04602923,Keratometric Change After XEN Trabeculectomy and Tube Shunts,https://clinicaltrials.gov/study/NCT04602923,RECRUITING,INTERVENTIONAL
NCT02390284,Stop Retinal Ganglion Cell Dysfunction Study,https://clinicaltrials.gov/study/NCT02390284,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT03912584,Study Comparing the P200TE and the P200TxE in Glaucoma Patients,https://clinicaltrials.gov/study/NCT03912584,COMPLETED,INTERVENTIONAL
NCT00494923,Early Diagnosis Pathogenesis and Progression of Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00494923,UNKNOWN,OBSERVATIONAL
NCT01507584,The Effects of the Water Drinking Test on Intraocular Pressure,https://clinicaltrials.gov/study/NCT01507584,COMPLETED,INTERVENTIONAL
NCT04037384,Training of Eye Movements in Glaucoma,https://clinicaltrials.gov/study/NCT04037384,UNKNOWN,INTERVENTIONAL
NCT01230736,Safety and Efficacy of Changing to DuoTrav From Prior Therapy,https://clinicaltrials.gov/study/NCT01230736,COMPLETED,INTERVENTIONAL
NCT00848536,Efficacy Study of Travoprost APS Versus TRAVATAN,https://clinicaltrials.gov/study/NCT00848536,COMPLETED,INTERVENTIONAL
NCT00527501,IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00527501,COMPLETED,INTERVENTIONAL
NCT00559234,Potential Research Participants for Future Studies of Inherited Eye Diseases,https://clinicaltrials.gov/study/NCT00559234,COMPLETED,OBSERVATIONAL
NCT05503901,A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT05503901,RECRUITING,INTERVENTIONAL
NCT01849536,Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients,https://clinicaltrials.gov/study/NCT01849536,COMPLETED,INTERVENTIONAL
NCT00332436,Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332436,COMPLETED,INTERVENTIONAL
NCT04205201,The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04205201,COMPLETED,INTERVENTIONAL
NCT03651336,Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG),https://clinicaltrials.gov/study/NCT03651336,COMPLETED,INTERVENTIONAL
NCT05253534,GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05253534,SUSPENDED,INTERVENTIONAL
NCT04784234,Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin,https://clinicaltrials.gov/study/NCT04784234,RECRUITING,INTERVENTIONAL
NCT04038034,Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04038034,UNKNOWN,INTERVENTIONAL
NCT05536401,P200TE Agreement and Precision Study,https://clinicaltrials.gov/study/NCT05536401,TERMINATED,INTERVENTIONAL
NCT04735601,Ahmed Valve Implantation Coated With Poly Lactic -Co-glycolic Acid (PLGA) Saturated With Mitomycin-C in the Management of Adult Onset Glaucoma in Sturge Weber Syndrome,https://clinicaltrials.gov/study/NCT04735601,RECRUITING,INTERVENTIONAL
NCT04285580,A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04285580,COMPLETED,INTERVENTIONAL
NCT01896180,Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost,https://clinicaltrials.gov/study/NCT01896180,COMPLETED,INTERVENTIONAL
NCT04947124,A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101,https://clinicaltrials.gov/study/NCT04947124,COMPLETED,INTERVENTIONAL
NCT05147701,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases,https://clinicaltrials.gov/study/NCT05147701,RECRUITING,INTERVENTIONAL
NCT03338101,Comparative Study Between Tonometers,https://clinicaltrials.gov/study/NCT03338101,COMPLETED,OBSERVATIONAL
NCT01879501,Living Successfully With Chronic Eye Diseases,https://clinicaltrials.gov/study/NCT01879501,UNKNOWN,INTERVENTIONAL
NCT01879501,Living Successfully With Chronic Eye Diseases,https://clinicaltrials.gov/study/NCT01879501,UNKNOWN,INTERVENTIONAL
NCT01879501,Living Successfully With Chronic Eye Diseases,https://clinicaltrials.gov/study/NCT01879501,UNKNOWN,INTERVENTIONAL
NCT01879501,Living Successfully With Chronic Eye Diseases,https://clinicaltrials.gov/study/NCT01879501,UNKNOWN,INTERVENTIONAL
NCT02050880,OCT Agreement and Crossed Precision Study,https://clinicaltrials.gov/study/NCT02050880,COMPLETED,OBSERVATIONAL
NCT05703724,Prevalence of Glaucoma in Belgium: a Multicenter National Trial,https://clinicaltrials.gov/study/NCT05703724,COMPLETED,INTERVENTIONAL
NCT01628601,GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy,https://clinicaltrials.gov/study/NCT01628601,COMPLETED,OBSERVATIONAL
NCT04132401,AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care,https://clinicaltrials.gov/study/NCT04132401,COMPLETED,INTERVENTIONAL
NCT04132401,AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care,https://clinicaltrials.gov/study/NCT04132401,COMPLETED,INTERVENTIONAL
NCT04132401,AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care,https://clinicaltrials.gov/study/NCT04132401,COMPLETED,INTERVENTIONAL
NCT05269680,STAR-LIFE: a Post-market Registry on MINIject,https://clinicaltrials.gov/study/NCT05269680,RECRUITING,OBSERVATIONAL
NCT04448080,Comparison of Topical Anesthesia and Analgosedation in Micropulse Transscleral Glaucoma Treatment,https://clinicaltrials.gov/study/NCT04448080,COMPLETED,INTERVENTIONAL
NCT06174324,Visual Field Progression and RNFL Change After PreserFlo MicroShunt Implantation,https://clinicaltrials.gov/study/NCT06174324,RECRUITING,OBSERVATIONAL
NCT00443924,Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma,https://clinicaltrials.gov/study/NCT00443924,COMPLETED,INTERVENTIONAL
NCT03750201,A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT03750201,COMPLETED,INTERVENTIONAL
NCT03750201,A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT03750201,COMPLETED,INTERVENTIONAL
NCT03750201,A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT03750201,COMPLETED,INTERVENTIONAL
NCT03750201,A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT03750201,COMPLETED,INTERVENTIONAL
NCT00327301,Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease,https://clinicaltrials.gov/study/NCT00327301,WITHDRAWN,OBSERVATIONAL
NCT06000280,Evaluation of Retina in Patients With Glaucoma Using Topical Prostaglandins Undergoing Trabeculectomy Surgery,https://clinicaltrials.gov/study/NCT06000280,COMPLETED,INTERVENTIONAL
NCT03310580,Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT03310580,COMPLETED,INTERVENTIONAL
NCT00644280,Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery,https://clinicaltrials.gov/study/NCT00644280,TERMINATED,INTERVENTIONAL
NCT01561001,IOP Fluctuations in Primary Open Angle Glaucoma Patients Before and After Deep Sclerectomy With Collagen Implant,https://clinicaltrials.gov/study/NCT01561001,TERMINATED,INTERVENTIONAL
NCT03086980,Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT03086980,UNKNOWN,INTERVENTIONAL
NCT02875158,Cyclophotocoagulation in Glaucoma,https://clinicaltrials.gov/study/NCT02875158,COMPLETED,INTERVENTIONAL
NCT00221923,African Descent and Glaucoma Evaluation Study,https://clinicaltrials.gov/study/NCT00221923,UNKNOWN,OBSERVATIONAL
NCT01170884,Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®,https://clinicaltrials.gov/study/NCT01170884,COMPLETED,INTERVENTIONAL
NCT01391078,Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry,https://clinicaltrials.gov/study/NCT01391078,COMPLETED,INTERVENTIONAL
NCT04553523,Hydrus® Microstent New Enrollment Post-Approval Study,https://clinicaltrials.gov/study/NCT04553523,RECRUITING,INTERVENTIONAL
NCT02339584,Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT02339584,COMPLETED,INTERVENTIONAL
NCT03931564,SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.,https://clinicaltrials.gov/study/NCT03931564,RECRUITING,INTERVENTIONAL
NCT02917564,Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery,https://clinicaltrials.gov/study/NCT02917564,RECRUITING,INTERVENTIONAL
NCT03624361,MINIject Glaucoma Implant in European Patients,https://clinicaltrials.gov/study/NCT03624361,COMPLETED,INTERVENTIONAL
NCT03274323,Trabeculectomy Versus 2-iStent and Prostaglandin Study,https://clinicaltrials.gov/study/NCT03274323,WITHDRAWN,INTERVENTIONAL
NCT04530084,A Single Center Proof Of Concept Study To Assess Intra And Perioperative Safety Profile Of OMNI Surgical System,https://clinicaltrials.gov/study/NCT04530084,UNKNOWN,INTERVENTIONAL
NCT04088084,Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram,https://clinicaltrials.gov/study/NCT04088084,COMPLETED,INTERVENTIONAL
NCT00801658,Efficacy of SLT in Patients With Insufficient IOP Control Under Maximum Tolerated Drug Therapy (Eye Drops),https://clinicaltrials.gov/study/NCT00801658,COMPLETED,INTERVENTIONAL
NCT02199158,Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies,https://clinicaltrials.gov/study/NCT02199158,COMPLETED,INTERVENTIONAL
NCT01052558,GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01052558,COMPLETED,INTERVENTIONAL
NCT02405884,Intraocular Pressure and Hemodialysis Midwestern Brazil,https://clinicaltrials.gov/study/NCT02405884,COMPLETED,INTERVENTIONAL
NCT01779284,Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy,https://clinicaltrials.gov/study/NCT01779284,COMPLETED,INTERVENTIONAL
NCT00847158,A Clinical Trial of Phacoemulsification Versus Phacoemulsification & the iStent Implantation in POAG Patients,https://clinicaltrials.gov/study/NCT00847158,COMPLETED,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04878458,Phacotrabeculectomy Versus Phacogoniotomy (PVP) in Advanced Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT04878458,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04060758,Open Label Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma,https://clinicaltrials.gov/study/NCT04060758,RECRUITING,INTERVENTIONAL
NCT06139523,Optimize Pediatric OCT Imaging,https://clinicaltrials.gov/study/NCT06139523,NOT_YET_RECRUITING,OBSERVATIONAL
NCT00348023,Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT00348023,COMPLETED,INTERVENTIONAL
NCT01654484,A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT,https://clinicaltrials.gov/study/NCT01654484,COMPLETED,INTERVENTIONAL
NCT02177123,Post Market Study of the InnFocus MicroShunt,https://clinicaltrials.gov/study/NCT02177123,COMPLETED,INTERVENTIONAL
NCT06158984,Managing Dry Eye in Patients Using Glaucoma Drops,https://clinicaltrials.gov/study/NCT06158984,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05844384,Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial,https://clinicaltrials.gov/study/NCT05844384,RECRUITING,INTERVENTIONAL
NCT03804684,visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry,https://clinicaltrials.gov/study/NCT03804684,COMPLETED,INTERVENTIONAL
NCT02045823,OCT Agreement and Precision Study,https://clinicaltrials.gov/study/NCT02045823,COMPLETED,OBSERVATIONAL
NCT02247284,Reproducibility of RNFL and ONH Measurements in OAG With Heidelberg Spectralis SD-OCT Glaucoma Module Premium Edition,https://clinicaltrials.gov/study/NCT02247284,COMPLETED,INTERVENTIONAL
NCT00756184,Value of an Intervention to Enhance Adherence in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00756184,COMPLETED,INTERVENTIONAL
NCT03065036,Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG,https://clinicaltrials.gov/study/NCT03065036,COMPLETED,INTERVENTIONAL
NCT01514734,Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil,https://clinicaltrials.gov/study/NCT01514734,TERMINATED,INTERVENTIONAL
NCT00647101,A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT00647101,COMPLETED,INTERVENTIONAL
NCT02901236,Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma,https://clinicaltrials.gov/study/NCT02901236,COMPLETED,INTERVENTIONAL
NCT02858284,Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02858284,TERMINATED,INTERVENTIONAL
NCT03267134,Hydrus Microstent for Refractory Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT03267134,COMPLETED,INTERVENTIONAL
NCT01037036,A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG,https://clinicaltrials.gov/study/NCT01037036,COMPLETED,INTERVENTIONAL
NCT02036541,AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma,https://clinicaltrials.gov/study/NCT02036541,COMPLETED,INTERVENTIONAL
NCT05876936,Prospective Open Label Study to Assess 24hs IOP Recorded With Triggerfish® in Patients With OAG Before and After DSCI,https://clinicaltrials.gov/study/NCT05876936,TERMINATED,INTERVENTIONAL
NCT04547036,Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation,https://clinicaltrials.gov/study/NCT04547036,COMPLETED,OBSERVATIONAL
NCT00397241,24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations,https://clinicaltrials.gov/study/NCT00397241,COMPLETED,INTERVENTIONAL
NCT05871034,Electroretinogram and Retinal Vascular Changes After Cataract Surgery,https://clinicaltrials.gov/study/NCT05871034,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02003534,A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT02003534,COMPLETED,INTERVENTIONAL
NCT01263834,Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome,https://clinicaltrials.gov/study/NCT01263834,COMPLETED,INTERVENTIONAL
NCT05964634,Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia,https://clinicaltrials.gov/study/NCT05964634,NOT_YET_RECRUITING,OBSERVATIONAL
NCT00788541,A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00788541,TERMINATED,INTERVENTIONAL
NCT03551834,Ahmed Glaucoma Valve Implantation; Graft-Free Short Tunnel Small Flap Versus Scleral Patch Graft,https://clinicaltrials.gov/study/NCT03551834,UNKNOWN,INTERVENTIONAL
NCT00800540,Circadian Ocular Perfusion Pressure and Ocular Blood Flow,https://clinicaltrials.gov/study/NCT00800540,COMPLETED,INTERVENTIONAL
NCT05426044,Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT05426044,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04447157,The Efficacy of a 6-point Transscleral Suture Fixation of a 3-looped Haptics PC-IOL Implantation Through Scleral Pockets for Surgical Management for Microspherophakia,https://clinicaltrials.gov/study/NCT04447157,COMPLETED,OBSERVATIONAL
NCT04921098,CPC in Adult Refractory Glaucoma,https://clinicaltrials.gov/study/NCT04921098,RECRUITING,INTERVENTIONAL
NCT00796198,Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure,https://clinicaltrials.gov/study/NCT00796198,UNKNOWN,INTERVENTIONAL
NCT00972257,24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination,https://clinicaltrials.gov/study/NCT00972257,COMPLETED,INTERVENTIONAL
NCT00449098,Ologen (OculusGen)-Glaucoma MMC Control Trial in India,https://clinicaltrials.gov/study/NCT00449098,UNKNOWN,INTERVENTIONAL
NCT01145898,Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data,https://clinicaltrials.gov/study/NCT01145898,COMPLETED,OBSERVATIONAL
NCT00306657,Normal Tension and Chronic Open Angle Glaucoma and Cerebrospinal Fluid Composition,https://clinicaltrials.gov/study/NCT00306657,UNKNOWN,INTERVENTIONAL
NCT03052257,Improve Glaucoma Medication Adherence,https://clinicaltrials.gov/study/NCT03052257,COMPLETED,INTERVENTIONAL
NCT06058598,Exercise Training in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT06058598,NOT_YET_RECRUITING,INTERVENTIONAL
NCT06058598,Exercise Training in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT06058598,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05151757,Developing and Testing a Low Cost Opportunistic Glaucoma Screening Model by Non-physician Graders in Vietnam,https://clinicaltrials.gov/study/NCT05151757,COMPLETED,INTERVENTIONAL
NCT00428740,Long-Term IOP Fluctuation and VF Progression After Triple Procedure,https://clinicaltrials.gov/study/NCT00428740,COMPLETED,OBSERVATIONAL
NCT05624398,Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery,https://clinicaltrials.gov/study/NCT05624398,RECRUITING,INTERVENTIONAL
NCT03924544,Decorin in Sub Scleral Trabeculectomy,https://clinicaltrials.gov/study/NCT03924544,UNKNOWN,INTERVENTIONAL
NCT04172857,Treatment of Malignant Glaucoma by Anterior Vitrectomy From Two Different Approaches,https://clinicaltrials.gov/study/NCT04172857,COMPLETED,OBSERVATIONAL
NCT02852057,Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses,https://clinicaltrials.gov/study/NCT02852057,COMPLETED,INTERVENTIONAL
NCT02136940,Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02136940,COMPLETED,INTERVENTIONAL
NCT00326040,A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects,https://clinicaltrials.gov/study/NCT00326040,COMPLETED,INTERVENTIONAL
NCT00284440,Choroidal Blood Flow Response to Hand-grip Test in Progressive Glaucoma,https://clinicaltrials.gov/study/NCT00284440,WITHDRAWN,OBSERVATIONAL
NCT01444040,Subjects With Open-angle Glaucoma Pseudoexfoliative Glaucoma or Ocular Hypertension Naïve to Medical and Surgical Therapy Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost,https://clinicaltrials.gov/study/NCT01444040,COMPLETED,INTERVENTIONAL
NCT00452998,Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study,https://clinicaltrials.gov/study/NCT00452998,COMPLETED,INTERVENTIONAL
NCT01547598,Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction,https://clinicaltrials.gov/study/NCT01547598,COMPLETED,INTERVENTIONAL
NCT03949244,Nailfold Capillary Blood Flow With Latanoprost Bunod,https://clinicaltrials.gov/study/NCT03949244,COMPLETED,INTERVENTIONAL
NCT02641457,Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis,https://clinicaltrials.gov/study/NCT02641457,COMPLETED,INTERVENTIONAL
NCT04499157,Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04499157,RECRUITING,INTERVENTIONAL
NCT00705757,The Effects of Xalatan Travatan and Lumigan on Skin Pigmentation Near the Eye,https://clinicaltrials.gov/study/NCT00705757,COMPLETED,INTERVENTIONAL
NCT03255798,A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra,https://clinicaltrials.gov/study/NCT03255798,TERMINATED,INTERVENTIONAL
NCT05581498,Glaucoma Exercise as Medicine Study (GEMS).,https://clinicaltrials.gov/study/NCT05581498,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00332540,Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00332540,COMPLETED,INTERVENTIONAL
NCT02016898,The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device,https://clinicaltrials.gov/study/NCT02016898,COMPLETED,INTERVENTIONAL
NCT04337944,Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo),https://clinicaltrials.gov/study/NCT04337944,RECRUITING,INTERVENTIONAL
NCT04994457,Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care,https://clinicaltrials.gov/study/NCT04994457,RECRUITING,OBSERVATIONAL
NCT00369057,Intra Ocular Pressure During Robotic Prostatectomy,https://clinicaltrials.gov/study/NCT00369057,COMPLETED,OBSERVATIONAL
NCT02053298,Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients,https://clinicaltrials.gov/study/NCT02053298,UNKNOWN,INTERVENTIONAL
NCT01518244,Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America,https://clinicaltrials.gov/study/NCT01518244,COMPLETED,INTERVENTIONAL
NCT00691340,Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease,https://clinicaltrials.gov/study/NCT00691340,WITHDRAWN,OBSERVATIONAL
NCT04828057,Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness Tolerability and Safety in a Real World Setting,https://clinicaltrials.gov/study/NCT04828057,COMPLETED,OBSERVATIONAL
NCT01177098,Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01177098,COMPLETED,INTERVENTIONAL
NCT00629044,Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD,https://clinicaltrials.gov/study/NCT00629044,COMPLETED,INTERVENTIONAL
NCT00803998,Ocular Hypertension Treatment Study (OHTS),https://clinicaltrials.gov/study/NCT00803998,COMPLETED,OBSERVATIONAL
NCT04624698,iStent Inject New Enrollment Post-Approval Study,https://clinicaltrials.gov/study/NCT04624698,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02743780,A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma,https://clinicaltrials.gov/study/NCT02743780,COMPLETED,INTERVENTIONAL
NCT00683501,Safety Efficacy and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT00683501,COMPLETED,INTERVENTIONAL
NCT05271734,Evaluation of the Compatibility of Different Eye Lid Retractors to the Direct Selective Laser Trabeculoplasty (DSLT) Procedure,https://clinicaltrials.gov/study/NCT05271734,COMPLETED,INTERVENTIONAL
NCT02526680,Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients?,https://clinicaltrials.gov/study/NCT02526680,COMPLETED,INTERVENTIONAL
NCT02031380,iDropper Usability in Glaucoma,https://clinicaltrials.gov/study/NCT02031380,WITHDRAWN,INTERVENTIONAL
NCT01976624,Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea,https://clinicaltrials.gov/study/NCT01976624,COMPLETED,OBSERVATIONAL
NCT00824824,Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG),https://clinicaltrials.gov/study/NCT00824824,COMPLETED,INTERVENTIONAL
NCT04673201,Management Steroid Induced Glaucoma,https://clinicaltrials.gov/study/NCT04673201,UNKNOWN,INTERVENTIONAL
NCT00304824,Assessment of the Ability to Distinguish Odors in Glaucoma Patients,https://clinicaltrials.gov/study/NCT00304824,COMPLETED,OBSERVATIONAL
NCT02748824,Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal,https://clinicaltrials.gov/study/NCT02748824,COMPLETED,OBSERVATIONAL
NCT00595101,A Phase 2 Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.,https://clinicaltrials.gov/study/NCT00595101,COMPLETED,INTERVENTIONAL
NCT04770324,Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2),https://clinicaltrials.gov/study/NCT04770324,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01464424,Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®),https://clinicaltrials.gov/study/NCT01464424,COMPLETED,INTERVENTIONAL
NCT00911924,A Prospective Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00911924,COMPLETED,INTERVENTIONAL
NCT00515424,Tolerability Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT00515424,COMPLETED,INTERVENTIONAL
NCT01915680,Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions,https://clinicaltrials.gov/study/NCT01915680,COMPLETED,OBSERVATIONAL
NCT01209624,Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01209624,COMPLETED,OBSERVATIONAL
NCT01841580,Proteomic Profiles in Trabeculectomy Patients,https://clinicaltrials.gov/study/NCT01841580,COMPLETED,OBSERVATIONAL
NCT00379834,12-Month Stability of Diurnal IOP Control on Cosopt,https://clinicaltrials.gov/study/NCT00379834,COMPLETED,INTERVENTIONAL
NCT03868124,Clinical Study Comparing Two Models of a Travoprost Intraocular Implant,https://clinicaltrials.gov/study/NCT03868124,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00478036,Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells,https://clinicaltrials.gov/study/NCT00478036,TERMINATED,INTERVENTIONAL
NCT03164941,Effect of SLT Location on Treatment Outcomes,https://clinicaltrials.gov/study/NCT03164941,UNKNOWN,OBSERVATIONAL
NCT03274024,The Asia Primary Tube Versus Trab (TVT) Study,https://clinicaltrials.gov/study/NCT03274024,UNKNOWN,INTERVENTIONAL
NCT00471380,A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00471380,COMPLETED,INTERVENTIONAL
NCT02863224,Advanced Glycation End Products as a Biomarker for Accelerated Ageing,https://clinicaltrials.gov/study/NCT02863224,COMPLETED,OBSERVATIONAL
NCT03057301,Assessment of Home Tonometry in Glaucoma,https://clinicaltrials.gov/study/NCT03057301,UNKNOWN,OBSERVATIONAL
NCT02594280,Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.,https://clinicaltrials.gov/study/NCT02594280,UNKNOWN,OBSERVATIONAL
NCT00444080,Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT00444080,COMPLETED,INTERVENTIONAL
NCT01668524,ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects,https://clinicaltrials.gov/study/NCT01668524,COMPLETED,INTERVENTIONAL
NCT05456724,A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT05456724,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01857440,The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study,https://clinicaltrials.gov/study/NCT01857440,COMPLETED,OBSERVATIONAL
NCT05710198,Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05710198,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02666144,Comparison of Optic Nerve Head and Retinal Nerve Fiber Layer Parameters Derived From Two Different Methods of Scan Alignment,https://clinicaltrials.gov/study/NCT02666144,COMPLETED,OBSERVATIONAL
NCT05401357,Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.,https://clinicaltrials.gov/study/NCT05401357,RECRUITING,INTERVENTIONAL
NCT00892398,Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab,https://clinicaltrials.gov/study/NCT00892398,COMPLETED,INTERVENTIONAL
NCT00277498,A 12-week Randomized Double-masked Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma,https://clinicaltrials.gov/study/NCT00277498,COMPLETED,INTERVENTIONAL
NCT01379144,A Study Comparing The Efficacy Safety And Tolerability Of Latanoprost 75 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension,https://clinicaltrials.gov/study/NCT01379144,COMPLETED,INTERVENTIONAL
NCT01739244,Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT01739244,COMPLETED,INTERVENTIONAL
NCT00155857,The Genetic Study of Primary Angle-Closure Glaucoma,https://clinicaltrials.gov/study/NCT00155857,UNKNOWN,OBSERVATIONAL
NCT04758598,The Effects of DSLT and SLT on the Corneal Endothelium: A GLAUrious Trial Sub-Study,https://clinicaltrials.gov/study/NCT04758598,COMPLETED,INTERVENTIONAL
NCT00694876,Impact of Health Literacy and Other Factors on Glaucoma Patient Adherence in South India,https://clinicaltrials.gov/study/NCT00694876,COMPLETED,OBSERVATIONAL
NCT01391676,Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography,https://clinicaltrials.gov/study/NCT01391676,COMPLETED,OBSERVATIONAL
NCT05747781,STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient,https://clinicaltrials.gov/study/NCT05747781,NOT_YET_RECRUITING,INTERVENTIONAL
NCT01342081,DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%,https://clinicaltrials.gov/study/NCT01342081,COMPLETED,INTERVENTIONAL
NCT03901781,Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects,https://clinicaltrials.gov/study/NCT03901781,COMPLETED,INTERVENTIONAL
NCT00767481,1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT,https://clinicaltrials.gov/study/NCT00767481,TERMINATED,INTERVENTIONAL
NCT01022281,Early Diagnosis in Glaucoma With GDxVcc,https://clinicaltrials.gov/study/NCT01022281,COMPLETED,OBSERVATIONAL
NCT02548676,Optical Angiography in Glaucoma,https://clinicaltrials.gov/study/NCT02548676,COMPLETED,OBSERVATIONAL
NCT01097174,CyPass Clinical Experience Study,https://clinicaltrials.gov/study/NCT01097174,COMPLETED,OBSERVATIONAL
NCT01442896,STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk,https://clinicaltrials.gov/study/NCT01442896,COMPLETED,OBSERVATIONAL
NCT00382395,SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma,https://clinicaltrials.gov/study/NCT00382395,SUSPENDED,INTERVENTIONAL
NCT05325996,Evaluating Home Testing Devices for the Management of Glaucoma,https://clinicaltrials.gov/study/NCT05325996,RECRUITING,INTERVENTIONAL
NCT00329095,An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance,https://clinicaltrials.gov/study/NCT00329095,COMPLETED,INTERVENTIONAL
NCT00652496,Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00652496,COMPLETED,INTERVENTIONAL
NCT00219596,Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00219596,COMPLETED,INTERVENTIONAL
NCT02290795,Vitreopapillary Interface and Optic Disc Morphology,https://clinicaltrials.gov/study/NCT02290795,UNKNOWN,OBSERVATIONAL
NCT00742196,Retinal Nerve Fiber Layer Thickness Measurement on Parapapillary Atrophy With the Cirrus High-Definition (HD) Optical Coherence Tomography (OCT),https://clinicaltrials.gov/study/NCT00742196,UNKNOWN,OBSERVATIONAL
NCT00457795,24-hour IOP-lowering Effect of Brimonidine 0.1%,https://clinicaltrials.gov/study/NCT00457795,COMPLETED,INTERVENTIONAL
NCT01001195,Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution,https://clinicaltrials.gov/study/NCT01001195,COMPLETED,INTERVENTIONAL
NCT00757835,24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG,https://clinicaltrials.gov/study/NCT00757835,COMPLETED,INTERVENTIONAL
NCT02829996,Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG,https://clinicaltrials.gov/study/NCT02829996,COMPLETED,INTERVENTIONAL
NCT02754596,Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution,https://clinicaltrials.gov/study/NCT02754596,COMPLETED,INTERVENTIONAL
NCT03610295,Prophylactic Peripheral Iridectomy Prevents Aphakic Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT03610295,COMPLETED,INTERVENTIONAL
NCT05583474,OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects,https://clinicaltrials.gov/study/NCT05583474,RECRUITING,INTERVENTIONAL
NCT00597181,A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy,https://clinicaltrials.gov/study/NCT00597181,TERMINATED,INTERVENTIONAL
NCT00376974,The Effect of Education on Patient Compliance,https://clinicaltrials.gov/study/NCT00376974,UNKNOWN,INTERVENTIONAL
NCT04508881,Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve,https://clinicaltrials.gov/study/NCT04508881,COMPLETED,INTERVENTIONAL
NCT06000176,Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT06000176,COMPLETED,OBSERVATIONAL
NCT01707381,BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01707381,COMPLETED,INTERVENTIONAL
NCT05344274,Retinal Blood Flow and Autoregulation,https://clinicaltrials.gov/study/NCT05344274,RECRUITING,INTERVENTIONAL
NCT00273481,Cosopt Versus Xalacom,https://clinicaltrials.gov/study/NCT00273481,COMPLETED,INTERVENTIONAL
NCT01099774,Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01099774,COMPLETED,INTERVENTIONAL
NCT02292381,Blood Flow Regulation in Glaucoma,https://clinicaltrials.gov/study/NCT02292381,COMPLETED,OBSERVATIONAL
NCT02964676,Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Primary Angle Closure Glaucoma,https://clinicaltrials.gov/study/NCT02964676,UNKNOWN,INTERVENTIONAL
NCT04486976,Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software,https://clinicaltrials.gov/study/NCT04486976,COMPLETED,INTERVENTIONAL
NCT02558374,Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02558374,COMPLETED,INTERVENTIONAL
NCT02348476,A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02348476,COMPLETED,OBSERVATIONAL
NCT03159481,Glaucoma Management Optimism for African Americans Living With Glaucoma,https://clinicaltrials.gov/study/NCT03159481,COMPLETED,INTERVENTIONAL
NCT04007276,The Effect of Lumify™ on Ocular Redness Intraocular Pressure and Eyelid Position in Glaucoma Patients,https://clinicaltrials.gov/study/NCT04007276,NOT_YET_RECRUITING,INTERVENTIONAL
NCT00051181,A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma,https://clinicaltrials.gov/study/NCT00051181,COMPLETED,INTERVENTIONAL
NCT05773976,An Interventional Confirmative Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients.,https://clinicaltrials.gov/study/NCT05773976,RECRUITING,INTERVENTIONAL
NCT04360369,Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry,https://clinicaltrials.gov/study/NCT04360369,COMPLETED,INTERVENTIONAL
NCT00321035,Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital,https://clinicaltrials.gov/study/NCT00321035,COMPLETED,INTERVENTIONAL
NCT02272569,STARflo European Safety and Efficacy Study,https://clinicaltrials.gov/study/NCT02272569,COMPLETED,INTERVENTIONAL
NCT00874913,Study of Ocular Blood Flow in Patients With Glaucoma and/or Obstructive Sleep Apnea Syndrome (OSAS),https://clinicaltrials.gov/study/NCT00874913,UNKNOWN,INTERVENTIONAL
NCT03762369,A Clinical Study to Evaluate the Efficacy and Safety of CKD-351,https://clinicaltrials.gov/study/NCT03762369,UNKNOWN,INTERVENTIONAL
NCT01979913,An Open Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More,https://clinicaltrials.gov/study/NCT01979913,COMPLETED,INTERVENTIONAL
NCT03797469,Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin),https://clinicaltrials.gov/study/NCT03797469,COMPLETED,INTERVENTIONAL
NCT00579969,Comparison of Latanoprost Vs. Timolol,https://clinicaltrials.gov/study/NCT00579969,TERMINATED,INTERVENTIONAL
NCT03861169,Use of the OMNI® Surgical System in Combination With Cataract Extraction in Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03861169,RECRUITING,INTERVENTIONAL
NCT05089474,A First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the STREAMLINE SURGICAL SYSTEM in Patients With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05089474,COMPLETED,INTERVENTIONAL
NCT01315574,Effects of Anti-Glaucoma Medications on the Ocular Surface,https://clinicaltrials.gov/study/NCT01315574,TERMINATED,INTERVENTIONAL
NCT00324181,Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient,https://clinicaltrials.gov/study/NCT00324181,UNKNOWN,OBSERVATIONAL
NCT05299281,Micropulse Transscleral Diode Laser Cyclophotocoagulation (MP-TSCPC) as a Treatment Modality for Glaucoma Patients,https://clinicaltrials.gov/study/NCT05299281,COMPLETED,INTERVENTIONAL
NCT00822081,Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00822081,COMPLETED,INTERVENTIONAL
NCT00810381,Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects,https://clinicaltrials.gov/study/NCT00810381,COMPLETED,INTERVENTIONAL
NCT03106181,A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent,https://clinicaltrials.gov/study/NCT03106181,COMPLETED,INTERVENTIONAL
NCT03106181,A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent,https://clinicaltrials.gov/study/NCT03106181,COMPLETED,INTERVENTIONAL
NCT03904381,Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03904381,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02674074,Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients,https://clinicaltrials.gov/study/NCT02674074,COMPLETED,INTERVENTIONAL
NCT00441181,Effects of Travoprost on Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT00441181,WITHDRAWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02613013,Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure,https://clinicaltrials.gov/study/NCT02613013,UNKNOWN,INTERVENTIONAL
NCT02358369,Dose-Ranging Study of the Bimatoprost Ocular Insert,https://clinicaltrials.gov/study/NCT02358369,COMPLETED,INTERVENTIONAL
NCT00546013,Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome,https://clinicaltrials.gov/study/NCT00546013,TERMINATED,OBSERVATIONAL
NCT06176170,VividWhite Glaucoma Implant (VW-51) Pivotal Study,https://clinicaltrials.gov/study/NCT06176170,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02984813,Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy,https://clinicaltrials.gov/study/NCT02984813,TERMINATED,INTERVENTIONAL
NCT02271269,Study on Incentives for Glaucoma Medications Adherence,https://clinicaltrials.gov/study/NCT02271269,COMPLETED,INTERVENTIONAL
NCT05500469,Endothelial Cell Loss in Pseudophakic Patients Receiving a Paul Glaucoma Drainage Device With Its Tube Inserted in the Anterior Versus Posterior Chamber: a Randomized Controlled Trial,https://clinicaltrials.gov/study/NCT05500469,RECRUITING,INTERVENTIONAL
NCT02394613,A Phase I Clinical Trial of DARC,https://clinicaltrials.gov/study/NCT02394613,UNKNOWN,INTERVENTIONAL
NCT00947869,Contrast Sensitivity in Glaucoma,https://clinicaltrials.gov/study/NCT00947869,UNKNOWN,OBSERVATIONAL
NCT05521334,MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma.,https://clinicaltrials.gov/study/NCT05521334,COMPLETED,INTERVENTIONAL
NCT02622334,A Study to Investigate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).,https://clinicaltrials.gov/study/NCT02622334,COMPLETED,INTERVENTIONAL
NCT03193736,MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications,https://clinicaltrials.gov/study/NCT03193736,COMPLETED,INTERVENTIONAL
NCT00572936,Circadian Rhythms of Aqueous Humor Dynamics in Humans,https://clinicaltrials.gov/study/NCT00572936,COMPLETED,INTERVENTIONAL
NCT05850936,Effect of IOP Lowering on Progressive HM,https://clinicaltrials.gov/study/NCT05850936,RECRUITING,INTERVENTIONAL
NCT01789736,A Study Assessing PG286 Ophthalmic Solution 0.5% Compared to Its Individual Components for 28 Days,https://clinicaltrials.gov/study/NCT01789736,COMPLETED,INTERVENTIONAL
NCT02656836,Home Tonometry With the I-care Tonometer for Glaucoma,https://clinicaltrials.gov/study/NCT02656836,COMPLETED,OBSERVATIONAL
NCT03333096,Assessing Neurovisual Function in Patients With Cognitive Impairment,https://clinicaltrials.gov/study/NCT03333096,UNKNOWN,INTERVENTIONAL
NCT03333096,Assessing Neurovisual Function in Patients With Cognitive Impairment,https://clinicaltrials.gov/study/NCT03333096,UNKNOWN,INTERVENTIONAL
NCT05606796,Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients at Guinness Eye Centre Lagos.,https://clinicaltrials.gov/study/NCT05606796,RECRUITING,INTERVENTIONAL
NCT04972435,Effect of Multifocal Intraocular Lens on Contrast Sensitivity in Primary Angle-Closure Patients,https://clinicaltrials.gov/study/NCT04972435,COMPLETED,INTERVENTIONAL
NCT03304535,Social Worker in an Eye-Care Service,https://clinicaltrials.gov/study/NCT03304535,COMPLETED,OBSERVATIONAL
NCT00981435,Steroids After Laser Trabeculoplasty for Glaucoma,https://clinicaltrials.gov/study/NCT00981435,COMPLETED,INTERVENTIONAL
NCT00981435,Steroids After Laser Trabeculoplasty for Glaucoma,https://clinicaltrials.gov/study/NCT00981435,COMPLETED,INTERVENTIONAL
NCT03057496,Collision Warning Device for Blind and Visually Impaired,https://clinicaltrials.gov/study/NCT03057496,COMPLETED,INTERVENTIONAL
NCT02167035,Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID),https://clinicaltrials.gov/study/NCT02167035,COMPLETED,INTERVENTIONAL
NCT01370135,Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma,https://clinicaltrials.gov/study/NCT01370135,COMPLETED,INTERVENTIONAL
NCT03491735,Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018,https://clinicaltrials.gov/study/NCT03491735,UNKNOWN,OBSERVATIONAL
NCT00941096,Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination,https://clinicaltrials.gov/study/NCT00941096,COMPLETED,INTERVENTIONAL
NCT00424996,Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression,https://clinicaltrials.gov/study/NCT00424996,COMPLETED,OBSERVATIONAL
NCT00347035,INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE,https://clinicaltrials.gov/study/NCT00347035,TERMINATED,INTERVENTIONAL
NCT03961035,Comparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation,https://clinicaltrials.gov/study/NCT03961035,COMPLETED,OBSERVATIONAL
NCT01263535,Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients,https://clinicaltrials.gov/study/NCT01263535,TERMINATED,INTERVENTIONAL
NCT04620135,Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04620135,COMPLETED,INTERVENTIONAL
NCT03292796,RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery.,https://clinicaltrials.gov/study/NCT03292796,COMPLETED,INTERVENTIONAL
NCT01110499,Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01110499,COMPLETED,INTERVENTIONAL
NCT00794170,Interactive Study to Increase Glaucoma Adherence to Treatment,https://clinicaltrials.gov/study/NCT00794170,COMPLETED,INTERVENTIONAL
NCT01937299,Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®,https://clinicaltrials.gov/study/NCT01937299,COMPLETED,INTERVENTIONAL
NCT01145911,The Study of Ocular Hemodynamics With Glaucoma Progression,https://clinicaltrials.gov/study/NCT01145911,COMPLETED,OBSERVATIONAL
NCT01495299,24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery,https://clinicaltrials.gov/study/NCT01495299,WITHDRAWN,OBSERVATIONAL
NCT05278299,Asia Glaucoma Registry,https://clinicaltrials.gov/study/NCT05278299,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT00912470,Progressive Open Angle Glaucoma (OAG) and Ocular Blood Flow,https://clinicaltrials.gov/study/NCT00912470,WITHDRAWN,INTERVENTIONAL
NCT01128699,Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma,https://clinicaltrials.gov/study/NCT01128699,UNKNOWN,INTERVENTIONAL
NCT00917670,Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma,https://clinicaltrials.gov/study/NCT00917670,COMPLETED,OBSERVATIONAL
NCT00845299,Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00845299,COMPLETED,INTERVENTIONAL
NCT00705770,A Multi-Dose Study With a Treatment for Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT00705770,WITHDRAWN,INTERVENTIONAL
NCT01833741,A Study of LUMIGAN® RC in the Clinical Setting,https://clinicaltrials.gov/study/NCT01833741,COMPLETED,INTERVENTIONAL
NCT00153699,Relationship Between Topiramate Use and Ocular Angle Status,https://clinicaltrials.gov/study/NCT00153699,UNKNOWN,INTERVENTIONAL
NCT00760240,Ability of Patients With Low Vision to Properly Instill Eye Drops,https://clinicaltrials.gov/study/NCT00760240,COMPLETED,OBSERVATIONAL
NCT05411198,Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT05411198,RECRUITING,INTERVENTIONAL
NCT01915940,Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01915940,COMPLETED,INTERVENTIONAL
NCT04187157,Association Between Light Spectrum and Survival After Cataract Surgery,https://clinicaltrials.gov/study/NCT04187157,COMPLETED,OBSERVATIONAL
NCT00320957,Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital,https://clinicaltrials.gov/study/NCT00320957,COMPLETED,INTERVENTIONAL
NCT01085357,Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery,https://clinicaltrials.gov/study/NCT01085357,COMPLETED,INTERVENTIONAL
NCT01021657,Lipid Profile of Tenon's Capsule,https://clinicaltrials.gov/study/NCT01021657,COMPLETED,OBSERVATIONAL
NCT02547740,Macular Damage in Early Glaucoma and Progression,https://clinicaltrials.gov/study/NCT02547740,RECRUITING,OBSERVATIONAL
NCT04846140,Optimal Non-invasive Brain Stimulation for Peripheral Vision,https://clinicaltrials.gov/study/NCT04846140,RECRUITING,INTERVENTIONAL
NCT04846140,Optimal Non-invasive Brain Stimulation for Peripheral Vision,https://clinicaltrials.gov/study/NCT04846140,RECRUITING,INTERVENTIONAL
NCT04846140,Optimal Non-invasive Brain Stimulation for Peripheral Vision,https://clinicaltrials.gov/study/NCT04846140,RECRUITING,INTERVENTIONAL
NCT04846140,Optimal Non-invasive Brain Stimulation for Peripheral Vision,https://clinicaltrials.gov/study/NCT04846140,RECRUITING,INTERVENTIONAL
NCT04846140,Optimal Non-invasive Brain Stimulation for Peripheral Vision,https://clinicaltrials.gov/study/NCT04846140,RECRUITING,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02805257,Ahmed Glaucoma Valve Surgery With Mitomycin-C,https://clinicaltrials.gov/study/NCT02805257,COMPLETED,INTERVENTIONAL
NCT02330978,Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.,https://clinicaltrials.gov/study/NCT02330978,COMPLETED,INTERVENTIONAL
NCT00804323,PASCAL Trabeculoplasty,https://clinicaltrials.gov/study/NCT00804323,UNKNOWN,INTERVENTIONAL
NCT00435058,Visual Function Changes After Intraocular Pressure Reduction,https://clinicaltrials.gov/study/NCT00435058,COMPLETED,INTERVENTIONAL
NCT02295358,The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface,https://clinicaltrials.gov/study/NCT02295358,WITHDRAWN,OBSERVATIONAL
NCT01655758,24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension,https://clinicaltrials.gov/study/NCT01655758,COMPLETED,INTERVENTIONAL
NCT05874258,Effectiveness of NIBS and Perceptual Learning for Improving Visual Performance in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05874258,RECRUITING,INTERVENTIONAL
NCT05874258,Effectiveness of NIBS and Perceptual Learning for Improving Visual Performance in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05874258,RECRUITING,INTERVENTIONAL
NCT05874258,Effectiveness of NIBS and Perceptual Learning for Improving Visual Performance in Patients With Glaucoma,https://clinicaltrials.gov/study/NCT05874258,RECRUITING,INTERVENTIONAL
NCT05694858,Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting,https://clinicaltrials.gov/study/NCT05694858,RECRUITING,INTERVENTIONAL
NCT01254058,Saccadic Eye Movements Are Impaired In Glaucoma,https://clinicaltrials.gov/study/NCT01254058,UNKNOWN,OBSERVATIONAL
NCT01058278,Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01058278,COMPLETED,INTERVENTIONAL
NCT01058278,Impact Post-operative Treatment on Intraocular Pressure Post-SLT on Patients With Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT01058278,COMPLETED,INTERVENTIONAL
NCT00804102,Transcorneal Electrical Stimulation Therapy for Retinal Disease,https://clinicaltrials.gov/study/NCT00804102,COMPLETED,INTERVENTIONAL
NCT03461978,Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures,https://clinicaltrials.gov/study/NCT03461978,ENROLLING_BY_INVITATION,INTERVENTIONAL
NCT00508469,Adherence Assessment With Travalert Dosing Aid,https://clinicaltrials.gov/study/NCT00508469,COMPLETED,INTERVENTIONAL
NCT02727569,Quantification of Agreement and Variability of a Newly Developed Visual Field Algorithm With the Reference Standard,https://clinicaltrials.gov/study/NCT02727569,COMPLETED,OBSERVATIONAL
NCT03395535,Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT03395535,COMPLETED,INTERVENTIONAL
NCT04052269,Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS),https://clinicaltrials.gov/study/NCT04052269,SUSPENDED,INTERVENTIONAL
NCT03825380,Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients,https://clinicaltrials.gov/study/NCT03825380,COMPLETED,INTERVENTIONAL
NCT05666440,Visco-Circumferential-Suture-Trabeculotomy Versus Rigid Probe Viscotrabeculotomy in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT05666440,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04541524,Vienna Preserflo Cohort Study,https://clinicaltrials.gov/study/NCT04541524,UNKNOWN,OBSERVATIONAL
NCT04416724,Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma,https://clinicaltrials.gov/study/NCT04416724,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04416724,Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma,https://clinicaltrials.gov/study/NCT04416724,NOT_YET_RECRUITING,INTERVENTIONAL
NCT03752840,Village-Integrated Eye Worker Trial II,https://clinicaltrials.gov/study/NCT03752840,RECRUITING,INTERVENTIONAL
NCT03752840,Village-Integrated Eye Worker Trial II,https://clinicaltrials.gov/study/NCT03752840,RECRUITING,INTERVENTIONAL
NCT03752840,Village-Integrated Eye Worker Trial II,https://clinicaltrials.gov/study/NCT03752840,RECRUITING,INTERVENTIONAL
NCT01467440,Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines,https://clinicaltrials.gov/study/NCT01467440,UNKNOWN,OBSERVATIONAL
NCT01546740,Prevalence of Glaucoma in the Israeli Arab Population,https://clinicaltrials.gov/study/NCT01546740,UNKNOWN,OBSERVATIONAL
NCT00966940,Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00966940,COMPLETED,INTERVENTIONAL
NCT00331240,24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination,https://clinicaltrials.gov/study/NCT00331240,COMPLETED,INTERVENTIONAL
NCT01830140,A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01830140,COMPLETED,INTERVENTIONAL
NCT01241240,Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01241240,COMPLETED,INTERVENTIONAL
NCT04061044,A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert,https://clinicaltrials.gov/study/NCT04061044,COMPLETED,INTERVENTIONAL
NCT01476644,How Has Glaucoma Affected Your Quality of Life?,https://clinicaltrials.gov/study/NCT01476644,COMPLETED,INTERVENTIONAL
NCT03673644,Impact of Glaucoma and Visual Field Loss on Life Space,https://clinicaltrials.gov/study/NCT03673644,ACTIVE_NOT_RECRUITING,OBSERVATIONAL
NCT05932940,Incidence of Descemet Membrane Detachment Post GATT by AS OCT,https://clinicaltrials.gov/study/NCT05932940,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT01315340,Ocular Rigidity and Outflow Facility in Glaucomatous and Normal Eyes,https://clinicaltrials.gov/study/NCT01315340,RECRUITING,INTERVENTIONAL
NCT00656240,To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00656240,COMPLETED,INTERVENTIONAL
NCT00742378,Discriminating Ability of the Cirrus High Definition (HD) Optical Coherence Tomography (OCT) for Glaucoma,https://clinicaltrials.gov/study/NCT00742378,UNKNOWN,OBSERVATIONAL
NCT06119178,EX-PRESS® P-50 and EX-PRESS® P-200,https://clinicaltrials.gov/study/NCT06119178,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT00864578,Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy,https://clinicaltrials.gov/study/NCT00864578,WITHDRAWN,OBSERVATIONAL
NCT01779778,Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure,https://clinicaltrials.gov/study/NCT01779778,COMPLETED,OBSERVATIONAL
NCT01223378,Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01223378,COMPLETED,INTERVENTIONAL
NCT02059278,Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02059278,COMPLETED,INTERVENTIONAL
NCT02966678,Incidence of Dyschromatopsia in Glaucoma,https://clinicaltrials.gov/study/NCT02966678,COMPLETED,OBSERVATIONAL
NCT03365778,Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment,https://clinicaltrials.gov/study/NCT03365778,COMPLETED,INTERVENTIONAL
NCT02312544,Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT02312544,COMPLETED,INTERVENTIONAL
NCT03330574,To Study the Function of the Retina in Glaucoma Patients Using PERG,https://clinicaltrials.gov/study/NCT03330574,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT04360174,CLN-0045: Safety and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04360174,COMPLETED,INTERVENTIONAL
NCT01263444,Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy,https://clinicaltrials.gov/study/NCT01263444,COMPLETED,INTERVENTIONAL
NCT01293474,Choroidal Thickness in Glaucoma Patients and Healthy Controls,https://clinicaltrials.gov/study/NCT01293474,UNKNOWN,OBSERVATIONAL
NCT00347841,Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost,https://clinicaltrials.gov/study/NCT00347841,COMPLETED,INTERVENTIONAL
NCT00440141,Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%,https://clinicaltrials.gov/study/NCT00440141,COMPLETED,INTERVENTIONAL
NCT00986141,Effects of Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00986141,TERMINATED,OBSERVATIONAL
NCT03011541,Stem Cell Ophthalmology Treatment Study II,https://clinicaltrials.gov/study/NCT03011541,RECRUITING,INTERVENTIONAL
NCT00047541,Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70,https://clinicaltrials.gov/study/NCT00047541,COMPLETED,INTERVENTIONAL
NCT00759941,A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin,https://clinicaltrials.gov/study/NCT00759941,COMPLETED,INTERVENTIONAL
NCT01361841,Effects of Latanoprost Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma,https://clinicaltrials.gov/study/NCT01361841,UNKNOWN,INTERVENTIONAL
NCT02955641,Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy,https://clinicaltrials.gov/study/NCT02955641,UNKNOWN,INTERVENTIONAL
NCT00430274,Photographic Imaging of the Retina and Optic Nerve Head of Glaucoma Patients and Normal Controls,https://clinicaltrials.gov/study/NCT00430274,COMPLETED,OBSERVATIONAL
NCT03684174,Non-Contact Air Tonometry (Topcon CT-1®) Versus Goldmann,https://clinicaltrials.gov/study/NCT03684174,COMPLETED,OBSERVATIONAL
NCT01494974,Comparison of the Ahmed Glaucoma Valve FP7 and FP8 in Pediatric Glaucoma,https://clinicaltrials.gov/study/NCT01494974,UNKNOWN,INTERVENTIONAL
NCT00966576,Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy,https://clinicaltrials.gov/study/NCT00966576,COMPLETED,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT04698876,Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation,https://clinicaltrials.gov/study/NCT04698876,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT02945176,Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation,https://clinicaltrials.gov/study/NCT02945176,COMPLETED,INTERVENTIONAL
NCT04149899,Safety and IOP-Lowering Effects of WB007,https://clinicaltrials.gov/study/NCT04149899,COMPLETED,INTERVENTIONAL
NCT05394324,A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products,https://clinicaltrials.gov/study/NCT05394324,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT03695224,Matching Glaucoma With Impaired Cognition,https://clinicaltrials.gov/study/NCT03695224,RECRUITING,OBSERVATIONAL
NCT02152774,A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT02152774,UNKNOWN,INTERVENTIONAL
NCT04500574,Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT04500574,RECRUITING,INTERVENTIONAL
NCT01170481,Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema,https://clinicaltrials.gov/study/NCT01170481,COMPLETED,OBSERVATIONAL
NCT01743781,Uptake of Comprehensive Eye Examination Trial,https://clinicaltrials.gov/study/NCT01743781,COMPLETED,INTERVENTIONAL
NCT01743781,Uptake of Comprehensive Eye Examination Trial,https://clinicaltrials.gov/study/NCT01743781,COMPLETED,INTERVENTIONAL
NCT01254370,Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease,https://clinicaltrials.gov/study/NCT01254370,COMPLETED,INTERVENTIONAL
NCT01228799,Trabeculectomy Versus Canaloplasty,https://clinicaltrials.gov/study/NCT01228799,COMPLETED,INTERVENTIONAL
NCT03875911,Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy,https://clinicaltrials.gov/study/NCT03875911,TERMINATED,INTERVENTIONAL
NCT01912599,Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma,https://clinicaltrials.gov/study/NCT01912599,COMPLETED,INTERVENTIONAL
NCT01474070,GAT-DCT-Discordance Due to Corneal Properties,https://clinicaltrials.gov/study/NCT01474070,COMPLETED,OBSERVATIONAL
NCT02638181,The Expression of Matrix Metalloproteinase 13 Tissue Inhibitor of Metalloproteinases 3 and Calcium-sensing Receptor in Human Trabecular Meshwork,https://clinicaltrials.gov/study/NCT02638181,COMPLETED,INTERVENTIONAL
NCT04620876,Bimodal and Coaxial High Resolution Ophtalmic Imaging,https://clinicaltrials.gov/study/NCT04620876,RECRUITING,INTERVENTIONAL
NCT03480711,Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03480711,COMPLETED,INTERVENTIONAL
NCT05319470,Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives,https://clinicaltrials.gov/study/NCT05319470,COMPLETED,OBSERVATIONAL
NCT02754570,The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure,https://clinicaltrials.gov/study/NCT02754570,COMPLETED,INTERVENTIONAL
NCT03257813,Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK),https://clinicaltrials.gov/study/NCT03257813,COMPLETED,INTERVENTIONAL
NCT01726569,Post-operative Satisfaction With Glaucoma Surgery Trial,https://clinicaltrials.gov/study/NCT01726569,WITHDRAWN,INTERVENTIONAL
NCT00643669,24 Hour IOP Lowering Efficacy of AL-3789,https://clinicaltrials.gov/study/NCT00643669,COMPLETED,INTERVENTIONAL
NCT03807869,Reduction of Intraocular Pressure After I-stent By-pass Implantation in Eyes With Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT03807869,COMPLETED,INTERVENTIONAL
NCT01426113,A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma,https://clinicaltrials.gov/study/NCT01426113,TERMINATED,INTERVENTIONAL
NCT03697811,DE-117 Spectrum 5 Study,https://clinicaltrials.gov/study/NCT03697811,COMPLETED,INTERVENTIONAL
NCT03127813,PAIR Study-PAP And IOP Relationship: Study 1,https://clinicaltrials.gov/study/NCT03127813,TERMINATED,INTERVENTIONAL
NCT00327613,Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma,https://clinicaltrials.gov/study/NCT00327613,COMPLETED,OBSERVATIONAL
NCT01336569,Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol,https://clinicaltrials.gov/study/NCT01336569,COMPLETED,INTERVENTIONAL
NCT04430296,Cyclophotocoagulation in Primary Open Angle Glaucoma,https://clinicaltrials.gov/study/NCT04430296,UNKNOWN,INTERVENTIONAL
NCT03480295,Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%,https://clinicaltrials.gov/study/NCT03480295,COMPLETED,INTERVENTIONAL
NCT00145535,SOLX Titanium Sapphire Laser for Trabeculoplasty,https://clinicaltrials.gov/study/NCT00145535,COMPLETED,INTERVENTIONAL
NCT01641835,Optical Coherence Tomography (OCT) Data Collection Study,https://clinicaltrials.gov/study/NCT01641835,COMPLETED,OBSERVATIONAL
NCT01474135,AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure,https://clinicaltrials.gov/study/NCT01474135,COMPLETED,INTERVENTIONAL
NCT04412096,Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance,https://clinicaltrials.gov/study/NCT04412096,RECRUITING,INTERVENTIONAL
NCT04412096,Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance,https://clinicaltrials.gov/study/NCT04412096,RECRUITING,INTERVENTIONAL
NCT04412096,Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance,https://clinicaltrials.gov/study/NCT04412096,RECRUITING,INTERVENTIONAL
NCT01766596,Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Montrachet Cohort),https://clinicaltrials.gov/study/NCT01766596,UNKNOWN,INTERVENTIONAL
NCT00825396,An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension,https://clinicaltrials.gov/study/NCT00825396,COMPLETED,INTERVENTIONAL
NCT01503996,Drinking Habits of Glaucoma Patients and Age Matched Controls,https://clinicaltrials.gov/study/NCT01503996,COMPLETED,OBSERVATIONAL
NCT01298635,Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG),https://clinicaltrials.gov/study/NCT01298635,COMPLETED,INTERVENTIONAL
NCT01298635,Comparison of Phacotrabeculectomy and Trabeculectomy in the Treatment of Primary Angle-closure Glaucoma (PACG),https://clinicaltrials.gov/study/NCT01298635,COMPLETED,INTERVENTIONAL
NCT05277870,Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension,https://clinicaltrials.gov/study/NCT05277870,RECRUITING,INTERVENTIONAL
NCT05938699,Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution,https://clinicaltrials.gov/study/NCT05938699,NOT_YET_RECRUITING,INTERVENTIONAL
NCT04381611,INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register,https://clinicaltrials.gov/study/NCT04381611,ENROLLING_BY_INVITATION,OBSERVATIONAL
NCT05309811,Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT05309811,NOT_YET_RECRUITING,INTERVENTIONAL
NCT02520674,Glaucoma Screening With Smartphone Ophthalmology,https://clinicaltrials.gov/study/NCT02520674,COMPLETED,INTERVENTIONAL
NCT00000144,Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS),https://clinicaltrials.gov/study/NCT00000144,COMPLETED,INTERVENTIONAL
NCT01489670,Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01489670,COMPLETED,OBSERVATIONAL
NCT03331770,Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost,https://clinicaltrials.gov/study/NCT03331770,COMPLETED,INTERVENTIONAL
NCT01528111,Study to Evaluate the Safety Tolerability and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT01528111,COMPLETED,INTERVENTIONAL
NCT03624699,Investigation of the iStent Inject® Devices in Open-Angle Glaucoma,https://clinicaltrials.gov/study/NCT03624699,COMPLETED,INTERVENTIONAL
NCT01314170,Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.,https://clinicaltrials.gov/study/NCT01314170,UNKNOWN,INTERVENTIONAL
NCT02385370,Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method,https://clinicaltrials.gov/study/NCT02385370,UNKNOWN,INTERVENTIONAL
NCT00967811,A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG,https://clinicaltrials.gov/study/NCT00967811,COMPLETED,INTERVENTIONAL
NCT03639870,Investigation of the Glaukos® Trabecular Micro-Bypass System Model iS3 in Subjects With Refractory Glaucoma,https://clinicaltrials.gov/study/NCT03639870,UNKNOWN,INTERVENTIONAL
NCT02347670,Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population,https://clinicaltrials.gov/study/NCT02347670,COMPLETED,INTERVENTIONAL
NCT04654611,Tafluprost Preservative Free Switch Study,https://clinicaltrials.gov/study/NCT04654611,COMPLETED,INTERVENTIONAL
NCT00440011,Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%,https://clinicaltrials.gov/study/NCT00440011,COMPLETED,INTERVENTIONAL
NCT02105311,Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure,https://clinicaltrials.gov/study/NCT02105311,COMPLETED,INTERVENTIONAL
NCT04334499,Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma.,https://clinicaltrials.gov/study/NCT04334499,WITHDRAWN,OBSERVATIONAL
NCT01327599,Efficacy of Changing to DUOTRAV® From Prior Therapy,https://clinicaltrials.gov/study/NCT01327599,COMPLETED,INTERVENTIONAL
NCT01594970,A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH),https://clinicaltrials.gov/study/NCT01594970,COMPLETED,INTERVENTIONAL
NCT02774811,Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication,https://clinicaltrials.gov/study/NCT02774811,TERMINATED,INTERVENTIONAL
NCT02774811,Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication,https://clinicaltrials.gov/study/NCT02774811,TERMINATED,INTERVENTIONAL
NCT02982499,Biomechanics of Optic Neuropathy,https://clinicaltrials.gov/study/NCT02982499,TERMINATED,OBSERVATIONAL
NCT05283395,Rocklatan® Evaluation,https://clinicaltrials.gov/study/NCT05283395,COMPLETED,INTERVENTIONAL
NCT05135195,A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training,https://clinicaltrials.gov/study/NCT05135195,COMPLETED,INTERVENTIONAL
NCT02466399,POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT02466399,COMPLETED,INTERVENTIONAL
NCT01540370,Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT),https://clinicaltrials.gov/study/NCT01540370,COMPLETED,OBSERVATIONAL
NCT05960513,Impact of Breathing Exercises and Meditation on Improving Quality of Life in Glaucoma Patients,https://clinicaltrials.gov/study/NCT05960513,NOT_YET_RECRUITING,INTERVENTIONAL
NCT05075369,Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT05075369,UNKNOWN,INTERVENTIONAL
NCT03172299,Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma,https://clinicaltrials.gov/study/NCT03172299,RECRUITING,INTERVENTIONAL
NCT04133311,A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT04133311,ACTIVE_NOT_RECRUITING,INTERVENTIONAL
NCT00567411,Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty,https://clinicaltrials.gov/study/NCT00567411,UNKNOWN,INTERVENTIONAL
NCT05904613,Evaluation of the Impact of the XEN® Implant on Endothelial Cell Density 3 Years After Surgery,https://clinicaltrials.gov/study/NCT05904613,COMPLETED,OBSERVATIONAL
NCT01621841,Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI,https://clinicaltrials.gov/study/NCT01621841,COMPLETED,OBSERVATIONAL
NCT01995136,Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma,https://clinicaltrials.gov/study/NCT01995136,COMPLETED,INTERVENTIONAL
NCT00440336,Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.,https://clinicaltrials.gov/study/NCT00440336,UNKNOWN,INTERVENTIONAL
NCT01415401,Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada,https://clinicaltrials.gov/study/NCT01415401,COMPLETED,INTERVENTIONAL
NCT03159780,Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma,https://clinicaltrials.gov/study/NCT03159780,COMPLETED,OBSERVATIONAL
NCT04572880,Evaluation of Minimal Invasive Glaucoma Surgery,https://clinicaltrials.gov/study/NCT04572880,RECRUITING,INTERVENTIONAL
NCT04727411,Analysis of Conjunctival Changes as Indicators for Ab-interno Gelatin Microstent Implantation Surgery Outcomes,https://clinicaltrials.gov/study/NCT04727411,RECRUITING,INTERVENTIONAL
NCT00863811,Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops,https://clinicaltrials.gov/study/NCT00863811,WITHDRAWN,OBSERVATIONAL
NCT02642211,IOP Changes Associated With SICS and Phako,https://clinicaltrials.gov/study/NCT02642211,COMPLETED,INTERVENTIONAL
NCT05495269,Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP),https://clinicaltrials.gov/study/NCT05495269,COMPLETED,INTERVENTIONAL
NCT00554411,Assessing Ocular Surface Changes After Changing Glaucoma Medications,https://clinicaltrials.gov/study/NCT00554411,COMPLETED,OBSERVATIONAL
NCT02067013,Analysis of Aqueous and Vitreous Humor,https://clinicaltrials.gov/study/NCT02067013,UNKNOWN,INTERVENTIONAL
NCT00761995,Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension,https://clinicaltrials.gov/study/NCT00761995,COMPLETED,INTERVENTIONAL
NCT05024695,Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.,https://clinicaltrials.gov/study/NCT05024695,RECRUITING,INTERVENTIONAL
NCT02867995,Efficacy of Glaucoma Drop Aids in Medication Compliance in the Patient Population at Boston Medical Center,https://clinicaltrials.gov/study/NCT02867995,COMPLETED,INTERVENTIONAL
NCT04972695,Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images,https://clinicaltrials.gov/study/NCT04972695,COMPLETED,OBSERVATIONAL
NCT00279695,Ultrasonic Evaluation of Ocular Tissues,https://clinicaltrials.gov/study/NCT00279695,UNKNOWN,OBSERVATIONAL
NCT00328835,Optic Nerve Compliance Study,https://clinicaltrials.gov/study/NCT00328835,COMPLETED,INTERVENTIONAL
NCT00621335,A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt,https://clinicaltrials.gov/study/NCT00621335,COMPLETED,OBSERVATIONAL
NCT05786196,Multicenter Glaucoma Study Investigating Standalone Canaloplasty,https://clinicaltrials.gov/study/NCT05786196,RECRUITING,INTERVENTIONAL
NCT04427995,Standalone OMNI Surgical System for Open-angle Glaucoma,https://clinicaltrials.gov/study/NCT04427995,TERMINATED,OBSERVATIONAL
NCT02807935,The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure,https://clinicaltrials.gov/study/NCT02807935,UNKNOWN,INTERVENTIONAL
NCT04658095,Study of OMNI Surgical System and iStent for Eyes With OAG (Trident),https://clinicaltrials.gov/study/NCT04658095,TERMINATED,INTERVENTIONAL